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Abstract 
The D-mandelate dehydrogenase from Rho dotorula graminis is an 
NAD-dependent 2-hydroxyacid dehydrogenase which catalyses the reversible 
D-mandelate -* phenylglyoxylate reaction (Baker and Fewson, 1989). The gene 
encoding the enzyme has been cloned and sequenced and the enzyme expressed in E. 
coli (Iffias, 1997). The recombinant form of the D-mandelate dehydrogenase from R. 
graminis was obtained in very small quantities and did not purify as the native form of 
the enzyme. Several alternative expression systems were created and protein was 
produced at similar levels to the native form. A purification aid (in the form of a 
Histidine-tag) was engineered onto both the N-terminus and the C-terminus of the 
protein. Expression levels were maintained close to those from R. graminis, but the 
purification system failed to produce pure protein. 
L-mandelate dehydrogenase from R. graminis (a flavocytochrome b2) 
was cloned and overexpressed in high yield in E. coil. The flavin-binding domain of 
the enzyme was independently expressed to high levels (Iffias et al., 1998). The 
steady-state turnover of both enzymes were measured. Within error, the kinetic 
parameters, ktat and Km, were identical with the artificial electron acceptor, 
ferricyanide (L-mandelate dehydrogenase: kcat = 550 ± 25s'; K. = 0.35 ± 0.02mM. 
L-mandelate dehydrogenase flavin-binding domain: kcat = 500 ± 50s'; K. = 0.33 ± 
0.05mM). With the physiological electron acceptor, cytochrome c, the intact enzyme 
gave a steady-state turnover rate of 225 ± 1 5s. The flavin-binding domain showed 
no activity. The pre-steady-state flavin reduction rate for L-mandelate dehydrogenase 
(280 ± 20s) was somewhat lower than for the flavin-binding domain (450 ± 30s'), 
presumably due to rapid reoxidation of flavin in the former case. Kinetic isotope effect 
experiments with [2- 2H]-mandelate suggest that C2—H bond cleavage contributes 
significantly to rate-limitation. 
A substrate specificity study of L-mandelate dehydrogenase flavin-binding 
domain revealed that 4-hydroxy-L-mandelate is the preferred substrate, and not, as the 
name suggests, mandelate. Since 4-hydroxymandelate is more prevalent than 
mandelate in nature, it is proposed that this is in fact, the physiological substrate. A 
Iv 
Hammett-Taft analysis on the pre-steady-state FMN reduction rates with a variety of 
substituted mandelates suggests that the inductive and resonance effects of the ring 
substituents on the transition state are almost equivalent. This is consistent with a 
planar transition state. 
L-mandelate dehydrogenase flavin-binding domain showed the ability to 
catalyse the oxidation of aliphatic long-chain 2-hydroxyacids. These acids are turned 
over at a rate considerably lower than the aromatic, substituted mandelates. A single 
branching of the side-chain appears not to hinder reaction, with substrate length more 
important than bulk. Hexahydromandelate (where the phenyl ring of mandelate is 
replaced by cyclohexane) could be used as a substrate by L-mandelate dehydrogenase 
flavin-binding domain, but 3,3-dimethyl-2-hydroxybutyrate (a tertiary butyl group 
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DNA deoxyribonucleic acid 
DTT dithiothreitol 
EDTA ethylenediaminetetraacetic acid 
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The work presented in this thesis is primarily concerned with the mandelate 
dehydrogenases from Rhodotorula graminis. This red yeast produces an enzyme for 
each of the enantjomerjc forms of mandelate: D-mandelate and L-mandelate. This 
chapter covers the main areas of background to the project, including an introduction 
to substrate, the two proteins and, where it proves useful, some similar proteins. 
1.1 Mandelic acid 
Mandelic acid (2-hydroxy-2-phenylacetic acid) is a chiral compound and as 
such can exist in two enantiomeric forms (Figure 1.1). These forms differ in 
stereospecificity at the chiral centre at the C-2 position. 
HO> HH 




Figure 1.1. The two enanhiomeric forms of mandelic acid 
We can see that mandelic acids belong to an important family of molecules: that of the 
2-hydroxyacids (Figure 1.2). There are many different and important compounds in 
this family including lactic acid (R = methyl), glyceric acid (R = hydroxymethyl) and 
2-hydroxyisocaproic acid (R = isobutyl). 
HO> OH 
Figure 1.2. General structure for the family of 2-hydroxyacids 
2 
Introduction 
While mandelic acid, and aromatic compounds in general, have particular interest to 
man (this will be discussed in more detail later), it is also of importance in nature. The 
aromatic ring is very stable and fairly chemically inert and is therefore difficult to 
break down. It is important that nature can find a method of releasing the large 
quantities of carbon locked into this stable system. 
1.2 Nature's Mandelic Acid 
Since the pKa for this compound is 3.37, in most natural, physiological 
conditions, mandelic acid actually exists as its carboxylate form: the mandelate ion 
(Figure 1.3). Mandelate has been found in the tissues of various plants e.g. in wheat 
leaves and in grapes (Fewson, 1988). However, the largest percentage of mandelate in 
the natural environment is derived from animal urine. 
H 
OH 
Figure 1.3. The physiological state of mandelic acid - the mandelate ion 
The normal concentration of mandelate in human urine is 1-15 .tM. Mandelate is 
formed within the body as a breakdown product of naturally occurring compounds 
(Luthe et al., 1983). Elevated levels may be found in the urine of animals after 
industrial or domestic exposure to styrene (Chakrabarti,, 1979) or after doping with 
the stimulant pemoline (Fewson 1988). Administration of certain pharmaceutical 
formulations (those of which mandelic acid is a component) e.g. 
3,3,5-trimethylcyclohexanylmandelate (Middleton et al., 1983), a vasoactive drug, 
also results in raised levels of mandelate in the urine. 
Despite these methods of mandelate entering the environment, it has never 
been shown to be a particularly prevalent compound. This may seem somewhat 
strange since many organisms e.g. certain strains of Acinetobacter calcoaceticus, 
3 
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Pseudomonas purida, Aspergillus niger and Rhodotorula graminis have been isolated 
that are able to utilise mandelate as a carbon source (Fewson, 1988). Many of the 
mandelate utilising enzymes can also use ring-substituted analogues of mandelate. An 
example of these is the mandelate dehydrogenase from A. calcoaceticus (Kennedy and 
Fewson, 1968). This opens up a whole new range of substrates since 
4-hydroxy-3 -methoxymandelate (vanillylmandelate), 3 ,4-dihydroxymandelate and 
4-hydroxymandelate, for example, are metabolites of adrenaline, noradrenaline and 
octopamine and are therefore excreted continuously to the environment in more 
substantial amounts than mandelate itself (Goodall and Alton, 1969). 
1.3 Rhodotorula graminis 
Rhodotorula graminis was first isolated in New Zealand on the leaves of 
pasture grasses (Di Menna, 1958). Since then, this yeast has been found in many 
places all round the world for example, trees in Argentina (Spencer, 1995) and soil in 
Slovakia (Vadkertiova and Slavikova, 1994). In 1984, Durham et al. isolated a strain 
of R. graminis (KGX 39) that had the ability to use mandelate as a sole source of 
carbon and energy. This is not a characteristic common to all members of the 
Rhodotorula genus. R. graminis strain KGX39 does not form true mycelia or 
baffistospores, grows on vitamin-free medium and can utilise nitrate or nitrite as a 
source of nitrogen. 
1.4 Mandelate Dehydrogenases 
It has been widely reported in the literature that there are several different 
types of mandelate dehydrogenase depending on the source organism and the 
enantiomer being oxidised. All of these enzymes can be placed into one of two major 
groups (Table 1.1): the nicotinamide adenine dinucleotide (phosphate) 
(NAD(P))-independent enzymes and the NAD(P)-dependent enzymes (Fewson et al., 
1993). All known mandelate dehydrogenases catalyse stereospecific reactions. The 
4 
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bacterial mandelate dehydrogenases previously studied have been found to be 
NAD(P)-independent integral bound membrane proteins which require flavin as a 
Table 1.1. Cofactor dependency of several 2-hydroxyacid dehydrogenases 
NAD(P)-dependent 
D-(-)-mandelate dehydrogenase 	 R. graminis 
D-(-)-mandelate dehydrogenase 	 Lactobacillus curvatus 
D-(-)-hydroxyisocapro ate (mandelate) dehydrogenase Streptococcus faecalis 
D-(-)-hydroxyisocaproate dehydrogenase 	 Lactobacillus casei 
NAD(P)-independent 
FMN-dependent 


































prosthetic group (e.g. both the D- and L-mandelate dehydrogenases from P. putida 
(Hegeman, 1966)). This group may be further subdivided into those that contain FAD 
(flavin adenine dinucleotide) and those that contain FMN (flavin mononucleotide). 
There has been shown to be some distinct similarities between bacterial membrane 
bound mandelate dehydrogenases and certain bacterial membrane bound 
NAD(P)-independent lactate dehydrogenases. For example, both the D-mandelate 
dehydrogenase and the D-lactate dehydrogenase from A. calcoaceticus (Allison et al., 
1985) and D-lactate dehydrogenase from Escherichia coli (Futai, 1973) contain FAD 
as a non-covalently bound cofactor and have a monomeric molecular weights of 
around 60 kDa. The L-mandelate dehydrogenases and L-lactate dehydrogenases from 
A. calcoaceticus, E. coli and P. putida all contain FMN and have monomeric 
molecular weights of about 40 kDa (Tsou et al., 1990; Fewson, 1992). The 
NAD(P)-independent enzymes may or may not contain a haem prosthetic group. The 
second group, the soluble NAD(P)-dependent enzymes have no flavin or haem 
cofactor. There are many example of such NAD(P)-dependent 2-hydroxyacid 
dehydrogenase. These include the D-hydroxyisocaproate (mandelate) dehydrogenase 
of Streptococcus faecalis (Lerch et al., 1989), the D-hydroxyisocaproate 
dehydrogenase from Lactobacillus casei (Taguchi and Ohta, 1991) and D-mandelate 
dehydrogenase from R. graminis (Baker and Fewson, 1989). These enzymes show 
distinct similarities to each other and to other D-2-hydroxyacid dehydrogenases. Each 
enzyme exists as a dimer and has a native molecular mass of approximately 80 kDa. 
The two groups of 2-hydroxyacid dehydrogenases shown in Table 1.1 are very 
different. However, within each group there are distinct similarities between enzymes, 
for example, L-mandelate dehydrogenase from A. calcoaceticus is very similar to the 
L-lactate dehydrogenase from the same organism (Hoey et al., 1987). They both 
contain FMN, no haem and have very similar subunit mass (44 kfla). The 
D-enantiomer specific enzymes are very similar, both containing FAD and mass of 60 
kDa. Clearly, comparing the properties of the four enzymes leads to the conclusion 
that while the D-enantiomer specific enzymes resemble one another, they do not 
resemble the L-enantiomer specific enzymes. The likelihood is that each pair of 
enzymes may have had a common evolutionary origin and at a later time diverged to 
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catalyse reaction of different 2-hydroxyacid substrates. It is unclear why bacterial 
mandelate and lactate dehydrogenases should have only one, flavin containing, 
domain while yeast mandelate and lactate dehydrogenases should have both flavin and 
haem domains. 
1.5 Mandelate Degradation 
For many micro-organisms it is vital that they are able to degrade aromatic 
rings. The aromatic ring of mandelate is not degraded directly, but is first converted to 
catechol or protocatechuate (Figure 1.4). In certain situations, the first stage in 
mandelate metabolism is a racemisation step. P. putida contains both a mandelate 
racemase and an L-mandelate dehydrogenase, but no D-mandelate dehydrogenase 
(Hegeman, 1966; Tsou et al., 1990; Hegeman et al., 1970) and thus if the organism is 
to utilise D-mandelate, it must first convert it to L-mandelate. Many organisms, 
however, can utilise both enantiomers of mandelate, since they possess the 
dehydrogenase for each enantiomer. The product of this dehydrogenation, 
phenyiglyoxylate, then undergoes decarboxylation to benzaldehyde by a 
phenyiglyoxylate decarboxylase. Benzaldehyde is then oxidised to benzoic acid. At 
this stage in the metabolism of mandelate, the pathway splits with some organisms, 
e.g. A. calcoaceticus using a benzoate- 1 ,2-oxygenase to di-hydroxylate the ring to 
3,5-cyclohexadiene-1,2-diol-carboxylic acid. This is converted to catechol by a 
3,5-cyclohexadiene-1,2-diol-carboxylate dehydrogenase. In other organisms, e.g. R. 
graminis, A. niger and Neurospora crassa (Durham, 1984; Jamaluddin et al., 1970; 
Ramakrishna et al., 1977) benzoic acid is hydroxylated in the para-position and then 
hydroxylated in the meta-position to give protocatechuate. It is accepted that the 
dihydroxylated compounds are required for further enzymatic degradation of the 
benzene ring (Gibson, 1968). 
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Figure 1.4. Pathway for metabolism of mandelate. The enzymes involved in the pathway 
are shoiwz: a, mandelate racemase; b', L-mandelate dehydrogenase; b", D-mandelate 
dehydrogenase; c, phenyiglyoxylate decarboxylase; d, benzaldehyde dehydrogenase; e, 
L-mandelate 4- hydrarylase; f L-4-hydroxymandelate dehydrogenase; g, 
L-4-hydroxymandelate oxidase; h, benzoate 4-hydroxylase; i benzoate 1, 2-oxygenase; j, 
3, 5-cyclohexadiene-1 , 2-1-carboxylate dehydrogenase; i+j, 'benzoate oxidase'; k, 
4-hydroxybenzoate 3-hydrolase (Fewson, 1988). 
Organism 	 Enzymes used in mandelate 
metabolism 
Acinetobacter calcoaceticus b' (b'), c, d, i, j 
Pseudomonasputida (a), b', c, d, i j 
Pseudomonas convexa e, g, d, k 
Rhizobium leguminosarum b' (f), c, d, i, j 
Aspergillus niger b' (b'), c, d, Ii, k 
Neurospora crassa b' (b'), c, d, Ii, k 
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1.6 The 3-ketoadipate pathway 
It is at the level of catechol or protocatechuate that the aromatic ring is 
broken. This pathway for aromatic dissimilation is similar though not identical in 
bacterial and eukaryotic systems (Figure 1.5) (Ornston and Stanier, 1964; Harwood 
and Parales, 1996). It is generally accepted that most bacteria and eukaryotes use both 
the catechol and protocatechuate routes to -ketoadipate. This, however, is not 
always the case. The yeast Rhodotorula mucilaginosa and the fungus N. crassa are 
unable to use the catechol pathway (Cain, 1969; Cain et al., 1968)). There are two 
main differences between the bacterial pathway and the eukaryotic pathway. In 
bacteria, -carboxymuconate is converted to 7-carboxymuconolactone. This is 
converted to -ketoadipate enol-lactone where the catechol and protocatechuate 
branches converge. In eukaryotes, the 3-carboxymuconate is converted to 13-
carboxymuconolactone. This is then converted to 13-ketoadipate. It is at this stage that 
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1.7 Mandelate Dehydrogenases from Rhodotorula graminis 
Initial work on R. graminis showed that the yeast was capable of growing on 
various aromatic or substituted aromatic compounds by oxidation to either catechol 
or protocatechuate (Durham, 1984). These are then broken down further in the 
3-ketoadipate pathway (Stanier and Omston, 1973). This is not a uniform property of 
all yeasts or even the whole Rhodotorula genus. Trichosporon cutaneum (Anderson 
and Dagley, 1980) does not have a ring cleavage enzyme for protocatechuate. 
Instead, protocatechuate is oxidised to 1 ,3,4-trihydroxybenzene and is broken down 
further in a different catabolic pathway. Conversely, R. mucilaginosa contains only 
the protocatechuate branch of the f3-ketoadipate pathway (Cook and Cain, 1974). The 
ability of R. graminis to grow on mandelate was clearly demonstrated by Durham 
(Durham, 1984; Durham et al. (1984)). This work showed that the yeast contained a 
soluble NAD-dependent D-mandelate dehydrogenase and a dye-linked L-mandelate 
dehydrogenase (found to contain FMN and haem (Yasin and Fewson, 1993). This is 
discussed in further detail later in this chapter). The latter was thought to be a 
membrane associated protein, but was readily soluble on preparation of cell extract. 
1.8 D-Mandelate Dehydrogenase 
D-mandelate dehydrogenase from R. graminis does not contain a bound 
cofactor. It must obtain this from the surrounding medium. In particular, this enzyme 
uses nicotinamide adenine dinucleotide (NAD), the enzyme showed no activity with 
nicotinamide adenine dinucleotide phosphate (NADP) (Baker and Fewson, 1988). 
1.8.1 Nicotinamide Adenine Dinucleotide 
Nicotinamide adenine dinucleotide (NAD) is used as a cofactor in one of the 
most common biological oxidation reactions - that of the dehydrogenation of an 
alcohol to a ketone or aldehyde. When reduction of oxidised NAD (NAD) occurs, 
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only one of the hydrogen atoms removed from the alcohol attaches to the NAD 
(forming NADH). The other becomes a free proton. 
From deuterated alcohol studies, it has been shown that dehydrogenases 
catalyse the transfer of the hydrogen that is bonded to the carbon in the alcohol to 
NAD. The remaining hydrogen is released as H into the medium, suggesting that it 
is a hydride, Fr that bonds to the NAD. There is never any exchange with protons of 
the medium (Metzler, 1977; Morrison and Boyd, 1992) 
NAD absorbs at a wavelength of 260 nm and NADH absorbs at 340 nm. This 
can be important when developing an assay for enzyme activity. The rate of 
consumption or formation of NADH can be followed spectroscopically. 
1.8.2 D-Mandelate Dehydrogenase from R. graminis 
Preliminary work on the D-mandelate dehydrogenase (Baker and Fewson, 
1989), induced in the yeast by supplementation of the growth medium with 
10 mM-D,L-mandelate, showed that a four-step purification system gave a 63% yield 
of total enzyme in the crude extract. This was, however, only 1 2 mg from 40-5 0 g 
wet weight of cells. This, whilst being an effective purification system, lead to very 
little protein. Both gel ifitration and SDS-PAGE were used to determine the enzyme 
mass. The denatured protein showed a subunit mass of 38 kDa. The mass obtained by 
gel filtration was 77 kDa, showing that in its native form, the enzyme exists as a 
dimer. This was in line with many other NAP-dependent D-2-hydroxyacid 
dehydrogenases e.g. the D-lactate dehydrogenases from Lactobacillus acidophilus, L. 
fermenti and L. jensenii which are all dimeric and have molecular weights of 
approximately 80 kDa (Gasser et al., 1970) and the D-2-hydroxyisocaproate 
dehydrogenase from Streptococcus faecalis, which is again dimeric and has a 
molecular weight of 72 kDa (Yamazaki and Maeda, 1986). D-mandelate 
dehydrogenase from R. graminis is somewhat larger than the D-mandelate 
dehydrogenase from L. curvatus, a dimer with a native molecular weight of 60 kDa 
(Hummel et al., 1988; Hummel and Kula, 1989). Other initial work showed that there 
was no bound flavin or cytochrome as cofactor (the 1IJV-visible spectrum showed no 
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peak above 340 nm and a maximum at 280 nm). This is contrary to other D-mandelate 
dehydrogenases, for example, that from A. calcoaceticus, which contains FAD 
(Affison et al., 1985). Studies altering pH showed that the oxidation of D-mandelate 
was best at pH 9.5 and the reduction of phenyiglyoxylate was optimal at pH 5.85. 
Both equilibrium and kinetic studies point to the reverse reaction catalysed by 
D-mandelate dehydrogenase as being the major reaction (Figure 1.6). It is thought that 
during growth on mandelate, the reaction is forced in the forward reaction by removal 
of phenylglyoxylate (decarboxylation reaction) and by the oxidation of NADH. 
D-mandelic acid 	 Phenyiglyoxylic acid 
Figure 1.6. The reaction catalysed by D-mandelate dehydrogenase. The major reaction is 
in the reverse direction 
1.8.3 Structure of D-Mandelate Dehydrogenase from R. 
graminis 
Preliminary crystallographic studies on the enzyme were carried out and 
showed that it gave three different forms of crystal (containing different asymmetric 
units). The structure, however, has not been solved (Basak et al., 1993). The gene 
encoding D-mandelate dehydrogenase has been cloned and sequenced (Figure 1.7) 
(Iffias, 1997). An amino-acid sequence comparison was carried out and extensive 
sequence identity was found with many D-2-hydroxyacid dehydrogenases 
(approximately 27-33% identity). These included D-3-phosphoglycerate 
dehydrogenase from Haemophilus influenza (Fleischman et al., 1995), D-glycerate 
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dehydrogenase from Hyphomicrobium methylovorum (Yoshida et al., 1994)) and 
D-lactate dehydrogenase from Lactobacillus delbrueckii (Bernard et al., 1991). There 
was also high sequence identity to formate dehydrogenase (not a D-2-hydroxyacid 
dehydrogenase) from N. crassa and Hansenulapolymorpha (Tishkov etal., 1993). 
A sequence alignment of these D-2-hydroxyacid dehydrogenases shows some 
interesting conserved residues (Figure 1.8). The crystal structure of D-glycerate 
dehydrogenase from H. methylovorum (Figure 1.9) is known and with such high 
amino-acid sequence identity to D-mandelate dehydrogenase from R. graminis, 
provides a good model. 
1.8.4 The Structure of D-Glycerate Dehydrogenase (Goldberg 
et aL, 1994) 
D-glycerate dehydrogenase from H. methylovorum was initially purified and 
characterised by Izumi et al., in 1990. As with all the known glycerate 
dehydrogenases, it is a dimer (glycerate dehydrogenase from cucumber is a dimer of 
subunit 42 kDa, the bovine enzyme has a subunit 34 kDa (Greenler et al., 1989; 
Rosenbium et al., 1971)) and has identical subunits, each of 38 kDa. The enzyme 
reduces hydroxypyruvate in the presence of NADH. This is the favoured reaction and 
thus some have preferred to call the enzyme a hydroxypyruvate reductase, although 
this does not specify the chirality of the product. 
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Figure 1.7. The complete eDNA sequence of the gene encoding D-mandelate 




1. ---------+---------+---------+---------+---------+---------+ 60 
tacggagcgggagcgcaggaagaggagccgctggggcgagccgtggagctgctggatacc 
M PR PR V L L L GD P A RH L D DL W 
agcgacttccagcaaaagttcgaagtcatccctgccaacctgaccacgcacgacgggttt 
61 ---------+---------+---------+---------+---------+---------+ 120 
tcgctcaacctcgttttcaagcttcagtagggacggttggactggtgcgtgctgcccaaa 
SD F 00K FE V I P A Nb T T H D G F 
aaacaggccctgcgcgagaagcgctatggcgacttcgaagccatcatcaagcttgccgtc 
121 ---------+---------+---------+---------+---------+---------+ 180 
tttgtccgggacgcgctcttcgctataccgctgaagcttcggtagtagttcgaacggcag 
K Q AL RE KR Y GD FE All K LA V 
gagaacggcaccgagagctatccctggaacgccgacctcatctcgcacctcccttcgtcc 
181 ---------+---------+---------+---------+---------+---------+ 240 
ctcttgccgtggctctcgatagggaccttgcggctggagtagagcgtggagggaagcagg 
EN G T E S Y P W N A D L I S H L PS S 
ctcaaagtctttgccgccgccggcgcaggcttcgactggctcgacctcgacgcactcaac 
241 ---------+---------+---------+---------+---------+---------+ 300 
gagtttcagaaacggcggcggccgcgtccgaagctgaccgagctggagctgcgtgagttg 
L K V F A A A G A G F D W L DL D AL N 
gagcgcggagtcgcgtttgccaactcgcgcggcgcaggcgacacggcgacatccgatctc 
301 ---------+---------+---------+---------+---------+---------+ 360 
ctcgcgcctcagcgcaaacggttgagcgcgccgcgtccgctgtgccgctgtaggctagag 
E R G V A F A N SR G A G D T A T SD L 
gcgctgtacctcatcctgtccgtcttccgcctcgcgagctactcggagcgcgccgcgcgc 
361 ---------+---------+---------+---------+---------+---------+ 420 
cgcgacatggagtaggacaggcagaaggcggagcgctcgatgagcctcgcgcggcgcgcg 
AL Y LI L S V F Rb AS Y SE R A AR 
acgggcgaccccgagacgttcaaccgcgtgcacctcgagattggcaagtcggcgcacaac 
421 ---------+---------+---------+---------+---------+---------+ 480 
tgcccgctggggctctgcaagttggcgcacgtggagctctaaccgttcagccgcgtgttg 
T GD P E T F N R V H L El G KS A H N 
ccgcgcgggcacgtcctcggcgcggtcgggctcggcgcgatccagaaggagatctctagg 
481 ---------+---------+---------+---------+---------+---------+ 540 
ggcgcgcccgtgcaggagccgctccagcccgagccgcgctaggtcttcctctagagatcc 




541 ---------+---------+---------+---------+---------+---------+ 600 
ttccgccacgtaccggaaccctacttcgagcagatgatgctgcagcgcggacggctgcgc 
K A V HG L GM K LV Y Y DV A P A D A 
gagacggagaaggcgctcggtgctgagcgcgtcgactcgctcgaagagctggcgaggagg 
601 ---------+---------+---------+---------+---------+---------+ 660 
ctctgcctcttccgcgagccacgactcgcgcagctgagcgagcttctcgaccgctcctcc 
E T E K A L G A E R V D S L E E LA R R 
agcgactgtgtcagcgtgtcggtgccgtatatgaagttgacgcaccatgtcattgacgaa 
661 ---------+---------+---------+---------+---------+---------+ 720 
tcgctgacacagtcgcacagccacggcatatacttcaactgcgtggtacagtaactgctt 
SD CV S V S VP Y M K L T H H L I D E 
gccttcttcgccgcgatgaagcccggctcgcgcattgtcaatactgcgcgtggccccgtc 
721 ---------+---------+---------+---------+---------+---------+ 780 
cggaagaagcggcgctacttcgggccgagcgcgtaacagttatgacgcgcaccggggcag 
A F F A AM K PG S R I V N T A R G P V 
atctcgcaggacgcaattatcgccgcgctcaagtcgggcaagctgctcagtgcaggcctc 
781 ---------+---------+---------+---------+---------+---------+ 840 
tagagcgtcctgcgttaatagcggcgcgagttcagtttgttcgacgagtcacgtccggag 
IS Q D A L I A AL KS G K L L S A G L 
gacgtgcacgagttcgagccacaggtgtccaaggaactcatcgagatgaagcacgtcacg 
841 ---------+---------+---------+---------+---------+---------+ 900 
ctgcacgtgctcaagctcggtgtccacaggttccttgagtagctctacttcgtgcagtgc 
DV HE FE P Q VS K E L I EM K H VT 
ctcacgacgcacatcggcggcgtggcgatcgagaccttccacgagttcgagcggctcacc 
901 ---------+---------+---------+---------+---------+---------+ 960 
gagtgctgcgtgtagccgccgcaccgctagctctggaaggtgctcaagctcgccgagtgg 
L T T HI G G V Al E T F HE F ER L T 
atgaccaacatcgaccgcttcctcctgcaaggcaagcccttgctgaccgtgcgtctttgc 
961 ---------+---------+---------+---------+---------+---------+ 1020 
tactggttgtagctggcgaaggaggacgttccgttcgggaacgactggcacgcagaaacg 
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DMDH SRIVNTAGP VISQDDLIAA LKSGKLLSAA LDVHEF PQV 
DGDH AIVVNTARGD LVDNELVVAA LEAGRLAYAG FDVFAG PNI 
DPG DH AlL INAARGT VVDIDALAQA LKDGKLQGAA IIDVFPVIPAS 
DLDH VVIVNVSRGP LVDTDAVIRG LDSGKVFGYA MDVYEGEVGV 
DMDH SI LIE 1*HVTLTTHI 
DGDH NEG YYD LPTFLFPHI 
DPGDH INEE ...... . . .FISPLRE FDNVILTPHI 
DLDH FNEDRZGF PDARLADLIA RPNVLVTPHT 
Figure 1.8. 	Sequence alignment of selected D-2-hydroxyacid dehydrogenases 
showing extensive homology (DMDH, D-mandelate dehydrogenase from R. graminis; 
DGDH, D-glycerate dehydrogenase from H. methylovorum; DPGDH, D-3-phosphoglycerale 
dehydrogenase from H. influenza; DLDH, D-lactate dehydrogenase from L. delbrueckii. For 
references, see text). Amino acids marked with an izericA are active site residues. The 
formale dehydrogenases from N. crassa and H. polymorpha have a glutamine in the marked 
glutamate position. 
The structure of D-glycerate dehydrogenase (Goldberg et al., 1994; Figure 
1.9) is very similar (in a secondary and tertiary sense) to that of formate 
dehydrogenase from Pseudomonas sp. 101 (Lamzin el al., 1992; Lamzin et al., 1994; 
Stoll et al., 1996) and has a domain structure that is seen in many N AD-dependent 
dehydrogenases (e.g. in the D-2-hydroxyisocaproate dehydrogenase from 
Lactobacillus casei (Lerch et al., 1989). A model of D-lactate dehydrogenase from 
Lactobacillus bulgaris has been shown to have the same structure (Vinals et al., 
1995; Vinals et al., 1993)). Each subunit consists of two domains, between which 
there is a deep cleft. One of these domains, the co-enzyme binding domain is so-called 
due to the characteristic Rossman-fold topology (Rao and Rossman, 1973). This 
consists of a single 190 amino acid polypeptide chain (residues 100-290). The 
essential property of this fold is the formation of a cleft that will specifically bind a 
pyridine nucleotide molecule. The other domain, called the catalytic domain seems to 
serve to create the cleft at the bottom of which the active site sits. It is likely that 
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binding NAD into the active site induces a conformational change in the protein (e.g. 
glyceraldehyde-3-phoshate dehydrogenase, Skarzynski and Wonacott. 1988). While, 
with no NAD, the structuie is "open", leaving the active site accessible to co-enzyme 
and solvent. On binding, the structure "closes", in order to create the hydrophobic 
environment for hydride transfer. Three residues were highlighted as having a likely 
catalytic role. These are Arginine 240, Glutamate 269 and Histidine 287. These 
residues are conserved in D-mandelate dehydrogenase from R. graminis. Figure 1.1 Oa 
shows the active site as found, while figure 1.1 Ob shows this with an estimate of how 
D-mandelate would bind in. 
Co-enzyme 
binding domain 
Active site, NAD 
binding site 
/ lvs~ Catalytic domain 
Figure 1.9. The crystal structure of D-glycerate dehydrogenase from Hyphomicrobium 
methylovorum. The two subunits are shown, one in red ribbon form and one in blue 
backbone form. In the red subunit, the two distinct domains are shown and the position of 
the active site and the NAD binding site is labelled 
The conversion of D-glycerate and D-mandelate to hydroxypyruvate and 
phenyiglyoxylate, respectively, is analogous to the NAD-dependent lactate 
dehydrogenases (Holbrook et al., 1975). Clarke et al. (1989) showed that pyruvate 
was reduced to lactate by the donation of a proton from a protonated imidazole ring 
of a histidine in the active site, and a hydride ion from the 4-position of the 
dihydronicotinamide ring of NADH. It has been proposed that a similar mechanism is 















Figure 1.10. (a) The active site of o-glycerate dehydrogenase with (b) a speculative active 
site for o-mandelate dehydrogenase (a rough representation of D-mandelate position). 
1.8.5 Why Work on D-Mandelate Dehydrogenase? 
There are several reasons for conducting a study on D-mandelate 
dehydrogenase. With some preliminary work carried out on the native protein (Baker 
and Fewson. 1989), it would be important to ensure that there were no significant 
differences between this and a recombinant form of the enzyme. A more detailed 
characterisation of the enzyme would be useful in the understanding of the 
NAD-dependent 2-hydroxyacid dehydrogenases. 
The fact that the major reaction of D-mandelate dehydrogenase is the 'reverse' 
reaction (i.e. the reduction of phenyiglyoxylate to D-mandelate, Baker and Fewson., 
1989) could raise interest in the enzyme in industry. The development of a good 
expression system would be useful in synthetic chemistry. The enzyme would enable 
the conversion of relatively inexpensive, non-chiral phenyiglyoxylate (and derivatives) 
to valuable 100% pure D-mandelate and derivatives. This is of particular importance 
both commercially and medically. Commercially, it is, of course, very difficult to 
separate a racemic mixture of products. This would not be necessary using an 
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enzymatic method like this. Medically (and commercially), D-mandelate and its 
derivatives are very useful as chiral precursor molecules in the production of various 
pharmaceuticals, e.g. seniisynthetic f-lactam antibiotics. 
Another potential use of D-mandelate dehydrogenase is as a diagnostic tool. It 
has been shown that while D-mandelate dehydrogenase catalyses the oxidation of 
D-mandelate to phenyiglyoxylate, it has sufficiently relaxed substrate specificity to 
allow the utilisation of derivative compounds e.g. D-4-hydroxy-3-methoxymandelic 
acid (D-vanillylmandeic acid) (Figure 1.11). The importance of the detection of 








homovanitlic acid (HVA) 
Figure 1.11. Structure of D-vanilylmandelic acid and homovanihic acid. 
The catecholamines, adrenaline, noradrenaline and dopamine are synthesised 
in the adrenal medulla and nervous tissue and are secreted into the circulation in 
response to the appropriate stimuli. This causes a variety of cardiovascular and 
metabolic effects. Most of the excess catecholamines are degraded, with the major 
urinary metabolites being D-vanillylmandelate from adrenaline and noradrenaline and 
homovanillic acid from dopamine. It has been noted that patients with catecholamine 
secreting tumours such as phaeochromocytoma and neuroblastoma can excrete up to 
10 times the normal level of these metabolites in the urine (Robinson, 1980). 
Phaeochromocytoma is reported as being a relatively benign tumour. 
However, the secretion of adrenaline and noradrenaline causes episodes of 
unexplained hypertension in patients that can, in extreme circumstances, result in 
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death due to cerebral haemorrhage or renal failure. A simple measurement of urinary 
D-vanillylmandelate would allow this condition to be detected in hypertensive patients. 
Whereas phaeochromocytoma is a benign tumour, neuroblastoma is a 
particularly malignant tumour affecting young children. If this tumour is diagnosed 
sufficiently rapidly, before significant metastasis, then surgical removal of the tumour 
andlor chemotherapy may be curative. This tumour generally secretes dopamine 
which in turn elevates urinary homovanillic acid, although increased levels of 
D-vanillylmandelic acid is seen in some patients (Gitlow et a!, 1973). Neuroblastomas 
are often present at birth and could be rapidly detected by screening the urine of all 
newly born children. Screening would also be very important in ensuring that there 
was no reoccurrence of the tumours. 
There are screening procedures currently available for D-vanillylmandelic acid 
and homovanillic acid in urine. These include GC-MS and liquid chromatography 
techniques. However, these techniques are expensive and time consuming and are 
therefore not commercially viable. Other, more complex procedures have been 
developed, e.g. an enzyme linked immunoassay for urinary D-vanhlylmandelic acid and 
homovanillic acid (Yokomori et al, 1989). Few clinical laboratories are equipped for 
this type of assay. What is required is a method, suitable for large scale screening, 
which is rapid, specific for D-vanillylmandelic acid and homovanillic acid, and is 
inexpensive. 
1.9 L-Mandelate Dehydrogenase 
L-mandelate dehydrogenase is an enzyme which catalyses the oxidation of a 
2-hydroxyacid (L-mandelate) to a 2-oxoacid (phenyiglyoxylate). It has been found to 
be a flavocytochrome b2 . The following part of the introduction will discuss reasons 
for working with the enzyme, what the enzyme is and what it is similar to. Previous 
work will also be discussed. 
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1.9.1 Why Work on L-Mandelate Dehydrogenase? 
Like D-mandelate dehydrogenase, there are a number of reasons why we might 
want to investigate the enzyme L-mandelate dehydrogenase. There is again, the 
possibility of using the enzyme to produce enantiomerically pure compounds 
(L-mandelate and derivatives). This may not be as viable as in the case of the 
alternative enantjomer since the reaction is favoured in the forward direction. The 
L-mandelate, however, can be separated from phenyiglyoxylate by, for example, thin 
layer chromatography (mandelic acid Rf = 0.32, phenyiglyoxylic acid Rf = 0.38, 
Chakrabarti, 1979). 
There is also a medicinal reason for studying this enzyme. The production of 
plastic polymers and synthetic rubber amongst other things, exposes the workers to an 
increased level of styrene (Figure 1.12). Only about 1% of styrene is excreted in an 
unchanged form. Around 99% is metabolised within the body, and the major 
metabolites in the urine are mandelic acid and phenyiglyoxylic acid (El Masri et al., 
1958; James and White, 1967). There have been a number of methods developed to 
estimate the levels of each acid in urine. These include colorimetric, 
gas-chromatographic (Ohtsuji and Ikeda, 1970; Dalgliesh et al., 1966)) and 
fluorometric methods (Chakrabarti,, 1979). While these methods are increasingly 
sensitive, a simple assay using such a specific enzyme would prove to be invaluable to 
the medical profession. However, in order to carry out such a piece of work, the 
enzyme must be fully characterised (the rates of turnover must be known and the 
specificity of the enzyme must be investigated). 
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Both L-mandelate dehydrogenase and L-lactate dehydrogenase are 
flavocytochromes. Flavocytochromes all contain either flavin adenine dinucleotide 
(FAD) or flavin mononucleotide (FMN) as cofactors (both are derived from 
riboflavin Figure 1.13). Both possess the same active site (the isoalloxazine ring) 
capable of undergoing reversible oxidation and reduction by donating or accepting the 
formal equivalent of two hydrogen atoms respectively. The role of flavin is varied. 
Some are active in the primary dehydrogenation of organic substrates, some are 
involved in an electron transfer chain as hydrogen carriers and others react directly 
with molecular oxygen and form hydrogen peroxide. The advantage that flavin 
coenzymes have over, for example, nicotinamide coenzymes, is that while they both 
undergo two-electron oxidation and reduction reactions, only flavins have a stable 
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Flavins can be detected in all oxidation states spectrophotometrically. The 
fully oxidised coenzyme is yellow, fully reduced is colourless, while the semiquinone 
can either be red or blue depending on whether it is neutral or anionic. It is the ability 
to form the semiquinone that allows flavocytochromes to mediate electron transfer 
between an organic substrate (a two-electron donor/acceptor) to a one-electron 
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Figure 1.14. The oxidation states of flavin: (a) oxidised; (b) semiquinone; (c) fully 
reduced 
1.9.2.2 Cytochromes 
Cytochromes belong to a group of proteins called haem proteins. The haem 
prosthetic group is a cyclic tetrapyrrole with an atom of iron chelated within the ring 
system (Figure 1.15). The haem moiety contained within both L-mandelate 
dehydrogenase and L-lactate dehydrogenase is protoporphyrin IX. This is the same 
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group as is in baemoglobin and myoglobin. Electron transfer by the cytochrome 
involves the one-electron reversible oxidation/reduction of the iron. 
Fe2 	Fe3 + e 
Figure 1.15. The haem prosthetic group from both L-mandelate dehydrogenase and 
L-!actate dehydrogenase (protoporphyrin IX). 
1.9.3 L-Mandelate Dehydrogenase from Rhodotorula 
graminis 
The characterisation of L-mandelate dehydrogenase began with the 
determination of the relative molecular mass of the enzyme. The native molecular 
mass of L-mandelate dehydrogenase was found to be 235000 Da (by non-denaturing 
gel filtration) and the subunit mass was 59100 Da (similar to L-lactate dehydrogenase 
from S. cerevisiae). This suggests that the enzyme is a tetramer. Since a single 
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N-terminal sequence (Figure 1.16) was found, it was suggested that the intact enzyme 
was, in fact, a tetramer of four identical subunits. The N-terminal sequence (the 
cytochrome domain) of L-mandelate dehydrogenase from R. graminis had a strong 
similarity to L-lactate dehydrogenases from S. cerevisiae (Jacq and Lederer, 1972; 
Guiard, 1985; Lederer et al., 1985) and H. anomala (Black et al., 1989; Laberyrie 
and Baudras, 1972) and to micro somal cytochrome b5 from beef (shown to 
homologous to the cytochsome domain of L-lactate dehydrogenase (Guiard et al., 
1974; Guiard and Lederer, 1976; Haumont et al., 1987). 
EPKLDMNKQKI SPAEVAKHNKPDDCWVV 
DAQLPVKQRGRARS I SAAB VARENSRD SMWVV 
DV—PHWKDIELTPEIVSQHNKKDDLWVV 
SKAVKTYTLEQIEKENNSISTWLI 
Figure 1.16. Comparison of the N-terminal amino acid sequences. Shown are: I L-lactate 
dehydrogenase from S. cerevisiae; 2. L-mandelate dehydrogenase from It graminis; 3, 
L-lactate dehydrogenase from H. anomala; 4. Microsomal cytochrome b 5from beef 
Like L-lactate dehydrogenase from S. cerevisiae, L-mandelate dehydrogenase 
is a soluble component of the intermembrane space of yeast mitochondria (Figure 
1.17, adapted from Daum et al., 1982). It catalyses the oxidation of L-mandelate to 
phenyiglyoxylate and transfers the resulting electrons to cytocbrome c, thus acting as 
an L-mandelate:cytochrome c oxidoreductase (similar to L-lactate dehydrogenase, 
Appleby and Morton, 1954). As L-lactate dehydrogenase allows S. cerevisiae to use 
L- lactate (Pajot and Claisse, 1974), the L-mandelate dehydrogenase enables R. 
graminis to use L-mandelate as a source of carbon and energy. 
L-mandelate dehydrogenase from R. graminis has been shown to be a 
flavocytochrome b2 , similar to the L-lactate dehydrogenases from S. cerevisiae and 
H. anomala (Chapman et al., 1991). As well as having a high degree of N-terminal 
amino-acid sequence similarity, all three enzymes have similar molecular masses and 
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2-oxoacid with electron transfer to cytochrome c, and all the enzymes occupy a 
similar location in their yeast host. 
Figure 1.17. The location of L-mandelate in the iniermembrane space in the 
mitochondria of R. graminis. 
There has been an extensive study of L-lactate dehydrogenase from S. 
cerevisiae over many years and this protein has been used as a model system for 
protein electron transfer (both within and between proteins). The gene which encodes 
this protein has been both cloned and sequenced (Guiard, 1985) and the protein has 
been overexpressed in E. coli (Black et aL, 1989). The flavin-binding domain of 
L-lactate dehydrogenase has been overexpressed independently, allowing insights into 
the flavin and active site in general, to be more easily examined (Balme et al., 1995). 
Importantly, the structure of this enzyme - presumed to be similar to L-mandelate 
dehydrogenase - has been solved in both the native and recombinant forms (Xia and 
Mathews, 1990; Tegoni and Cambillau, 1994). 
Some of the subsequent work carried out on L-mandelate dehydrogenase in 
both native and recombinant forms is discussed here. 
30 
Introduction 
The similarities with L-lactate dehydrogenase (and therefore classing the 
enzyme as a flavocytochrome b2) were further investigated by Smékal et al. (1993), 
where a detailed comparison of L-mandelate dehydrogenase and L-lactate 
dehydrogenase was carried out. Steady-state kinetic comparisons were made (Table 
1.2) 
Table 1.2. Steady-stale kinetic parameters for L-mandelale dekydrogenase and L-laclale 
dehydrogenase. Experiments carried out at 25 C in Tris/HC1 buffer, pH 7.5 (10.10 Al) with 
ferricyanide as electron acceptor. 
Substrate Enzyme kcat (s') K. (mM) 
	
L-mandelate L-MDH 	109 	0.27 
L-LDH 	- 	 - 
L-Iactate 	L-MDH 	- 	 - 
L-LDH 	400 	0.49 
While we can see that L-mandelate dehydrogenase turns L-mandelate over at a 
lower rate than L-lactate dehydrogenase turns over L-lactate, the most striking result 
is that there is substrate exclusivity between the enzymes. The experiments were also 
carried out using the physiological electron acceptor, cytochrome c. This resulted in a 
substrate oxidation rate of approximately half of that using ferricyanide. Both 
L-mandelate dehydrogenase and L-lactate dehydrogenase showed a dependence on 
cytochrome c concentration. The binding constant for cytochrome c was similar in 
both cases (10 .tM with L-lactate dehydrogenase and 22 tM with L-mandelate 
dehydrogenase) suggesting that the enzymes interacted with cytochrome c in a similar 
fashion. 
The major difference between these enzymes (fueffing speculation about a 
different mechanism of substrate oxidation) was in the kinetic isotope effect using 
D,L-[2-21{j-mandelate/lactate (Figure 1.18). This indicated that while L-lactate 
dehydrogenase exhibited a kinetic isotope effect of 5, L-mandelate dehydrogenase 








Figure 1.18. Deuterated mandelic acid and deulerated lactic acid 
These results suggested that while the rate of substrate oxidation was limited by 
cleavage of the C-2 hydrogen bond in L-lactate dehydrogenase, this had no part in the 
rate-determining step of L-mandelate dehydrogenase. The rate-limiting step in this 
case was thought to be later in the reaction pathway, and thus the transition states of 
the two enzymes must have been different. 
A proposal regarding the possible reasons for substrate exclusivity will be 
included in section 1.10.1 as part of the discussion of the structure of L-lactate 
dehydrogenase. 
The breakthrough in carrying out a detailed biochemical investigation into 
L-mandelate dehydrogenase was the cloning of the gene coding for the protein (Iffias 
et al., 1998). The gene was sequenced and the amino-acid sequence deduced. The 
mature protein was predicted to have 492 amino acid residues including the 
incorporated N-terminal methionine. The calculated molecular weight of the protein 
was determined to be 54604 Da compared to the value of 59100 Da as estimated by 
Yasin and Fewson (1993). Sequence alignment studies showed that the deduced 
amino-acid sequence of L-mandelate dehydrogenase from R. graminis exhibited 
extensive sequence identity to the L-lactate dehydrogenases from S. cerevisiae (42%, 
Guiard, 1985), H. anomala (42%, Black et al., 1989) and E. coli (27%, Hoey et al., 
1987), lactate oxidase from M smegmatis (24%, Giegel et al., 1990), glycolate 
oxidase from spinach (35%, Volokita and Somerville, 1987) and an L-mandelate 
dehydrogenase from P. putida (25%, Tsou et al., 1990). The most notable result of 
the sequence alignment was that all the enzymes are members of the family of 
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FMN-dependent 2-hydroxyacid oxidising enzymes (Le and Lederer, 1991). It is with 
the high sequence identity (approximately 40%) in mind that we can make a number 
of predictions about the structure of L-mandelate dehydrogenase. Since it can be 
assumed that L-mandelate dehydrogenase from R. graminis is a flavocytochrome b2 , it 
can be predicted that it will have a similar structure to L-lactate dehydrogenase from 
S. cerevisiae. An initial study of the sequence alignments of the two shows four 
distinct areas. There are two regions in which the sequences are very different. 
Residues 92 to 103 (as numbered in the L-lactate dehydrogenase from S. cerevisiae) 
comprise what is known as the hinge region. This is a single polypeptide chain that 
links the cytochrome domain to the flavodehydrogenase domain (Chapman et al., 
1991). The second differing region (residues 298 to 314) is a protease sensitive ioop 
in L-lactate dehydrogenase (Ghrir and Lederer, 1981). A discussion of the general 
structure of L-lactate dehydrogenase and in particular the two major domains follows 
in section 1.10.1. 
1.10 L-Lactate Dehydrogenase from Saccharomyces 
cerevisiae 
L-lactate dehydrogenase activity was first reported in yeast by Bernheim in 
1928. By 1942, a soluble cytochrome, thought to be responsible for the L-lactate 
dehydrogenase activity, had been isolated in yeast extract (Bach et al.). L-lactate 
dehydrogenase, from S. cerevisiae, was first purified by crystaffisation by Appleby and 
Morton (1954). This form was found to be unstable. The instability was overcome 
when the enzyme was isolated in the presence of PMSF (phenylmethylsulfonyl 
fluoride, a serine protease inhibitor) to prevent the proteolysis which had occurred 
originally (Jacq and Lederer, 1972). The molecular weight of L-lactate dehydrogenase 
is around 57500 Da. L-lactate dehydrogenase from Hansenula anomala was isolated a 
little later (1972 by Labeyrie and Baudras). L-lactate dehydrogenase from S. 
cerevisiae has been successfully expressed at high levels in E. coil (Black et al., 
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1989). This allows mutations in the enzyme to be made using site directed 
mutagenesis (Reid etal., 1988). 
1.10.1 The Structure of L-Lactate Dehydrogenase 
L-lactate dehydrogenase from S. cerevisiae has been crystallised and its 
structure determined (Xia and Mathews, 1990). The protein consists of four identical 
subunits containing both a haem-containing domain (residues 1-99) and a 
flavin-binding domain (residues 100-486). These subunits are arranged with a 
molecular four-fold axis of symmetry with the four flavin-binding domains forming a 
disc of about I ()0A in diameter and 60 A in thickness. The C-terminal tails of each 
subunit make contacts with the other subunits of the tetramer. This C-terminal tail is 
absent in L-mandelate dehydrogenase (Iffias et al., 1998). However, this is unlikely to 
indicate a significantly difference structure for L-mandelate dehydrogenase since 
removing this from L-lactate dehydrogenase does not appear to significantly alter 
tetramer formation (White et al., 1989). It is interesting to note that glycolate oxidase 
from spinach also has no C-terminal tail and yet still forms a tetramer (Lindqvist et al., 
1991). The haem-binding domain is situated on the outer edge of the flavin-binding 
domain (Figure 1.19a Figure 1.19b). The two domains are linked via a single 
polypeptide called the hinge region. This small section of peptide has been shown to 
be very important for interdomain electron transfer (White et al., 1993; Sharp et al., 






Figure 1.19. The structure of L-Iactate dehydrogenase (Xia and Mathews, 1990). Figure 
1. 19a. The cytochrome domain is shown in red and the flavin domain is shown in green. 
The hinge region; linking the twv domains together is represented in blue and the 
C-terminal tail, providing contacts between the four subunits is shown in orange. Figure 
1. 19b showc a single subunit of L-lactate de/ydrogenaseftoin S. cerevisiae. The colouring 
is as before, with the cofactors shown in black slick form. 
The structure of L-lactate dehydrogenase was solved in the presence of 
pyruvate (the product of the oxidation of L-lactate) bound into the active site. This 
gave two crystallographically distinguishable subunits. In subunit one, the 
haem-binding domain and the flavin-binding domain are clearly visible in the electron 
density map, but in subunit two, where pyruvate is bound, the haem-binding domain is 
disordered. An NMR study by Labeyrie el al. (1988) showed evidence that the 
haem-binding domain is mobile with respect to the flavin-bindmg domain. 
The haem-binding domain was found not only to have high sequence identity 
to microsomal cytochrome b5 , but also structural similarities (Cristino and Steggler, 
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1989). The fold of this domain consists of 6 strands of-sheet (5 in one direction, 1 in 
the other). There are also 5 helices (1 on one side of the sheet, and 4 on the other). 
Two of the four ct-helices on one side create a hydrophobic pocket, where haem is 
bound. Since this fold is maintained within proteins with similar sequences, it would 
seem logical to predict this type of fold for the haem-binding domain of L-mandelate 
dehydrogenase from R. graminis. 
The flavin-binding domain has a 08a8 barrel structure (Banner et al., 1975). 
This general structure has been seen before in other flavoenzyines, for example 
glycolate oxidase from spinach (Lindqvist and Branden, 1989; Lindqvist, 1989). The 
FMN is held in the flavin-binding domain non-covalently via interactions with four 
buried side-chains. Arg413 and Arg433 both interact with the negatively charged 
phosphate groups. Asp409 interacts with a hydroxyl group on the ribose chain, and 
Lys 349 with N-I and 0-2 of the isoalloxazine ring and with a hydroxyl group on the 
ribose chain. This residue has an important role to play in the chemical properties of 
the FMN within the protein. 
The active sites in the two ciystallographically distinct subunits are very 
similar, but not the same. Subunit I has an active site that contains only water 
molecules. These four water molecules occupy the region in which pyruvate (reaction 
product) is situated. Other than this, there is one main difference in subunit active 
sites. In subunit 1, an interdomain contact is made in the form of a hydrogen bond, 
between the haem propionate group and Tyr143. Subunit 2 (where pyruvate is bound) 
shows Tyr143 hydrogen bonding to the carboxylate of pyruvate. Several other amino 
acid residues in the active site have been recognised as important in binding. Arg376 
provides a positive charge to stabilise the substrate/product carboxylate. The Nc of 
Arg376 also aids binding by forming a hydrogen bond with substrate. Both Tyr254 










Figure 1.20. The active site of L-Iaclate dehydrogenase from S. cerevisiae. Shown are 
important active site residues and the product of substrate oxidation, pyruvaze. 
The stereospecificity of the enzyme is fairly tightly controlled. The 
hydrophobic pocket that contains the methyl side-chain is uncrowded, and is made up 
from the side-chains of Ala 198, Leu 230, Leu 286 and lIe 326. Perhaps most 
importantly is Leu 230 which is in van der Waals, contact with the methyl group. 
None of these residues are well conserved in other, similar 2-hydroxyacid 
dehydrogenases. In fact it would seem that the key residue is, as expected., Leu 230. 
In glycolate oxidase, the equivalent is a tryptophan. This tells us that in the case of the 
smallest substrate side-chain (hydrogen; Figure 1.21), the largest amino-acid fills up 
the space. This theory would appear to be confirmed by the L-mandelate 
dehydrogenase from R. graminis, where the equivalent residue is a glycine - the 
smallest amino-acid, leaving room for the phenyl ring - an elegant piece of 
evolutionary design. A more detailed discussion of work carried out on substrate 











Figure 1.21. Various 2-hydroxyacids. The substrate specflciIy of the enzymes discussedfor 
these compounds is altered, for the most part, by the amino acid equivalent to Leu 230 in 
the lactate dehydrogenase from S. cerevisiae. 
1.10.2 Oxidation of Substrate and Flavin Reduction 
Upon substrate binding, the active site base (His373, Gaume et al., 1995) 
abstracts a proton. While the role of His373 is central to catalysis, it has so far been 
impossible to unambiguously prove whether the proton abstracted by His373 is from 
the a-carbon or the hydroxy group of L-lactate (leading to the carbanion mechanism 
(Figure 1. 22a) or the hydride mechanism (Figure 1 .22b) respectively). In the event of 
abstraction of the a-carbon hydrogen, a carbanion that covalently binds to N5 of the 
flavin results. This bond is then broken to leave product and reduced flavin. In the 
hydride mechanism, His373 abstracts the hydroxyl proton and the a-carbon hydrogen 
leaves as a hydride. In an attempt to distinguish between the mechanisms, Pompon 
and Lederer (1979) replaced the FMN with 5-deaza-FMN. In 5-deaza-FMN, N5 is 
replaced by CH and so a covalent intermediate would not be cleaved to yield product. 
However, it was found that the 5-deaza-FMN L-lactate dehydrogenase turns over 
L-lactate to pyruvate (very slowly). In an additional investigation using [2- 3H]-lactate, 
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Figure 1.22. Possible reaction mechanisms for L-lactaie dehydrogenase. The carbanion 
mechanism is shown in (a). Here the a-carbon hydrogen is abstracted as a proton and the 
carbanion left binds covaienily to N5 of the flavin. Product is released when this bond is 
broken. (b) shows the hydride mechanism. His 373 abstracts the hydroxyl proton and the 
a-carbon hydrogen leaves in the form of a hydride to N5 of the flavin. 
The rate-determining step for flavin reduction is the abstraction of the 
hydrogen on the a-carbon. In the pre-steady-state, a deuterium kinetic isotope effect 
was measured by Miles (1992) using pre-steady-state reduction of flavin. A kinetic 
isotope effect of 8 was obtained, which is compatible with both mechanisms 
discussed. Flavin reduction is not, however, rate detennining in the catalytic cycle. 
The rate constant for flavin reduction has been measured at 600 s_ I while the overall 
cycle has a rate constant of 100 s_ I . 
The remainder of the catalytic cycle involves two interdomain and two 
interprotein electron transfer steps. The first of these is the transfer of a single 
electron from fully reduced flavin to haem which in turn passes the electron onto 
cytochrome c. Once cytochrome c has removed the first electron, the semiquinone 




The development of the independently expressed flavin-binding domain of 
L-lactate dehydrogenase showed that the haem-binding domain is of paramount 
importance in the interprotein electron transfer step. Whereas wild-type enzyme 
passes electrons to cytochrome c at a rate of 207 s_I,  the flavin-binding domain is very 
much less efficient at 0.02 I  (a 10,000-fold decrease; Balme et aL, 1995). Thus, the 
haem domain must facilitate electron transfer between the reduced flavin (either fully 
reduced or semiquinone) and the oxidised cytocbrome c. 
1.10.3 Electron Transftr Pathway 
The flow of electrons after catalysis in L-mandelate dehydrogenase is the same 
as that in L-lactate dehydrogenase. Electrons pass from the substrate to the flavin 
moiety (a two-electron process). From there, they are passed to the haem and on to 
cytochrome c in two one-electron steps. The published steady-state rate constant for 
cytochrome c reduction by L-lactate dehydrogenase is 207 s 1 per electron transferred 
(Miles et al., 1992) and therefore the overall rate for one entire catalytic cycle is 
approximately 100 s  since two equivalents of cytochrome c are reduced. The rate 




1.11 Aims of the Project 
There are several aims to this project: 
• Overexpress, puriIy and characterise the D-mandelate dehydrogenase from R. 
graminis. 
. Characterise the recombinant L-mandelate dehydrogenase and the independently 
expressed flavin-binding domain. 
• Use L-mandelate dehydrogenase flavin-binding domain to investigate the substrate 
specificity of the enzyme with both aromatic substrate analogues and aliphatic 
2-hydroxyacids. 
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Chapter 2: 
Materials and Methods 
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2. MATERIALS AND METHODS 
2.1 Growth and Maintenance of Strains 
2.1.1 Bacterial and Yeast Stocks 
Name 	Genotype 	 Reference 
R. graminis 	KGX39 	 Durham, 1984 
E. co/i TG1 
	
	supE hsdzl5 thi ,i(lac-proAB) Gibson, 1984 
F'[traD36 proAB iacP lacZ 
zlMi 5] 
E. coil JM1O9 	recAl supE44 endAl hsdRl 7 StratageneTM 
gyrA96 relAl thi zl(lac-proAB) 
E. coil NFl 	K12AHJ, zltrp, lacZ-, AJ',TAM7, Stanley and Luzio, 1984 





E. coli BDS 
E. coil 
F- ompT gal [dcm][ion] 
hsdSB(rg-, mtr) met (DE3) 
F- ompT gal [dcm][lon] 
hsdSB(rB-, mm) (DE3) 
F- ompT gal [dcm][ion] 
hsdSB(rB-, mB -) (DE3) [plysS Cam T] 
recA 1 supE44 endA 1 hsdRl 7 
Denjumukhametov et ai., 
1998 
StratageneTm  
Miroux and Walker, 1996 
Lab Stock 
JMI09(DE3) 	gyrA96 re/Al thi zl(lac-proAB) 
(DE3) 
E. coil BW3 13 thi pro hsdR hdsM recA, Kunkel and Roberts, 1987 
chromosomal insertion of RP4-2 
(FC..Mu Km::Tn7) dut ung (hi-i 
re/A spoT/F' iysA 
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2.1.2 Growth of E. coli cultures 
E. co/i cells were grown by inoculating a single colony into an appropriate 
volume of the given medium. These were grown at 30 °C or 37 °C dictated by the 
permissive growth temperature of the particular strain or the experimental application. 
R. graminis culture was similarly grown by inoculating a single colony into 
appropriate media. These were incubated at 30 °C or below. 
2.1.3 Maintenance and storage of cultures 
Bacterial and yeast colonies were maintained for up to 4 weeks on agar plates 
stored at 4 °C. 
2.1.4 Growth media for E. coli 
2.1.4.1 Luria-Bertani Medium 
per litre 
Bacto-tryptone 	 10 g 
Bacto-yeast 	 5 g 
NaCl 	 5g 
2.1.4.2 TerrfIc Broth 
per 900 ml 
Bacto-tryptone 	 12 g 
Bacto-ycast 	 24 g 
glycerol 	 4ml 
This was made up to 900 ml with dH 20 and autoclaved. 
KH2PO4 	 2.31 g 
K2HPO4 	 12.54g 
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The potassium salts were made up to 100 ml with dH20 and autoclaved 
The tryptone/yeast/glycerol solution and the potassium salts were mixed after 
autoclaving. 
2.1.4.3 SOC Medium 
per 950 ml 
Bacto-tryptone 	 20 g 
Bacto-yeast 	 5 g 
NaCl 	 0.5 g 
The tryptone/yeastlsodium chloride solution was made up to 950 ml then 10 ml of 
250 mM KC1 was added and pH adjusted to pH 7.0 with 5 M NaOH. Made up to 1 
litre with dH20 and autoclaved. Cooled to 60°C and 20 ml of sterile I M glucose was 
added. Immediately prior to use, 5 ml of sterile 2 M MgC12 was added. 
2.1.4.4 M9 Minimal Media 
5xM9salts 	 200m1 
Made up to 1 litre with sterile dH 20 
20% glucose 	 20 ml 
5 x M9 salts 
per litre dH20 
Na2HPO4 .7H20 	 64 g 
KH2PO4 	 15g 
NaCl 	 2.5 g 
N}LCl 	 5.Og 
The above solution was autoclaved prior to use. 
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2.1.4.5 Agar Plates 
per litre 
Bactotryptone 	 10 g 
NaCl 	 5g 
yeast extract 	 5 g 
Agar 	 14g 
When the above solution was cool enough to touch. 25 mg of carbenidillin or 50 mg 
of ampicillin was added. The solution was then poured into plates, allowed to cool 
and stored at 4 °C. 
2.1.4.6 Antibiotics 
Working concentration 
Ampicihin 100 tg/ ml in liquid media 
50 j.tg/ml in solid media 
Carbenicillin 50 j.g/m1 
The antibiotic solution was filtered using 0.22 tm filter immediately prior to use. 
2.1.5 Growth Media for Rhodotorula graminis 
per litre 
Nutrient Broth 26 g 
D,L-mandelic acid 1.5 g 
L-glutanhic acid 0.9 g 
KH2PO4 2.0 g 
(NIL)2SO4 1.0 g 
MgSO4 .7H20 0.4 g 
The solution was adjusted to pH 7.0 with 10 M NaOH 
This medium was used to induce R. graminis cells for the production of mandelate 
dehydrogenases. 
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2.2 Solutions 
2.2.1 Transformation Bufftr (Ultracompetent cells prep.) 
Concentration 
PIPES 10mM 
MnC12 55 mM 
CaC12 15mM 
KC1 250mM 
PIPES, CaC12 and KCI were dissolved in dH20 and p11 adjusted to 6.7. The 
MnC12 is then added and the mixture filter sterilised. The solution was stored at 4 °C 
in 100 ml volumes. 
2.2.2 TEG/Lysozyme (DNA isolation) 
per 10 ml 
Tris/HC1pH8.0 0.25 ml 
0.5MEDTA 0.2 ml 
20% glucose 0.45 ml 
dH2O 9.lml 
Lysozyme 100 mg 
2.2.3 Solution B (DNA isolation) 
per 10 ml 
3 M sodium acetate pH 5.2 	 0.33 ml 
0.5MEDTA 	 20 jtl 
20% SDS 	 50 p.! 
lMTris/HCIpH8.0 	 0.4m1 
dH20 	 9.2 ml 
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2.2.4 T1 E1 solution (DNA isolation) 
Concentration 
Tris/HC1 pH 8.0 10mM 
EDTA 1 mM 
2.2.5 0.2 MNaOHI1% SDS (DNA isolation) 
Concentration 
NaOH 0.2 M 	 -used fresh 
SDS 1% 
2.2.650 x TAE Gel Running Buffrr (DNA electrophoresis) 
per litre 
Tris base 242 g 
glacial acetic acid 57.1 ml 
Na2EDTA.2H20 2 g 
2.2.75 x Phosphorylation Buffer (SDM) 
Per 100 p.1 
1 M Tris/HC1 pH 7.5 25 pJ 
1MMgC12 5I 
0.1 M Dithiothreitol 25 tI 
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2.2.810 x Annealing Buffer (SDM) 
per 1 ml 




2.2.9 5 x Synthesis Bufftr (SDM) 
per 100 tl 
lMTris/HC1pH7.5 5p.1 
5 mM dNTP mix (5mM of each) 50 p.1 
0.1MATP 5p.1 
0.1 M Dithiothreitol 10 p.! 
dH2O 30p.1 
2.2.104% Stacking Gel (SDS PA GE) 
Volume 
Acrylamide 1.3 m! 
dH2O 6.lml 
0.5 M TrisfHCl pH 6.8 2.5 ml 
10%SDS lOOp.! 
10% APS (used fresh) 50 p.! 
TEMED lOp.! 
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2.2.11 12% Resolving Gel (SDS PA GE) 
Volume 
Acrylamide 4 ml 
dH20 3.35 ml 
1.5MTrisIHC1pH8.8 2.5 ml 
10%SDS 100 j.il 
10% APS (used fresh) 50 tl 
TEMED 10 tl 
2.2.12 5 x Running Bufftr (SDS PA GE) 
Mass!Volume 
Trisbase 15.1g 
Glycme 94 g 
10%SDS 50m1 
dH20 to 1 litre 
2.2.13 	2 x Loading Bufftr (SDS PAGE) 
Mass/Volume 
1 M TrisfHCl pH 6.8 3.31 g 
SDS 2g 
Glycerol 9 ml 
2-mercaptoethanol 5 ml 
1% bromophenol blue 1 ml 
dH20 tolOOmi 
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2.2.14 lOx Transfer Buffer (Western Transftr) 
Concentration 
TrisIHCl pH 8.3 
	
250mM 
Glycme 	 1.5M 
Made up to I x in dH20. 
2.2.15 TBS (Western Transftr) 
Volume 
1MTrisIHCLpH7.5 lOmI 
4MNaC1 37.5 ml 
dH20 952.5 ml 
2.2.16 Developing Solution (Western Transftr) 
Volume 
5 mg/mi dianisidine 0.5 ml 
0.1MimidazolepH7.4 Imi 
30%H202 0.1ml 
dH20 8.4 ml 
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2.2.17 100 mM Phosphate pH 7.0 (m-MDH Assay, 
Purfication) 
per litre 
Na2HPO4 . 71120 	 16.36 g 
K112PO4 anhydrous 	 5.31 g 
Made up to 1 litre with dH 20 
2.2.18 50 mM Tris/HCI pH 8.0 with 1 mM Dithiothreitol 
(Purification) 
per litre 
Tris base 6.06g 
Dithiothreitol 0.154 g 
Made up to pH 8.0 with 1M HC1 
2.2.19 10 mM Tris/HCI pH 7.5 (I 0.101W (Purification, 
Kinetics) 
Mass/Volume 
NaCl 5.265 g 
1MHCL lOmi 
dH20 to 1 litre 
The solution was adjusted to pH 7.5 with Tris base 
2.2.20 200 mM Phosphate pH 5.85 (D-MDHAssay) 
per litre 
Na2HPO4 . 71120 5.42 g 
KH2PO4 anhydrous 24.45 g 
The solution was made up to 1 litre with dH20. 
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100 mM phosphate pH 7.0 	 500 tl 
2.2.22 10mM Phenyiglyoxylate in 200 mM Phosphate 
pH 5.85 (D-MDH Assay) 
per 25 ml 
Phenyiglyoxylate (Aldrich) 	 0.0375 g 
200 mM phosphate pH 5.85 	 25 ml 
2.3 Preparation and Transformation of Ultracompetent E. 
coli 
2.3.1 Preparation of Ultracompetent E. coli 
The required strain of E. coil was grown to 0D600 = 0.6 in 200 ml of LB in a 1 
litre flask at 18-23 °C. The flask and cells were incubated on ice for approximately 15 
minutes then spun in chilled centrifuge pots at 2500 g for 10 minutes at 4 °C. The cell 
pellets were gently resuspended in a total of 80 ml of ice-cold transformation buffer 
solution. Again, the cells solution was left on ice for at least 15 minutes and spun at 
2500 g for 10 minutes at 4 °C. The cell pellets were then resuspended in a total of 
20 ml in ice-cold transformation buflèr solution and DMSO was added to a final 
concentration of 7%. The cells were left on ice for a further 15 minutes, aliquoted into 
pre-chilled sterile Eppendorfs and frozen in a dry ice/ethanol bath (or liquid nitrogen). 
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Ultracompetent cells were stored at —80 °C. Viability drops with time, but successful 
transformation can be achieved with cells stored for 6 months or more. 
2.3.2 Transformation of Ultracompetent E. coli 
10-100 ng of the DNA of interest (usually 1-10 jtl) was added to a chilled 
Eppendorf tube. 150-200 j.il of the thawed ultracompetent cells were added. The tube 
was incubated on ice for approximately 20 minutes, after which time, the cells were 
heat shocked at 42 °C in a waterbath for 30-40 s. The cells were then promptly 
returned to an ice/water slurry and left for 5 minutes. 800 jtl of Soc medium was 
added and the DNA/cells mixture was incubated with shaking for 1 hour at 37 °C. 
This allows phenotypic expression of the selectable marker e.g. antibiotic resistance. 
The cells were spun (5 minutes, 13000 rpm) in a benchtop Eppendorf centrifuge, and 
the cells resuspended in approximately 200 .il of the residual supernatant. The cell 
pellets were plated out onto an appropriate selective medium e.g. LB/ampidilhin plates 
and incubated overnight at 37 °C. 
2.4 Isolation of DNA 
2.4.1 Small Scale Isolation 
The appropriate E. coli strain containing the plasmid of interest was 
inoculated in 5 ml LB plus the appropriate concentration of the relevant antibiotic and 
incubated at 37 °C overnight. After growth, 1.5 ml of this culture was placed in an 
Eppendorf tube and the cells were spun down (5 minutes, 13000 rpm) in a benchtop 
Eppendorf centrifuge. The supernatant was discarded and a further 1.5 ml was spun 
down. Again the supernatant was discarded and the pellet was resuspended in 100 j.tl 
of TEG/lysozyme. The contents were mixed thoroughly using a Gilson pipette and left 
at room temperature for 5 minutes. Sodium hydroxide (0.2 M) and SDS (1%) (total 
volume of 200 tl) was added, the solution was mixed by inversion and left at room 
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temperature for 5 minutes. Sodium acetate (150 p1,, 3 M, pH 5.2) was added, the 
solution was mixed by inversion and left on ice for 5 minutes. This was then spun in a 
benchtop Eppendorf centrifuge for 5 minutes at 13000 rpm. The supernatant was 
transferred to a fresh, clean Eppendorf and 800 p1 ethanol was added. The solution 
was incubated on ice for at least 5 minutes and then spun down in a benchtop 
Eppendorf centrifuge for 5 minutes at 13000 rpm. The pellet was resuspended in 200 
p1 1120 and phenol / chloroform extracted (twice or three times if necessary). This 
was followed by a chloroform extraction. The DNA was precipitated by adding 0.1 
volumes 3 M sodium acetate, pH 5.2 plus 2.5 volumes ethanol and placing the tubes 
on ice for at least 15 minutes (or lOminutes at —20 °C). The pellet was washed with 
70% ethanol and then resuspended in 50-100 p1 H 20. 
2.4.2 Large Scale Isolation 
The E. co/i strain containing the relevant plasmid was inoculated into 50 ml of 
the appropriate medium and antibiotic and grown overnight at the permissive 
temperature (usually 37 °C). The culture was transferred to a corex tube and the cells 
were spun down. The pellet was resuspended in a total volume of 2 ml of 
TEG/lysozyme, mixed to homogeneity using a Gilson pipette and left on ice for at 
least 15 minutes. Sodium hydroxide (0.2 M) and SDS (1%) (total volume of 4m1) was 
then added and the tube contents mixed thoroughly by inversion until the solution was 
evenly translucent. This was left on ice for 5 minutes. Sodium acetate (3 ml, 3 M, 
pH 5.2) was then added and gently mixed until the green/yellow tinge to the solution 
had gone. The mixture was left on ice for 20 minutes, and then spun at 10000 rpm for 
10 minutes in a Sorvall RC-5B. The supernatant was retained and transferred to a 
fresh, clean corex tube and 16 ml ethanol was added. This was placed on ice for 15 
minutes, and spun at 10000 rpm for 10 minutes in a Sorvall RC-5B. The pellet was 
retained and resuspended in 4 ml of solution B. Once the pellet was properly 
dissolved, 4 ml of phenol/chloroform was added. This was thoroughly mixed by 
swirling, left at room temperature for 5 minutes and then spun for 2 minutes at 4000 
rpm. The aqueous phase was transferred to a fresh tube and repeatedly extracted with 
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a further 4 ml of phenol/chloroform as before until no further white material at the 
organic/aqueous phase interface was visible. The upper aqueous layer was again 
transferred to a fresh, clean corex tube and 8 ml ethanol was then added. This solution 
was incubated on ice for at least 15 minutes and then spun at 10000 rpm for 10 
minutes in a Sorvall RC-5B. The resulting pellet was resuspended in 400 jtl T 10E 1 and 
transferred to an Eppendorf tube where 20 lii of boiled RNase A was added. The 
solution was incubated in a waterbath at 37 °C for 1 hour, then 20 1114 M NaCl was 
added and the aqueous phase was then extracted at least twice with equal volumes of 
phenol/chloroform until no further interface material was precipitated, and finally 
extracted with an equal volume of chloroform. Ethanol (800 Ltl) was added to the 
final aqueous phase and the solution was incubated on ice for at least 15 minutes. This 
was spun in a benchtop Eppendorf centrifuge for 5 minutes at 13000 rpm (4 °C) and 
the resulting pellet was washed with 70% ethanol, air dried and then resuspended in 
200-400 til dH20 to give a final concentration in the region of 1 tg/tl. If necessary, 
this volume was adjusted following the determination of the DNA concentration of 
the solution. 
2.4.3 Restriction Enzyme Digests 
Plasmid DNA (0.1-2.0 rig) was typically cut using a 15 jil digest volume 
containing 1.5 tl of the appropriate 10 x buffer, 1.5 j.d of 10 x bovine serum albumen 
(BSA) and 20 units of each appropriate restriction enzyme, and then made up to 15 
il with dH20. This mixture was incubated in a waterbath at the required temperature 
(typically 37 °C) for at least 3 hours. 
2.4.4 DNA Blunt Ending 
DNA of concentration approximately 0.1 mg/nil was suspended in 1 x Mung 
Bean Nuclease Buffer (New England Biolabs). Mung Bean nuclease (1 unit per mg of 
DNA) was added and the resulting solution was incubated in a waterbath for 30 
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minutes at 30 °C. After this time, the enzyme was inactivated by phenol/chloroform 
extraction. The DNA was precipitated by adding 0.1 volumes 3 M sodium acetate, 
pH 5.2, plus 2.5 volumes ethanol and placing the tube on ice for at least 15 minutes 
prior to centrifügation in a benchtop centrifuge at 13000 rpm for at least 5 minutes 
(4 °C). The resulting pellet was washed with 70% ethanol, air-dried and then 
resuspended in 50-100 til dH20. 
2.4.5 Ligation of DNA 
DNA ligations were typically carried out using 0.1 jig of vector DNA cut with 
appropriate restriction enzymes and agarose gel purified, and a range of similarly 
prepared "insert" DNA fragment concentrations centred around a 3:1 molar ratio of 
insert to vector DNA, in a 10 jil or 15 j.tl volume. The appropriate volume of 10 x 
ligation buffer (10 mM TrisfHCl pH 7.2, 1 mM EDTA, 10 mM MgC1 2, 10 mM DTT 
and 1 mM ATP; Promega, 3 units/j.tl) and 1 jil ligase were added. The mixture was 
incubated at room temperature for at least 4 hours and then diluted at least 2-fold 
prior to transformation of aliquots into the appropriate recipient E. co/i strain. 
2.4.6 Agarose Gel Electrophoresis of DNA 
Electrophoresis grade agarose (0.8% in 1 x TBE buffer), to which 3 ,.tl of 10 
mg/mi ethidium bromide was added (immediately prior to pouring), was used to 
separate DNA by size. The DNA samples were mixed with about ¼ volume of DNA 
loading buffer prior to loading into the wells. The gel was run in a horizontal bed gel 
apparatus at 40-50 mA. The DNA was visualised directly on a UV transilluminator 
and photographed. 
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2.4.7 Isolation of DNA from Agarose Gel (G eneclean® 
Protocol) 
Following digestion of the relevant DNA with the appropriate restriction 
enzymes, the digest mix was run on a 0.8% agarose gel, prepared with UltraPure 
agarose. The appropriate band was excised from agarose gel using a fresh sterile 
scalpel blade, placed in an Eppendorf tube, weighed, and 3 volumes of Na1 was 
added. This was incubated at 55 °C in order to melt the agarose gel. The 
EZ-GLASSMITLK® suspension was added and mixed by inversion. The 
EZ-GLASSMILK®IDNA complex was pelleted in a benchtop Eppendorf centrifuge 
for 5 seconds. The pellet was resuspended with NEW Wash ® and repelleted three 
times. Finally, the GenecleanfDNA pellet was air-dried and the DNA eluted into a 
total of 20-50 ml of"Elution" solution as appropriate. 
2.4.8 Isolation of Single Stranded DNA 
2.4.8.1 Growth of E. coli Culture for Preparation of 
Single-Stranded Uracil Containing DNA 
The relevant double-stranded plasmid DNA was transformed into the host 
strain BW313. These cells were grown up in LB + ampicillin (100 ig/ml) at 37 °C to 
approximately mid-log phase (0D600 = 0.5-0.7). 2 ml of this culture was retained and 
to this was added 1 l of Ml 3K07 helper phage. The infected culture was shaken at 
37 °C for a further 1.5 hours. After this time, 10 ml of LB, in a 250 ml flask, 
containing Ampidilhin (100 j.tg/ml) and Kanamycin (70 p.g/ml), was inoculated with 
500 j.tl of the infected cells. This was grown up overnight with vigorous shaking at 
37 °C. 
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2.4.8.2 Extraction and Purflcation of Single-Stranded Uracil 
Containing DNA 
The overnight culture was divided into 6 Eppendorf tubes and spun down at 
13000 rpm for 5 minutes in a benchtop Eppendorf centrifuge. 1.4 ml of the 
supernatant from each tube was retained and transferred to fresh Eppendorf tubes. 
These were again, spun down at 13000 rpm for 5 minutes in a benchtop Eppendorf 
centrifuge. The supernatant from each tube (1.2 ml) was retained and placed into 
fresh Eppendorf tubes to which 300 .tl PEG solution was added. The tubes were well 
shaken and left at room temperature for 15 minutes. The tubes were spun at 
13000 rpm for 5 minutes in a benchtop Eppendorf centrifuge. The supematant was 
carefully removed without disturbing the small pellet and the pellet was retained. The 
pellets from the 6 tubes were resuspended into a total of 400 j.tl of T 10E 1 pH 8.0. 
Tris-equilibrated (pH 8.0) phenol (400 il) was added and the tube shaken vigorously 
and left at room temperature for 5 minutes. After being shaken vigorously a second 
time, the tube was spun at 13000 rpm for 5 minutes in a benchtop Eppendorf 
centrifuge. The aqueous (upper) layer was retained. If necessary, this was repeated 
until no further white material was precipitated at the interface of the aqueous and 
organic layers. Chloroform (400 tl) was added to the aqueous phase and the tube was 
shaken vigorously. The tube was spun at 13000 rpm for 5 minutes in a benchtop 
Eppendorf centrifuge. The aqueous layer was again retained. To this was added 40 j.tl 
of 3 M sodium-acetate, pH 5.2, and 1 ml of ethanol. The resulting solution was placed 
at —20 °C for 1 hour. The precipitated DNA was pelleted by spinning at 13000 rpm 
for 10 minutes at 4 °C. The pellet was washed with 75% ethanol for 5 minutes. The 
75% ethanol was removed and the pellet was air dried and resuspended in 50 .tl 
dH2O. 
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2.5 Site-Directed Mutagenesis 
25.1 Phosphorylation of Oligonucleotides 
The relevant oligonucleotide (100 picomoles) was placed in an Eppendorf 
tube. To this was added 5 jil of 5 x phosphorylation buffer, 5 units of T4 
polynucleotide kinase (concentration stated on label) and sufficient water to give a 
total volume of 25 t1. The tube was incubated at 37 °C for 40 minutes, heated to 
70 °C for 10 minutes and either used in the annealing reaction straight away or stored 
in aliquots at —20 °C. 
2.5.2 Annealing Reaction 
The phosphorylated oligonucleotide was diluted 4-fold and 1.25 jtl of this was 
added to approximately 0.05 picomoles of single-stranded uradil-containing DNA and 
2 j.il of 10 x Annealing buffer. dH 20 was added to ensure a total volume of 20 tl. 
This solution was heated for 5 minutes at 70 °C and then allowed to cool to 35 °C 
over the following 40 minutes. On reaching 35 °C the tube was placed in ice and 
immediately used in the synthesis reaction. 
2.5.3 Synthesis Reaction 
On completion of the annealing reaction, 6 il of 5 x synthesis buffer, 
approximately 10 units of T4 DNA polymerase (concentration stated on label), and 
approximately 2 units of T4 DNA ligase (concentration stated on label) were added to 
give a total volume of 30 .tl. After being left on the bench for 1 minute, this was 
incubated at 37 °C for 2 hours. Aliquots of the resulting solution were transformed 
into ultracompetent TG1 cells. 
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2.6 Polymerase Chain Reaction 
The desired DNA fragments (with any required modifications incorporated 
via the primers) were amplified by means of the Polymerase chain reaction (PCR). 
PCR was carried out in 0.5 ml Eppendorf tubes. A total reaction volume of 50 i1 was 
used containing: 5 j.tl 10 x PCR buffer with MgC12 (Boebringer Mannheim); 2.6 units 
of Taq Polyinerase (Promega); 5 pmol of both forward and reverse primers; 5% 
DMSO (2.5 tl); 2 ml of 5 mM dNTPs (mix of 20 mM each dTTP, dCTP, dGTP, 
dATP); 1 tl of the DNA of interest. The reaction was covered with 50 gl of mineral 
oil to avoid evaporation. The tube was then placed in the Techne PHC-2 and the 
reaction was carried out for 35 cycles under appropriate denaturing, annealing and 
extension temperature with appropriate time for each step. PCR products were cloned 
and checked by restriction analysis. 
2.7 Cloning and Expression of L-Mandelate Dehydrogenase 
2.7.1 Cloning and Growth of E. coli Producing L-Mandelate 
Dehydrogenase 
The plasmid DNA containing the gene encoding for L-mandelate 
dehydrogenase was transformed into E. coli JMIO9 cells and these were grown for 48 
hours at 37 °C with shaking in Terrific Broth (with 150 mg/I ampidilhin). The cells 
were harvested by centrifugation in a Sorvall RC-5B centrifuge with a GS-3 rotor at 
5000 g for 10 minutes. The resulting red pellet was snap-frozen and stored at —20 °C. 
2.7.2 Cell Lysis and Column Chromatography 
Ahiquots of the cell pellet were snap-frozen in liquid nitrogen and resuspended 
in 0.1 M phosphate buffer (pH 7.0) + EDTA. The resulting solution was centrifuged 
(39000 g, 10 minutes) to remove insoluble cell debris and unlysed cells. 
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2.7.2.1 DE-52 Ion-Exchange Column 
The protein solution (the previously centrifuged cell lysate in phosphate 
buffer) was washed through a pre-equilibrated DE-52 colunm (a diethylaminoethyl 
cellulose anion exchange column). L-mandelate dehydrogenase did not bind, instead 
passing straight through the column at this ionic strength. Red fractions were retained, 
pooled and dialysed for 2 hours against a 10-fold greater volume of 30 mM phosphate 
buffer, pH 7.0. 
2.7.2.2 DEAE Sephacel Column 
The dialysed protein solution was loaded onto a pre-equilibrated DEAE 
Sephacel column. L-mandelate dehydrogenase was seen to bind tightly to the top. The 
protein was washed with several column volumes of buffer. A salt gradient (0-0.3 M 
NaCl in 30 mM phosphate buffer, pH 7.0) was used to elute the protein. Fractions of 
30% purity or greater were pooled and dialysed against a 10-fold greater volume of 
30 mM phosphate buffer, pH 7.0 to remove salt. 
2.7.2.3 Quaterna,y Ammonium (Q-) Sepharose Column 
After dialysis, the solution was loaded onto a Q-sepharose colunm 
(pre-equilibrated in 30 mM phosphate buffer, pH 7.0). Again, L-mandelate 
dehydrogenase bound and the same salt gradient (0-0.3M NaCl in 30 mM phosphate 
buffer, pH 7.0) was used to elute the protein. 50% pure fractions were pooled and 
dialysed to remove salt. The protein solution was concentrated by loading onto a 
small DEAE cellulose column (DE-52) and eluting immediately with 150 mM 
phosphate buffer, pH 7.0. 
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2.7.2.4 S300-HR Sephacryl Gel Filtration Column 
The concentrated solution was loaded onto an S300 Sephacryl column 
(equilibrated in 10 mM TrisIHCl, pH 7.5 1 0.10). The protein was washed with Tris 
buffer and eluted. Fractions of 90-100% purity were stored under liquid nitrogen. A 
purification table (Table 2.1) summarises the details. 
Table 2.1. A typical punficalion table for L-mandelate dehydrogenase (Illias et aL, 1998). 
The purity of each fraction was determined by measuring the ratio of the total protein peak 
(A 269 ) and the L-mandelate dehycfrogenase reduced haem Sore! peak (A 423  ,.,,). A pure 











Cell lysate -P1000 -140 100 1 
DEAE cellulose -750 -110 80 1.1 
DEAE -250 -80 60 2.3 
Seph acel 
Q Sepharose -100 -50 40 3.6 
S300 Sephacryl -20 -20 15 7.1 
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2.8 Cloning and Expression of L-Mandelate Dehydrogenase 
Flavin-Binding Domain 
2.8.1 Cloning and Growth of L-Mandelate Dehydrogenase 
Flavin-Binding Domain 
The plasmid DNA containing the gene encoding the flavin-binding domain was 
transformed into E. coli JM109 cells and these were grown overnight at 37 °C, with 
shaking, until the cells reached stationary phase. The cells were grown in Terrific 
Broth with 150 ig/ml ampicilhin. The cells were harvested by centrifugation in a 
Sorvall RC-5B centrifuge with a GS-3 rotor at 5000 g for 10 minutes. The resulting 
wet pellet of cells was yellow in colour. 
2.8.2 Cell Lysis and Column Chromatography 
Aliquots of the cell pellet were snap-cooled in liquid nitrogen and resuspended 
in 0.1 M phosphate buffer (pH 7.0) + EDTA. The solution was centrifuged (39000 g, 
10 minutes) to remove insoluble cell debris and unlysed cells. 
2.8.2.1 DE-52 Ion-Exchange Column 
The isolated L-mandelate dehydrogenase flavin-binding domain was purified 
by column chromatography using DE-52 (Whatman). The previously centrifuged cell 
lysate was loaded onto a DE-52 column (10 cm x 4.5 cm), which had been previously 
equilibrated in 0.1 M phosphate buffer (pH 7.0). The protein was eluted after washing 
the column with several column volumes of buffer. Protein fractions which were 
yellow in colour were immediately collected. The eluted fractions of L-mandelate 
dehydrogenase flavin-binding domain had a UVIVis ratio (A 269  ,1JA450 ) of around 
15. 
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2.8.2.2 DEAE Sephacel Column 
The eluted fractions were pooled and dialysed for 2 hours against a 10-fold 
greater volume of 30 mM phosphate, pH 7.0. The protein solution was then loaded 
onto a 20 cm x 3 cm DEAE sephacel column which had previously been equilibrated 
with 30 mM phosphate buffer. The enzyme was eluted using a 30 mM 
phosphate-0.3 M NaCl in 30mM phosphate buffer gradient (to A 269nm reading 
approaching 0-1 litre total volume). Fractions with an A269 nm/A450 ratio of 7.5 
were pooled, adjusted to 80% ammonium sulfate saturation and spun at 39000 g for 
10 minutes. 
2.8.2.3 Sephadex G25 Gel Filtration Column 
The ammonium sulfate pellet was redissolved in 0.01 M TrisfHCl buffer (pH 7.5) and 
loaded onto a G25 20 cm x 2 cm gel filtration column. This final column desalts the 
protein solution. The eluted protein was then aliquoted and frozen in liquid nitrogen. 
A purification table (Table 2.2) summarises the details. 
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Table 2.2. A typical purification table for L-mandelate dehydrogenase flavin-binding 
domain (L-MDHfd). The purity of each fraction was determined by measuring the ratio of 
the total protein peak (A 269 ,,J and the L-mandelate dehydrogenase flavin-binding domain 
oxidisedflavin peak 0450  ,,,). A pure protein solution has an A261A450  ratio of around 7.5. 
Total protein L-MDH fd L-MDH fd Purification 
(mg)Ilitre (mg)/Iitre Yield(%) (fold) 
culture culture 
Cell lysate -1000 -210 100 1 
DEAE -320 --144 69 2.1 
cellulose 
DEAE -130 -115 55 4.2 
Sephacel 
G25 -100 -90 42 4.8 
2.9 SDS PAGE 
SDS-polyacrylamide gel electrophoresis (Laemmli, 1970) was used to 
separate proteins according to their molecular weight. Two phases of polyacrylamide 
gel (typically a 4% stacking gel and a 12% resolving gel) were prepared. The 
resolving gel was poured between glass plates, topped with water and left to 
polymerise (between 10 minutes and 30 minutes). The water was removed and the 
stacking gel was poured on top and a comb was inserted into the stacking gel to 
create the wells. This was also allowed to polymerise. The resulting gel was clamped 
into a vertical electrophoresis tank filled with I x Running Buffer. The comb was 
removed and the protein sample (50 ig protein in 20 j.il 2 x SDS PAGE loading 
buffer) loaded into the wells. Markers were loaded into one lane. The electrophoresis 
was carried out at 150 volts for approximately 3 hours. The gel was stained with 1% 
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PAGE Blue Electran in 20% (v/v) methanol, 5% (v/v) acetic acid to visualise the 
separated proteins. 
2.9.1 Western Transftr 
An SDS PAGE gel was run and then soaked in 1 x transfer buffer for two 
minutes. It was then assembled into a "sandwich", in which the gel was adjacent to a 
piece if nitrocellulose membrane (Hybond-C) and this placed between two double 
layers of 3MM filter paper and foam sponge (all pre-soaked in 1 x transfer buffer). 
The assembly was then placed into the transfer tank (filled with 1 x transfer buffer) 
with the gel nearest the negative terminal. The proteins were transferred over 2 hours 
at 0.6 to 2 amps. The sandwich was disassembled and the membrane used 
immediately or air dried. The membrane was incubated overnight in 100 ml of 20% 
milk powder in TBS buffer to block the unblocked sites on the membrane. The 
solution was replaced with 40 ml of 5% milk in TBS. The appropriate primary 
antibody (anti-D-mandelate dehydrogenase) was added and incubated at room 
temperature for 3 hours. The membrane was washed in 100 ml TBS, 4 times and 
placed in 40 ml fresh 5% milk in TBS. At this point, Horseradish 
peroxidase-conjugated goat anti-rabbit IgG (BioRad) (l0jil) was added as the second 
antibody. This was incubated for 2 hours. The membrane was washed thoroughly and 
developed by shaking in 10 ml of developing solution, until an orange band appeared. 
Water was added to stop the reaction, and the membrane was left to dry. 
2.10 Steady-State Kinetic Analysis 
The effect of substrate concentration on reaction rate of L-mandelate dehydrogenase 
flavin-binding domain was determined under steady-state conditions. Steady-state 
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All kinetic experiments were carried out on a Shimadzu 1601 UV/Vis 
spectrophotometer at either 5 ° C or 25 ° C where stated (5 °C experiments were 
carried out with the lab temperature 12 °C to prevent condensation forming on the 
cuvette). In all cases, the buffer used was 10 mM TrisfHCl pH 7.5, I 0.10 M. 
L-mandelate dehydrogenase flavin-binding domain, also in 10 mM TrisfHCl pH 7.5, I 
0.10 M, was removed from the liquid nitrogen store, thawed and kept on ice for the 
duration of the experiment. All the substrates which were obtained as acids were 
prepared by dissolving the required amount of acid in 10 mM TrisIHCl pH 7.5, 
10.10 M and titrated to pH 7.5 by addition of NaOH. The assay was carried out using 
the substrate in question (to an appropriate final concentration), 3.33 mM [Fe(CN) 6} 3 
(electron acceptor) and made up to the final volume using the above Iris buffer. Such 
a high concentration of [Fe(CN) 6] 3 was required since the flavin domain of the 
enzyme has a high Km for the electron acceptor. This level was sufficient to give 
saturating conditions. The solution was equilibrated to the reaction temperature prior 
to use. The protein (assay concentration between 0.2 tM and 0.04 jtM depending on 
reaction rates) was injected into the 2mm path length cuvette (used due to the high 
concentration of [Fe(CN)613) before mixing with the assay solution. The assay 
solution was mixed by inversion and placed in the cuvette with the protein. Assays 
were followed over either 1 or 2 minutes by the rate of change of absorbance of the 
[Fe(CN)6] 3 (AA450/At). The gradient of the straightest and most consistent part of the 
trace was used in each case. Rates for each concentration (k b ) was calculated using 
the equation below. 
L\A450 	. _ (mm )xassayvol(I) 
x 60(s) x p.L x protein voL (1) x [protein] (M) 
where k = the observed reaction rate 
= the extinction coefficient of the electron acceptor, ([Fe(CN) 6] 3 ) 
p.L = the path length of the cuvette (cm). 
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The kb, were plotted against the concentration of the substrate and fitted to a 
Micbaelis-Menten equation using Origin (Microcal), which allowed calculation of the 
kinetic parameters, kcat and Km. 
2.11 Pre-Steady-State Kinetic Analysis 
The pre-steady state experiments were conducted on an Applied Photophysics SF. 17 
Micro Volume stopped-flow spectrofluorimeter. Data were collected and initially 
analysed on an Applied Photophysics SpectraKinetics Workstation V4.34 package. 
The temperature was held very accurately at the relevant reaction temperature (5°C or 
25°C) using a Grant LTD 6 waterbath. Data were then fitted to the Michaelis-Menten 
equation using Origin (Microcal). Flavin and haem reduction rates in the intact 
enzyme were monitored at 438.3 nm (a haem isosbestic) and 557 nm respectively. In 
each case, fully oxidised enzyme was used. In L-mandelate dehydrogenase 
flavin-binding domain, FMN reduction was monitored at 450 rim. Stock solutions of 
protein were made fresh before experiments to a concentration of 15 jiM resulting in 
a reaction concentration of 7.5 iM. The k were plotted against concentration of 
substrate and fitted to a Michaelis-like equation, allowing the calculation of the kinetic 





The intact enzyme concentration was calculated by measuring the absorbance of the 




x dilution factor 
183000 
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where 183000 M'cm' is the extinction coefficient for the reduced form of the 
intact enzyme (the same as L-lactate dehydrogenase; Pajot and (iroudinsky,1970). 
The concentration of the L-mandelate dehydrogenase flavin-binding domain 
was determined by measuring the absorbance at the flavin peak in the spectrum 
(450 nm). The following equation was used to calculate the concentration: 
[protein] = AAbSOnm  x dilution factor 
11100 
where 11100 M 1 cm' is the extinction coefficient for the oxidised form of the enzyme 
(the same as L-Iactate dehydrogenase; Iwatsubo et al., 1977). 
2.13 Preparation of D,L-[2 2H1-mande1ic acid 
Initially, it was necessary to freshly prepare NaO 2H. This is done by adding, in 
small pieces (approximately 20), sodium metal to 9ml of 2H20 in a nitrogen flushed 
3-necked flask. This was added very slowly to the chilled flask to slow the initial 
reaction. After preparing the Na0 2H, D,L-mandeic acid was added. This solution was 
refluxed in an oil bath at 110°C for 2 hours and left to cool overnight. 
The crude, crystalline product was dissolved in 1 20m1 HC1. This was extracted 
in a separating funnel using 30ml diethyl ether, 4 times. The D,L-[2-2H]-mandeic acid 
went into the ether (upper) layer. The ether layer was kept on ice to stop evaporation 
and was dried over MgSO4 (with stirring) for about 1 hour. A little more MgSO 4 was 
added to ensure dryness. This was then filtered off and the ether solution was 
carefully removed using rotary evaporation. The white product was vacuum dried for 
20 minutes. 
50-80m1 chloroform was added to this dried product and the solution was 
refluxed. Approximately twice the volume of cyclohexane was added to make the 
solvent non-polar. Immediately, a precipitate formed. The flask was cooled to 4°C for 
1 hour and the purified product was ifitered under vacuum and dried on a vacuum line 







3. D-MANDELATE DEHYDROGENASE 
3.1 Introduction 
As was discussed in Chapter 1, the investigation of the characteristics of the 
D-mandelate dehydrogenase from R. graminis is of enormous scientific value, both 
commercially and medically. The previous studies carried out by Baker and Fewson 
(1989) have given the work a basis on which to build. We have seen that the enzyme 
in question is very different from the very well understood L-mandelate 
dehydrogenase from the same organism. D-Mandelate dehydrogenase is a soluble, 
NAD-dependent enzyme, similar to the NAD-dependent D-mandelate dehydrogenase 
from Lactobacillus curvatus (Hunimel et al., 1988). An initial characterisation of the 
native enzyme was carried out resulting in a four step purification (DEAE-Sephacel, 
Phenyl Sepharose, DEAE-Sephacel, Matrex Gel Orange A chromatography) and 
yielded 1-2 mg of enzyme from 40-50 g wet weight of cells. It was found to have a 
subunit M of about 38 kDa and a native Mr of 77.2 kDa, suggesting that the protein 
is a dimer in the native host. The cofactor was investigated by UV-Vis spectroscopy. 
Neither bound flavin nor cytochrome was seen. The enzyme was found to be 
NAD-dependent and an enzyme activity assay was developed to follow the reaction. 
The gene encoding D-mandelate dehydrogenase was cloned and sequenced, 
allowing work on overexpression (Illias, 1997). The following chapter describes and 
discusses the efforts in trying to improve upon the native expression and attempts at 
different types of purification systems. 
3.2 Results and Discussion 
3.2.1 pRC231D-MandelateDehydrogenase Construct 
Iffias (1997) cloned the D-mandelate dehydrogenase gene (a 1 kbase fragment) 
into several expression systems. These were pKK223-3, pTZ19R and pRC23. E. coli 
72 
D-Mandelate Dehydrogenase 
transformants harbouring each of the recombinant plasmids were grown and suitably 
induced. The pRC23 clone gave the best results, although somewhat less protein was 
obtained than from the native host. No stringent purification procedures were 
recorded by Iffias (1997). 
3.2.1.1 Expression of D-Mandelate Dehydrogenase 
The pRC23/ D-mandelate dehydrogenase construct was transformed (using 
the protocol described in section 2.3.3) into the E. coli strain, NF-1, which contains a 
ci repressor, c1857 which is inactivated at 42 °C, allowing transcription to occur from 
the XpL promoter on the plasmid. This was grown at 30 °C to an 0D 600 = 0.6 after 
which the temperature was raised to 42 °C. The cells were harvested by centrifligation 
in a Sorvall RC-513 centrifuge with a GS-3 rotor at 5000 g for 10 minutes. The brown 
cells were lysed by sonication and the resulting protein solution was assayed for 
activity. A typical set of results is described here (17 g wet weight of cells 
resuspended in 75 ml of 100 mM phosphate buffer). These results also serve to 
introduce the calculations for activities. 
In order to calculate the specific activity of the protein solution in question, 
two experiments were carried out. Firstly, a known dilution of the solution was 
scanned in a UV-Vis spectrometer from approximately 600 nm to 250 nm (required to 
encompass both 280 nm and 260 nm). The result of this (Figure 3.1) was used in 
equation 3.1 to determine the concentration of protein in the solution. 
[protein] = {(1.55 x A280nm) - (0.76 X A260n0} x dilution factor (3.1) 
Typical values obtained by UV-Vis spectroscopy were: 
A260 2.929 
A280 = 1.672 
Dilution factor = 50 
=> [protein] = 18 mg/mi 
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Figure 3.1. A typical UVIVis spectrum of a protein solution from cells containing a 
recombinant plasmid expressing n-mandelate dehydrogenase. 
Secondly, the activity of the enzyme was measured. The reaction was followed by 
watching NADH oxidation by phenyiglyoxylate to NAD at 340 nm (Figure 3.2). The 
recorded activity was the change in absorbance over 1 minute. The recorded activity 
was used in equation 3.2. The extinction coefficient of NADH, CNADH = 6200 M 1 . 
Total = 
Recorded Activity x Total Volume in Cell x Total volume (3.2) 
Activity 	e NAM x Volume of protein 
Using a total volume of 1.4 ml and a volume of protein solution, 100 il, a recorded 
activity of 0.427 was obtained. This gave a total activity of 7.2 x I mol/min, and 
since 1 unit (1 U) = I 0 mol/min, the total activity was recorded as 72 units. A 
specific activity was calculated using equation 3.3. 
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Figure 3.2. A typical assay for r-mandelate dehydrogenase activity. Recorded at 340nm, 
the assay detects the oxidation of NADH to NAD. As staled in the text, this was obtained 
from a lOOp! sample. 
The specific activity of the example was 0.05 Umg'. This is around one sixth of the 
activity in the cell lysate from R. graminis (0.28 tJmg'). 
3.2.1.2 PurWcation 
The protein was dialysed against at least a 10-fold excess of the purification 
buffer, after which the total activity of the sample had dropped by —20%. However, 
the total amount of protein present dropped by slightly more, resulting in a 5% 
improvement in the specific activity. 
Column chromatography with the resulting sample proved very difficult since 
the protein was present in only very small quantities. The protein, however, was 
loaded on to a pre-equilibrated Whatman DE-52 column and fractions were collected. 
These fractions were assayed for activity and all significantly active fractions were 
pooled. At this stage, a further loss of 20% activity was noted. Many proteins were 
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removed at this stage, but unfortunately, due to the loss of D-mandelate 
dehydrogenase activity, the specific activity remained much the same. 
The sample was concentrated using ammonium suffate, but again there was a 
significant loss of activity. The resultant solution was dialysed into the subsequent 
purification buffer and loaded onto an hydroxyapatite colunm. The protein appeared 
to bind irreversibly to this material since no activity was found in the eluted fractions. 
With other new preparations of D-mandelate dehydrogenase, many different 
types of ion-exchange and affinity chromatographic columns were attempted (Table 
3.1). On each occasion, the protein eluted in the wash-through immediately after 
loading, showed less D-mandelate dehydrogenase activity than the loaded sample. No 
protein could be retrieved to account for the lost activity. 
Table 3.1. Column materials and purification buffers used in attempts to purify 
D-mandelate dehydrogenase. The protein washed through each column without binding. 
DIT denotes DithiothreitoL 
Column material 
DEAE-Sephacel (Sigma) 
Phenyl Sepharose (Sigma) 




NADH affinity (Sigma) 
NADH affinity (Sigma) 
NADH affinity (Sigma) 
AMP affinity (Sigma) 
Purification buffer 
50 mM Tris/HCI, pH 8.0, 1 mM DTT 
50 mM TrisIHCl, pH 8.0, 1 mM DTT 
50 mM TrisIHCl, pH 8.0, 1 mM DTT 
50 mM TrisfIICl, pH 8.0, 1 mM DTT 
100 mM phosphate, pH 7.0 
50 mM TrisIHCl, pH 8.0,1 mM DTT 
50 mM TrisJHCl, pH 9.0, 1 mM DTT 
50 mM Tris/HCI, p11 8.0,1 mM DTT 
50 mM TrisIHCI, pH 5.85, 1 mM DTT 
50 mM TrisfHCl, pH 8.0, 1 mM DTT 
AMP affinity (Sigma) 	 100 mM phosphate, pH 7.0 
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3.2.1.3 Alternative Growth Medium 
Since very little expression was obtained using LB, the cells were grown in 
Terrific Broth, with a view to increasing the amount of D-mandelate dehydrogenase 
produced. The resulting total activity was disappointing in that it was comparable to 
that from cells grown in LB, 0.461 versus 0.427. After further unsuccessful 
purification attempts, it was felt that a better chance of success with the project would 
arise by obtaining a higher level of expression of the cloned gene product. This 
strategy lead initially to several cloning experiments to change the expression vector 
systems being used. 
3.2.3 pT7- 7/D-Mandelate Dehydrogenase Construct 
The availability of the pT7-7 expression vector within the lab and its tightly 
controlled expression system made it an ideal plasmid to begin overexpression 
attempts (Figure 3.3). The T7 promoter does not recognise the E. co/i RNA 
polymerase. However, the T7 polymerase gene is encoded within the ?.DE3 lysogen, 
immediately downstream of the lac promoter gene. Addition of IPTG removes the 
ability of the lac repressor protein to bind to the lac promoter, therefore T7 
polymerase is produced. This enables the target gene to be expressed. 
Ifimnill 
Sal 
Ampkilhin 	 pT7-7 
res Lance 23bp 
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NM 
promot& r 	Xbl 	atg 
rhs 
Figure 3.3. A schematic representation of the p T7- 7 ecpression vector. The restriction 
sites in the multiple cloning region and the 77 promoter are shown. The ampicillin 




The DNA encoding the D-mandelate dehydrogenase protein was prepared 
from the pTZ 1 9R construct (Iffias, 1997) where the D-mandelate dehydrogenase gene 
fragment had been cloned using EcoRI and Bami-il restriction sites, and thus could be 
extracted in the same manner (method as described in section 2.4.3). The freshly 
prepared pT7-7 vector was also cut with these enzymes. The cut vector and the 
D-mandelate dehydrogenase fragment were ligated to give a 3.5 kB plasmid. This was 
transformed into E. coil TG-1 and a large-scale preparation of DNA was carried out. 
At this stage there were two problems: i) the atg start codon for the D-mandelate 
dehydrogenase fragment was 21 bases from the ribosome binding site. The ideal range 
for this is 5-15 bases with an optimum at 7-9 bases, and; ii) there was a vector 
encoded start codon between the ribosome binding site and the start codon for the 
D-mandelate dehydrogenase fragment. Recognition of this start codon put the 
D-mandelate dehydrogenase fragment out of the correct reading frame (Figure 3.4). 
rbs 
	 D-mdh 
aaggaatatacata tgctagaattct tgcct 
ttcctctatatgtataccgatcttaagtacgga 
21 bases 
Figure 3.4. The region from the nbosome binding site (rbs) and the D-mandelate 
dehydrogenase fragment (n-MDH) in the original pT7-71D-mandelate dehydrogenase 
construct. They are separated by too many bases and an aig start codon that would read 
the D-mandelate dehydrogenase gene out offrame. 
Within the sequence shown in Figure 3.4, there are two restriction sites. These 
cut the DNA as shown in Figure 3.5, leaving overhanging single-stranded DNA. 
There were two options available to enable the DNA to be religated. Both involved 
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blunt-ending the DNA by either 'end-filling' or by removing the single-stranded DNA. 
The option of religating 'end-filled' DNA (Figure 3.6) would have yielded a product 
where the D-mandelate dehydrogenase gene start codon was 15 bases from the 
ribosome binding site. While this would have been satisfactory, religation of DNA 
where the single-stranded DNA had been previously removed was preferred. Mung 
Bean nuclease was used to blunt end the DNA (method detailed in section 2.4.4) 
which was then religated (section 2.4.5). This gave a 9 base separation of the 
D-mandelate dehydrogenase start codon and the ribosome binding site (optimal range) 
and removed the vector-encoded atg (potential) start codon such that the D-mandelate 
dehydrogenase gene start codon would be the only one associated with the 
ribosome-binding site of the vector (Figure 3.6). Since the D-mandelate 
dehydrogenase fragment contained the first start codon downstream of the 
ribosome-binding site, the gene would be expressed in the correct reading frame and 
the mature protein would be obtained. 
The success of the experiment was determined by restriction analysis. The 
resulting plasmid DNA was incubated in four separate digests with restriction 
enzymes: 1, EcoRl; 2, EcoRI/BamHl; 3, NdeI/BamFH; and 4, NdeI. An agarose gel 
(section 2.4.6) showing the appropriate cutting pattern is shown. Both NdeI and 
EcoRI do not cut the DNA since the recognition sites were removed upon blunt 
ending the DNA. The Bami-il enzyme cut the plasmid to leave a linear fragment of 
size, 3.5 kbases (Figure 3.7). 
rbs 	NdeI 	 D-mdh 
ttcctctatatgtataccgatcttagtacgga 
EcoRt 














rbs 	 D-mdh 




Figure 3.6. The product of the blunt ended religations. 3.61) refers to the 'end-filled' 
DNA, while 3.6ii) shows the product of removing the single-stranded DNA with Mung 
Bean nuclease. Red colouring denotes the 'end-filled' bases. 
4-3.5kb 
12345 
Figure 3.7. Restriction analysis of pT7- 7/D-mandelate dehydrogenase clone. Lanes are as 
follows: 1, 1 kb marker ladder; 2, p77-7/D-mandelate dehydrogenase digest with EcoRl (no 
cut observed); 3, p77-716-mandelate dehydrogenase digest with EcoRl and BamHI (single 
cut observed); 4, p77-71D-mandelale dehydrogenase digest with Nde! and BamHI (single 
cut observed); and 5, p77-.71D-mandelale dehydrogenase digest with NdeI (no cut observed). 
This is the expected cutting pattern for a successful clone. 
80 
D-Mandelate Dehydrogenase 
3.2.3.2 Expression Attempts 
The pT7-7/D-mandelate dehydrogenase construct was transformed into a 
number of strains of E. coli suitable for overexpression. The various strains were then 
grown in LB (with ampicillin) to an 0D 600 = 0.6 and then induced (either by 
temperature shill or addition of IPTG). The cells were harvested by centrifugation in a 
Sorvall RC-5B centrifuge with a GS-3 rotor at 5000 g for 10 minutes. The cell pellets 
were resuspended in 100 mM phosphate buffer (J)H 7.0) and PMSF (1 mM) and 
somcated. The solution was centrifuged (39000 g, 10 minutes) to remove any 
insoluble cell debris and unlysed cells. The protein solutions were assayed in the same 
manner as before to determine the specific activities (Table 3.2). 
Table 3.2. The specific n-mandelate dehydrogenase activity of various strain of E. coli 
containing the pT7-71D-mandelate dehydrogenase construct. Each was grown in LB and 
assays carried out at 25 ¶'. 
Strain 	 Specific Activity (Umg) 
NF 1 	 0.02 
	
B834 (DE3) 	 0.01 
BL21(DE3) 	 0.08 
BDS 	 0.10 
JM109 (DE3) 	 0.06 
The specific activity values were still low, and much lower than the 
0.28 Umg' seen from the native host. This target value (the point at which 
overexpression is achieved) of 0.28 Umg' was surpassed however, when the BDS 
host strain was grown in Terrific Broth (Table 3.3). While this represented the first 
overexpression of the protein, the increase was not that significant. 
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Table 3.3. The specific n-mandelate dehydrogenase activity of various strain of E. coli 
containing the pT7-71D-mandelate dehydrogenase construct. Each was grown in TB and 
assays carried out at 25 'C. All strains show an increase compared to growth in LB. 
Strain 	 Specific Activity (Umg) 
NF 1 	 0.09 
B834 (DE3) 0.21 
BL21(DE3) 0.20 
ft .) 
JM1O9 (DE3) 	 0.15 
The method of lysing the cells was also examined. Using lysozyme to break 
the cell walls produced much less total protein but also significantly less activity. This 
meant the specific activity remained very low (0.04 Urng'). Sonication gave a less 
clean solution (more total protein), but released more D-mandelate dehydrogenase 
activity into solution, thus increased specific activity was seen (0.12 Umg). 
3.2.3.3 Purflcation 
With the increase in amount of protein and increases in specific activity, 
attempts were again made to purify the protein to homogeneity. Many different 
methods were used to try and increase the purity of the protein. Protamine sulfate was 
added to the initial solution to a concentration of 0.1% in an effort to remove nucleic 
acids as a precipitate. The protein solution was brought to various ammonium sulfate 
concentrations to selectively precipitate D-mandelate dehydrogenase, thus increasing 
the purity of the enzyme. Dialysis was used to remove the salt from the resuspended 
solutions. The column materials that proved so successful in purifying the native 
protein (Baker and Fewson, 1989) were tested with both Tris and phosphate buffers. 
All the above steps lead to a reduction in the total protein concentration but this was 
always accompanied by a large loss of D-mandelate dehydrogenase activity (usually 
between 20 and 50%). 
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Again it appeared that a low level of enzyme was the main obstacle to 
furthering the project, so an alternative expression system was created. 
3.2.4 pJFJJ8/D-Mandelate Dehydrogenase 
The vector pJFll8 was used in an attempt to produce large quantities of 
D-mandelate dehydrogenase for two reasons. The vector was available within the lab 
and had been used to develop a very successful overexpression system for L-lactate 
dehydrogenase. 
3.2.4.1 Cloning and Expression 
The DNA fragment containing the gene encoding D-mandelate dehydrogenase 
was cut from the pTZ19R/D-mandelate dehydrogenase construct using the restriction 
enzymes EcoRJ and BaniIH. This was cloned directly in the pJFll8 plasmid (similarly 
cut). This needed no further adaptation prior to transformation into a variety of strains 
of E. coli. The various strains were grown in Terrific Broth to an 0D 600 = 0.6 and 
induced. The cells were harvested by centrifugation in a Sorvall RC-5B centrifuge 
using a GS-3 rotor at 5000 g for 10 minutes. The cell pellets were resuspended in 
phosphate buffer, pH7.0 and PMSF (1 mM). The cells were then sonicated and the 
resulting solution was centrifuged (39000 g, 10 minutes) to remove insoluble cell 
debris and unlysed cells. The protein solutions were assayed and specific activities 
calculated (Table 3.4). 
Since the specific activities were so low, no purification trials were carried out 
with the protein produced by this method. 
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Table 3.4. The specflc D-mandelate dehydrogenase activity of various strain of E. coli 
containing the pJFIJ8Io-mandelate dehydrogenase construct. Each was grown in TB and 
assays carried out at 25 'C. 
Strain 	 Specific Activity (Umg') 
JM109 (DE3) 	 0.05 
BL21 (DE3) 	 0.05 
BDS 	 0.05 
3.2.5 pET Vectors (Novagen) 
The purification of small amounts of the protein proved diflicult. The protein 
did not bind to the relatively non-specific ion-exchange columns or the affinity 
columns (NADH and AMP), and thus, a new approach was required. The approach 
chosen at this stage was to engineer an 'affinity' site onto one or other protein 
termini. A number of the pET vectors allow the engineering of a Histidine-Tag (6 or 
10 histidines at the protein terminus). Under most conditions (denaturing or 
non-denaturing), these histidine moieties should bind specffically to a Nickel column 
and be released on addition of 500 mM imidazole. This would allow the purification 
of even the smallest amounts of protein from a large sample volume. 
There were several pET vectors available within the lab that provided both a 
tightly controlled expression system and allowed for a Histidine-tag to be added to the 
protein. Two were chosen for this work, pET19b which allowed a cleavable 
Histidine-tag to be produced on the N-terminus of the protein and pET20b which 



























BgIH T7 promoter 
Figure 3.8. Schematic diagrams for both pETI9b and pET20b. Both contain a region 
encoding a Histidine-tag at the multiple cloning region. 
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3.2.5.1 pET I 9b/D-Mandelate Dehydrogenase 
3.2.5.1.1 Cloning 
The cloning of the D-mandelate dehydrogenase gene fragment into pET19b 
and remaining in frame (with the Histidine-tag) required the manipulation of an EcoRl 
restriction site in the D-mandelate dehydrogenase fragment. An EcoRI site within the 
vector was removed in order to allow specific manipulation of the DNA in the 
D-mandelate dehydrogenase gene. The restriction site was deleted by opening the 
vector DNA using the EcoRI site and blunt-ending the DNA using Mung Bean 
Nuclease. This was religated and the resulting vector, pET I 9bARJ, was checked by 
restriction analysis to ensure the loss of the EcoRI site. 
The D-mandelate dehydrogenase gene fragment was removed from the 
original pT7-7 construct (not the construct with the NdeI and EcoRI sites deleted) 
using the restriction enzymes NdeI and BamI-H. This fragment was directly ligated 
into the vector pET19bARI (Figure 3.9). This ligation left the D-mandelate 
dehydrogenase fragment out of frame with the Histidine-tag coding region. The DNA 
sequence at the junction of the pET I 9bARI vector and the N-terminal end of the 
D-mandelate dehydrogenase gene (Figure 3.9) contained the regenerated NdeI site 
and the EcoRl site in a similar way to that encountered in the initial cloning of the 
D-mandelate dehydrogenase gene into pT7-7. 
Ndet 	 D-mdh 
gacgaaaagcatatggctagta;t:tcatggcc 
His-Tag 4 ctgctgttcgccgatctgtaccgg 
pET19bARI 	EcoR! 
Figure 3.9. The ligated pET! 9bARI/D-mandelale dehydrogenase gene. The region around 
the D-mandelate dehydrogenase start codon is shown. The first start codon after the 
ribosome binding site is that for the Histidine-tag. The alternate green and blue bases show 
the reading frame. Restriction sites and cutting patterns are also shown. 
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There were two possible means of realigning the sequence (as before with pT7-7). 
The DNA was cut using the restriction enzymes NdeI and EcoRl, leaving an 
overhanging section of single-stranded DNA. An 'end-filling' approach to 
blunt-ending the DNA yielded a gene that encoded a protein with 3 extra amino acids 
at the N-terminus upon cleavage of the Histidine-tag (using enterokinase). The gene 
and derived protein sequence are shown in Figure 3.1 Oa. The second option was to 
once again remove the single-stranded DNA using Mung Bean nuclease. This was 
seen as the preferred option since the mature protein would only have one extra 
amino acid after cleavage of the Histidine-tag (Figure 3.1 Ob). The gene was checked 










His-Tag 4 AspAspLys'HisMet 
(b) 
Figure 3.10. The resulting gene and predicted DNA sequence after realigning. Figure 
3. lOa shows the three amino acids beyond the cleavage site (EK (enterokinase), coloured 
black) using the 'end-filling' approach. Figure 3. lOb shows only one amino acid beyond the 
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Figure 3.11. Restriction analysis of the pET! 9bARI/D-mandelale dehydrogenase 
construct. The lanes are numbered as follows: 1, 1kB marker ladder; 2, undigested 
pETI9bARJ/o-mandelate dehydrogenase; 3+4, pETJ9bARJJD-mandelate dehydogenose 
digested with EcoRJ (no cut observed); 5, pET 19b control digested with EcoRl (single cut 
observea 5.7kb); 6, undigested pETI9bARJ!D-mandelate dehydrogenase; 7, 1kB marker 
ladder; 8+9, pETI9bARJ!D-mandelate dehydrogenase digested with XbaI (single cut 
observed at 67kb, undigested DNA appears at —2.2kb): 10. pET 19b control digested with 
XbaI (single cut observed, 5.7kb); 11 + 12, pETJ 9bARI/D-mandelale dehydrogenase digested 
with Ndel (no cut observed); 13, pET 19b control digested with NdeI (single cut observed. 
5.7kb). 
3.2.5.1.2 Expression 
The resulting vector was transformed into a number of different strains of 
E. co/i. The cells were grown as before in LB. The specific activities of the cell 
extracts were no greater than the previous attempts (Table 3.5) and neither the 
induced nor uninduced cell extracts showed any large, prominent bands at 38 kDa on 
an SDS-PAGE gel. A band was visualised on a Western blot of the cell extracts using 
anti-D-mandelate dehydrogenase antibodies (same as Illias, 1997) 
With induction at OD600 = 0.6 seeming to produce very little protein, the effect 
of inducing earlier in the growth log-phase was examined (Table 3.5). Inducing 
expression at OD600 = 0.45 increased the specific activity of all the strains. This was 
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caused by a reduction in the total protein concentration while the D-mandelate 
dehydrogenase activity remained the same. 
Table 3.5. The specific D-mandelate dehydrogenase activity of various strain of E. coli 
containing the pETI9bARIJD-mandelate dehydrogenase construct. All cells were groii in 
LB and induced at 0D 00 = 0.45 or 01)600 = 0.6. 
Strain 	Specific Activity (Umg'). Specific Activity (Umg'). 
0D600 = 0.45 	 0D600 = 0.6 
	
JM109 (DE3) 	 0.22 	 0.09 
B834 (DE3) 	 0.26 	 0.10 
BL21 (DE3) 	 0.22 	 0.10 
BDS 	 0.31 	 0.09 
The E. co/i strain that gave best results for this system was BDS. Further 
attempts to improve the levels of expression used this strain. A study into the effect of 
the length of time of induction was carried out (Table 3.6). The results suggested that 
growth of this strain in Terrific Broth and a short induction was optimal. The minimal 
media was poorest of all, with the added disadvantage of a 5 day growth to 0D600 = 
0.45. 
Table 3.6. The specjJic D-mandelate dehydrogenase activity after altering the medium of 
growth of BDS containing the pETJ9bARJID-mandelate dehydrogenase construct. 
Induction Time (hours) 	 Growth Medium 
TB 	LB 	Minimal 
3 	 0.29 	0.24 	0.16 
6 	 0.22 	0.20 	0.13 
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One further attempt to increase the yield of protein was made. Employing a 
harsher somcation (twice as long), it was hoped more protein would be released 
(Table 3.7). The specific activity of the resulting cell extracts looked as if a great 
advance had been made. The 3-hour induction of cells grown in Terrific Broth gave a 
10-fold increase in D-mandelate dehydrogenase specific activity. However, the activity 
(and thus the yield) of the protein was very much lower than the others. The high 
specific activity of the protein was an artefact of the very low total protein in solution. 
In all other cases, more total activity was seen from the growth induced for 6 hours. 
However, this gave proportionally more of the other proteins in the cell, i.e. the 
specific activity was reduced. 
Table 3.7. The specific D-mandelate dehydrogenase activity after a double sonication. All 
values from growth of BDS containing the pETI9bARJJD-mandelate dehydrogenase 
construct. 
Induction Time (hours) 	 Growth Medium 
2.81 	 0.23 
6 	 0.94 0.33 
c. 3.2.5.1.3 Purification 
Protein was produced for purification trials by growing BDS cells containing 
the pET 19bARI/D-mandelate dehydrogenase construct in Terrific Broth, inducing at 
0D600 = 0.45. The protein with an N-terminal Histidine-tag did not purif' on a nickel 
column under non-denaturing conditions. All activity washed through the column on 
loading. Attempts were made to denature the protein at various concentrations of 
guanidine hydrochloride and urea. This made following the protein very difficult since 
activity was lost. No activity was regenerated when either the denatured wash through 
or any proteins eluted using imidazole after washing the column were dialysed to 
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remove the denaturant. No significant bands were seen on SDS-PAGE or on a 
Western blot of the dialysed eluent. This indicated that there was no binding of the 
protein to the affinity column. 
An obvious next stage in this work was to engineer a Histidine-tag to the 
C-terminus of the protein. 
3.2.5.2 pET201D-Mandelate Dehydrogenase 
3.2.5.2.1 Altering the D-Mandelate Dehydrogenase Gene 
The need to adjust the reading frame of the protein after cloning, as carried 
out with pT7-7 and pET I 9b, was seen as a time consuming exercise. This was 
avoided by altering the D-mandelate dehydrogenase gene from the pTZ 1 9R/ 
D-mandelate dehydrogenase construct. The unaltered gene showed an tcoKi 
restriction site immediately before the start of the D-mandelate dehydrogenase 





Figure 3.12. The EcoRl site in the pTZI9RI o-mandelaie dehydrogenase construcL 
This EcoRl site provided the position into which we wanted to introduce an NdeI 
site (enabling direct cloning into most expression vectors). This could be done simply 







Figure 3.13. The required alteration to change the EcoRl site into an Ndel site. The tic 
bases are changed to cat. 
Initially, this was to be carried out using site-directed mutagenesis with the 
primer cggccagtgaa atgcctcgccc (the alteration is shown in red). 
The resulting restriction analysis of the product was inconclusive and an alternative 
method was used. 
The use of the polymerase chain reaction (PCR) was employed to incorporate 
the required changes into the DNA. This allowed both the NdeI site at the start of the 
gene to be inserted and the stop codon to be removed (this was necessary to allow 
incorporation of the C-terminal Histidine-tag). The latter was carried out by replacing 
the stop codon with a restriction site (Not!) that allowed direct cloning into the 
pET20b vector. Two primers were required for this process: 1) the primer with the 
sequence of the NdeI change. gaatcagcatatgcctcgcCCtCg (random 
bases in black, change in red, D-mandelate dehydrogenase sequence in blue); and 2) 
the primer with the complementary sequence of the Not! change (colours as above), 
atctgattgcggccgcgtaggcgCgaaaagC. 
The PCR was carried out and gave a correct sized band on an agarose gel 
(slightly more than 1kB). After purification, the PCR product was cloned into 
specialised PCR cloning vector pGEM-T (Promega) and the resulting plasmid was 
transformed into E. co/i TG 1. The altered D-mandelate dehydrogenase fragment was 
cut from pGEM-T using the engineered sites (this also acted as proof of the PCR 
having worked). The gene was ligated into the similarly cut pET20b vector to give the 
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D-mandelate dehydrogenase gene in frame with the Histidine-tag (Figure 3.14). The 
resulting pET20b/D-mandeate dehydrogenase construct was transformed into several 




tacgcggccgcac tcgagcac cac 
Not! 
Figure 3.14. The tail end of the pET20b/Li-mandeaie dehydrogenase construct. The 
histidine-tag is in the correct reading frame (shown by alternating colours) with respect to 
the D-mandelafe dehydrogenase gene. 
3.2.5.2.2 Expression and Purification 
The various strains were grown in Terrific Broth in the same manner as the 
pETl9b construct. Activity was noted from the NADH assay. This was taken as proof 
of successfi.il cloning. The specific activities of the cell extracts upon sonication were 
similar to those previously discussed (Table 3.8). 
Table 3.8. The spec jfic o-mandelaie dehydrogenase activity of various strain of E. coil 
containing the pET20b /L-mandelate dehydrogenase construct. All cells were grown in TB 
and induced at OD600 = 0.45. 
Strain 	 Specific Activity (Umg') 
JMI09 	 0.08  
B834 0.19 




Since the specific activity was largest with BL21 cells, a large-scale growth 
was carried out. The cells were sonicated and an appropriate purification procedure 
for the nickel column was tried. Again, the protein washed straight through the 
colunm upon loading. Denaturing experiments were again attempted, but activity 
could not be regenerated in either the wash through or the eluent. No bands were seen 
on SDS-PAGE of the eluent. 
3.3 Conclusion 
Despite a great deal of effort to clone the D-mandelate dehydrogenase gene 
into a variety of different vectors designed for protein overexpression, the actual 
levels of expression were disappointingly low. In each case, D-mandelate 
dehydrogenase activity was found (indicating the cloning steps had occurred as 
expected), but the specific activity was never greatly increased compared to the native 
yeast production. With the protein seeming to lose activity in the various purification 
steps attempted, the tiny quantity of protein was the main hindrance to the work. 
Surprisingly, the histidine-tagged proteins would not puriI' on the nickel columns, 
even under denaturing conditions. However, with no activity regenerated from any 
fractions, it would appear that being able to purif' the protein under denaturing 
conditions would be of little benefit. 
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4. INITIAL CHARACTERISATION OF L-MANDELATE 
DEHYDROGENASE 
4.1 Introduction 
L-mandelate dehydrogenase from R. graminis has been cloned, sequenced and 
expressed in E. coli (Illias, 1997) and shown to be very similar to the L-lactate 
dehydrogenase from S. cerevisiae. This chapter details the initial kinetic 
characterisation of the enzyme and its independently expressed flavin-binding domain. 
Since the mandelate and lactate dehydrogenase have some similar properties, many of 
the results will be compared to those with L-lactate dehydrogenase. Much of the work 
covered in this chapter was carried out in collaboration with Rhona Sinclair, also of 
this lab. 
4.1.1 Expression of L-Mandelale Dehydrogenase 
A very efficient expression system has been developed for L-mandelate 
dehydrogenase from R. graminis (Illias et al., 1998) The method of achieving 
overexpression was, however, somewhat surprising. Best results were achieved by 
cloning the L-mandelate dehydrogenase DNA fragment into pRC23 (which contains a 
?. PL promoter; Crowl et al., 1985). The resultant plasmid was transformed into an E. 
coli strain allowing only for constitutive growth (JM109). Transforming the plasmid 
into a strain expressing a temperature-senstive ci repressor, allowing for temperature 
shift induction (for example, NFl, Stanley and Luzio, 1983) resulted in a lower level 
of protein expression. Growth and purification procedures can be found in Chapter 2. 
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4.1.2 Expression 	of L-Mandelate 	Dehydrogenase 
Flavin-Binding Domain 
As has been stated in Chapter 1, each subunit of the intact enzyme contains 
two domains - a small cytochrome domain and a much larger flavin-binding domain. 
The bound flavin group is the key to the catalytic properties of the enzyme. It must 
accept two electrons from the oxidation of mandelate to phenyiglyoxylate. In the 
holoenzyme, the reduced flavin then passes electrons, one at a time to the haem in the 
cytochrome domain. The flavin mediates the flow of electrons to the haem (one 
electron at a time). The electron is then passed from the haem to cytochrome c before 
the haem can accept the second electron. 
The role of flavin in this complex system is difficult to ascertain since spectral 
changes in the flavin absorbance are largely masked by the absorbance of the haem 
group. It was clear that in order to investigate and properly understand the properties 
of the flavin and the flavin-binding domain in general, it would be useful to isolate the 
flavin-binding domain in the absence of haem. 
Site-directed mutagenesis was used to introduce a restriction site between the 
sequences encoding the haem and the flavin-binding domains. This also introduced an 
atg (start) codon immediately before the codon for Gly 99, the first residue of the 
flavin-binding domain (Figure 4.1) 
The gene encoding the flavin-binding domain was cloned into pRC23 (the 
same plasmid as was used for the intact enzyme). The recombinant plasmid was 
transformed into E. coli JM109 cells. The growth procedure was the same as for 
intact protein, with the cells grown at 37 °C for 48 hours in TB with ampicilhin. After 
centrifugation, the light brown pellet had a yellow tinge to it. This indicated a 
successful growth. The purification of L-mandelate dehydrogenase flavin-binding 
domain was also found to be easier and quicker than for the intact enzyme. A full 
account can be found in section 2.8. 
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DNA 	att ggc 	ge 	gaa ttc a12 uc 	aa2 aat 2c 
A.A. 1 G G 	 M G K N A 
II\F\I DONI \!\ Restriction Site F I \\I\-UI\DJ\C I)()'s! \i\ 
(Eco RI) 
Figure 4.1. The modjfications to the gene encoding L-mandelate dehydrogenase, to 
enable independent expression of L-mandelate dehydrogenase flavin-binding domain 
(L-MDHJd). A.A is the amino acid sequence predicted from the gene. 
4.2 Results and Discussion 
4.2.1 Steady-State Kinetic Properties of L-Mandelate 
Dehydrogenase 
Steady-state kinetic measurements were made using L-mandelate 
dehydrogenase and various mandelate derivatives: L-mandelate; D,L-mandelate; and 
D,L-[2- 2H]-mandelate. L-mandelate dehydrogenase catalyses the oxidation of 
mandelate to phenyiglyoxylate, transferring the electrons, physiologically, to 
cytochrome c. In this study, the enzymatic turnover of substrate has been measured 
using both the physiological electron acceptor and the artificial electron acceptor, 
potassium ferricyanide. Since one aim of this study was to compare the results to 
those found for L-Iactate dehydrogenase from S. cerevisiae, all the steady-state 
experiments were carried out under the same conditions (10 mM Tris/HC1, pH 7.5, 1 
0.10 at 25.0 ± 0.1 °C). All the data obtained were analysed by non-linear least-squares 
regression using the Michaelis-Menten equation (see section 2.10). 
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4.2.1.1 The Physiological Electron Acceptor, Cytochrome c 
It is clear from the data in Table 4.1 that both L-mandelate dehydrogenase and 
L-lactate dehydrogenase work well with cytochrome c as electron acceptor. The 
values Of kcat and Km are almost identical, suggesting that interaction with cytochrome 
c is similar for both enzymes. 
Table 4.1. Steady-state kinetic parameters for t-mandelate dehydrogenase (L-mdh) and 
L-lactate dehydrogenase (L..ldh) with horse heart cytochrome c as electron acceptor 
(35 pM). Assays were carried out at 25.0 ± 0.1 CC in Tris/HC1 pH7. 5 1 0.10. L-ldh values 
taken from Miles et al., 1992. 
Substrate 	 Enzyme 
L-mdh 	L-ldh 
i-mandelate kcat (s') 	225±15 	- 
L-mandelate Km (mM) 	0.35±0.15 	- 
L-lactate kcat (s) 	 - 	207±10 
L-lactate K. (mM) 	 - 	0.24±0.04 
Sinclair (1998) backed up the suggestion that L-mandelate dehydrogenase and 
L-lactate dehydrogenase interact with cytochrome c in a similar fashion by showing 
that both enzymes show a dependence of reaction rate on the concentration of 
cytochrome c. In fact, both enzymes show an identical Km for cytochrome c, 
10 ± 1 riM, indicating that the enzymes interact with their physiological electron 
acceptor in a similar way. 
The independently expressed flavin-binding domain was found to have no 
L-mandelate dehydrogenase activity with cytochrome c as electron acceptor. 
Electrons at the flavin in the intact enzyme are passed to cytochrome c via the 
haem-binding domain. Activity is abolished in the absence of the haem-binding 
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domain. A similar result was found for the independently expressed flavin-binding 
domain of L-lactate dehydrogenase. Here, an activity was measured, but this was 
104-fold lower than wild-type enzyme (0.02 s as compared to 207 s; Balme et al., 
1995). 
4.2.1.2 Ferricyanide as Electron Acceptor 
It is to be expected that the wild type, intact L-mandelate dehydrogenase 
should interact well with its physiological electron acceptor, but is the enzyme as 
efficient with an artificial electron acceptor, for example, ferricyanide? Table 4.2 
allows a comparison of the observed rate of the recombinant enzyme with previously 
reported parameters for L-lactate dehydrogenase. 
Table 4.2. Steady-state kinetic parameters for L-mandelate dehydrogenase (L-mdh) and 
L-lactate dehydrogenase (L-ldh) using ferricyanide as electron acceptor. All experiments 
carried out at 25.0 ± 0.1 'C in 10 mM Tris/HC1, pH 7.5, I 0.10. Ferricyanide (1 mM) was 
used as electron acceptor. 
Substrate 	 Enzyme 
L-mdh 	L-ldh 
L-mandelate k (s) 	550 ±25 	 - 
L-mandelate K. (mM) 	0.35 ± 0.02 	 - 
i-lactate kcat (s') 	 - 	 400 ± ba 
i-lactate K. (mM) 	 - 	 0.49 ± 0.05 
a  Miles et aL, 1992. 
Once again, the steady-state kinetic parameters for L-mandelate 
dehydrogenase with mandelate and L-lactate dehydrogenase with lactate are similar 
and thus, it would appear that these enzymes bind substrates and catalyse reactions in 
a similar fashion. 
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L-mandelate dehydrogenase and its fiavin-binding domain displayed different 
ferricyanide concentration dependence (Km = 100 .tM and 340 j.tM respectively). The 
steady-state assays were carried out at saturating concentrations of potassium 
ferricyanide (1 mM and 3.33 mM respectively). 
Although the flavin-binding domain of L-mandelate dehydrogenase was 
unable to pass electrons to cytochrome c, it showed good L-mandelate dehydrogenase 
activity with ferricyanide as electron acceptor. Within error, the ability of L-mandelate 
dehydrogenase flavin-binding domain to turn over substrate is indistinguishable from 







0 	 2 	 4 	 6 	 8 
[LandeIate] (mM) 
Figure 4.2. A comparison between the Michaelis-Men ten plots for L-mandelate 
dehydrogenase (L-mdh) and its flavin-binding domain (L-mdhfd) with L-mandelate. 
4.2.2 Pre-Steady-State Kinetic Properties of L-Mandelate 
Dehydrogenase 
The rate of fiavin reduction by L-mandelate was measured under 
pre-steady-state conditions. The FMIN reduction traces of both L-mandelate 
dehydrogenase and the flavin-binding domain were analysed as the sum of 2 
exponential functions (a double exponential fit). At first glance, both would be 
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Table 4.3. Steady-stale kinetic parameters of mandelale and lactate enzymes. The kinetic 
parameters of L-mandelate dehydrogenase (L-mdh), its flavin-binding domain (L-mdhfd) and 
the flavin-binding domain of L-lactate dehydrogenase (L-ldh fd) are compared. The latter 
are taken from Balme et al., 1995. All experiments carried out in 10 mM Tris/HC1, pH 7.5, 
I 0.10. Ferricyanide (1 mM for L-mdh; 3.33 mM for L-mdh fd; and 6 mM for L-ldh fd) was 
used as electron acceptor. 
Substrate Enzyme 
L-mdh L-mdh fd 	L-ldh fd 
L-mandetate k,, t (s') 	550 ±25 500 ±50 	 - 
L-mandelate K. (mM) 	0.35 ± 0.02 0.33 ± 0.05 	 - 
L-Iactate kcat (s 1 ) 	 - - 	 273 ± 6 
L-Iactate Km (mM) 	 - - 	 0.22 ± 0.05 
expected to fit to a single exponential, but for differing reasons, a double exponential 
fit was used. An explanation was proposed as to why pre-steady-state kinetic data 
obtained using intact flavocytochrome b2 should require a double exponential 
(Capeillere-Blandin et al., 1975). Initially, the substrates (4 in a tetramer) reduce the 
FMN (the fast phase). One electron for each FMN is distributed to each haem, leaving 
a flavin semiquinone and reduced haem. The second, slow phase is seen when there is 
electron redistribution amongst the flavins to allow 2 fully reduced and 2 fully 
oxidised fiavins. A further 2 substrate molecules enter and reduce the oxidised flavins 
(Figure 4.3). The L-mandelate dehydrogenase flavin-binding domain reduction rates 
were also analysed using a double exponential. This was also observed for the 
flavin-binding domain of L-lactate dehydrogenase from S. cerevisiae, where although 
the enzyme should display monophasic kinetics, enzyme that had lost some activity 
(through, for example, storage or purification) required fitting to a double exponential 
(Balme et al., 1995). A pre-steady-state trace, fitted to a double exponential function 
is shown in Figure 4.4. The values of FIvIN reduction in the mandelate dehydrogenase 
enzymes seemed at first to be somewhat surprising (Table 4.4). 
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Figure 4.3. Full reduction of the tetrameric L-mandelale dehydrogenase (electrons are 
shown as blue dots). A total of six molecules of mandelate are required to fully reduce 
L-mandelate dehydrogenase. Step 1 shows the four FAIN moieties being reduced (by four 
molecules of mandelate). There is a single electron transfer to haem from each FAIls (step 
2). Electron rearrangement occurs in step 3 leaving two fully oxidised and two fully 
reducedflavins. A further two molecules of mandelate fully reduce the enzyme in step 4. 
The rate of L-mandelate dehydrogenase FMN reduction by its substrate is 
approximately half that of L-lactate dehydrogenase. It is not immediately obvious why 
this should be the case. The initial assumption was that the enzyme did not have a full 
complement of flavin, but this was shown not to be the case (Sinclair. 1998). Neither 
fully reduced FMN nor the semiquinone form show any absorbance at the 450 nm (the 
wavelength absorbed by fully oxidised FMN). If step 3 (Figure 4.4) occurs sufficiently 
rapidly, then the rate of reduction of FMN is eroded by this rapid reoxidation 
(Pompon et al., 1980). 
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Figure 4.4. A typical pre-steady-state trace (raw data shown in blue, double exponential 
fit shown in red) for FMN reduction (L-mandelale dehydrogenase flavin-binding 
domain). The reaction shown was carried out with an L-mandelate concentration of 1 mM 
and an enzyme concentration of 10 uM and was recorded at 25 'C in Tris/HC1 buffer 
pH7.5, 10.10. 
Table 4.4. Pre-Steady-State FMN reduction kinetic parameters with L-mandelate 
dehydrogenase enzymes (L-mdh and L-mdh fd) and L-lactate dehydrogenase enzymes. All 
experimenls were carried out in 10 mM Tris/HCI, pH 7.5 10.10 at 25.0 ± 0.1 'C. 
Substrate 	 Enzyme 
L-mdh 	L-Idh 	- L-mdh fd 	L-Idh Id - 
L-mandelate k1 (s') 	280 ± 20 	- 	450 ± 30 	- 
L-mandelate K(mM) 0.35 ± 0.10 	- 	0.39 ± 0.10 	- 
L-Iactate k1 (s') 	 - 	604 ± 60' 	- 	400 ± 40b 
L-Iactate K (mM) 	- 	0.84 ± 0.20' 	- 	0.26 ± 
aMilesel aL 1992 	bflalmeet aL 1995 
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4.2.3 Kinetic Isotope Effects 
While the physical and chemical properties of isotopically substituted 
molecules are, in most cases, very similar, the same is not true for a hydrogen -* 
deuterium swap. The reason for this is that there is a huge discrepancy in mass 
between hydrogen and deuterium (the mass is doubled). It is this mass that determines 
the zero-point vibrational energy of the C—H and C—D bonds. The expression for 
calculating the vibrational energy at a particular vibrational energy level, v (equation 





E is energy, v is the vibrational energy level, h is Planck's constant (h = h/2 ) 
= (k/) where k is the force constant of the bond and .t is the reduced mass (see 
equation 4.3). 




This gives a Lc = 12/13 and a 
LCD = 12/7 thus the C—D unit has a larger reduced 
mass than C—H. This leads to a lower minimum vibrational energy (zero-point 
energy). The difference in the zero-point energy of these bonds is approximately 
5 kJmol' (Jencks, 1969; Figure 4.5). 
Both bonds dissociate at the same energy, thus the difference in dissociation 
energy is approximately 5 kJmot'. In terms of reaction rate, this corresponds to the 
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determine the contribution to the rate-determining step that cleavage of the C—H 
bond makes. If a k/k€ ratio is equal to I then the cleavage of this bond is not 
involved in the rate-determining step. If the ratio is equal to 7 then the rate is entirely 
limited by this step. If the ratio falls somewhere between I and 7, then we 
can assume that cleavage of this bond has an effect on the rate of the reaction, but is 
not the sole factor in rate limitation. 
Figure 4.6. Potential Energy (P. E.) diagram of C—H and C—D bonds. More energy is 
required to dissociate a C—D bond since the zero-point energy is lower, but both 
dissociate at the same energy. 
Steady-state kinetic isotope effect experiments had been carried out on native 
L-mandelate dehydrogenase in a previous piece of work (Smekal et al., 1993). This 
showed that there was no appreciable isotope effect (k€/k. = 1.1 ± 0.1). This 
was in stark contrast to the kinetic isotope effect obtained for L-lactate dehydrogenase 
(4.7 ± 0.4; Pompon et al., 1980) which suggested rate limitation by the aC—H bond 
breakage. Since there was such a clear difference here, the result was interpreted to 
mean the enzymes had different transition states. 
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The kinetic isotope effect for cleavage of the a-carbon hydrogen of substrate 
upon oxidation using recombinant L-mandelate dehydrogenase and its flavin-binding 
domain was investigated using both steady-state and pre-steady-state conditions. The 
preparation of [2- 2H]-mandelate (section 2.13) allowed only the racemic mixture. 
Direct comparison of rate constants were made using values for D,L-mandelate and 
[2-2H]-D,L-mandelate. The data presented in table 4.5 for steady-state turnover of 
mandelate contradicts the previous study of Smekal. 
Table 4.5. The steady-state kinetic isotope effect values for L-mandelate dehydrogenase 
and L-lactate dehydrogenase with respective substrates. Ferricyanide (1 mM) used as 




L-mdh 	 L-ldh 
'H substrate kcat 300 ± 5 400 ± 10 
'H substrate K. 0.47 ± 0.03 0.49 ± 0.05 
2H substrate kcat 88 ± 4 86 ± 5 
2H substrate K. 0.53 ± 0.05 0.76 ± 0.06 
ME 3.5± 0.2 4.7±0.4a 
'1Miles et aL, 1992 
The cleavage of the aC—H bond contributes significantly to rate limitation. 
This is in line with the value given for L-lactate dehydrogenase. The electron transfer 
steps following the breakage of the C—H bond further erode the kinetic isotope 
effect. The experiment using cytochrome c as electron acceptor showed a smaller 
value (Table 4.6). This is also seen in L-lactate dehydrogenase, although to 
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a lesser extent. This evidence however, would seem to support the fact that the 
transition state of both enzymes are similar. 
Table 4.6. The steady-state kinetic isotope effect for L-mandelaie dehydrogenase and 
L-lactate dehydrogenase with appropriate substrate. Cytochrome c (35 4uA'I) was used as 




'H substrate k,. t  155 ± 5 207 ± ba 
'H substrate K. 0.78 ± 0.02 0.24 ± 0.04 
2H substrate kcat 92 ± 10 70 ± ba 
2H substrate K. 1.33 ± 0.10 0.48 ± 0.10a 
ME 1.7± 0.3 3.0±0.6a 
aMiles et aL, 1992 
The pre-steady-state kinetic isotope effect gives an insight into the degree of 
rate limitation of flavin reduction (or substrate oxidation), by the breakage of the 
C-2--H bond. The results in Table 4.7 suggest that the rate constant for this step is 
almost completely dependent on this bond cleavage. This again indicates that there 
must be other factors in rate determination in the steady-state. The values for L-lactate 
dehydrogenase confirm the similarity of the two enzymes and the way they oxidise 
substrate. 
The steady-state and pre-steady-state values for the flavin-binding domain of 
L-mandelate dehydrogenase were in good agreement with those obtained using the 
intact enzyme (Tables 4.8 and 4.9). 
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Table 4.7. Pre-steady-state kinetic isotope effect for FMN reduction in L-mandelate 
dehydrogenase (L-MDH) and L-.lactate dehydrogenase (L-LDH; values taken from Miles 





'H substrate kf 210 ± 10 604 ± 60 
'H substrate K 0.47 ± 0.10 0.84 ± 0.20 
2H substrate k1 43 ± 5 75 ± 5 
2H substrate K 0. 35 ± 0.05 1.33 ± 0.28 
KIE 4.9±1.0 8.1±1.4 
Table 4.8. Steady-state kinetic isotope effect values for L-mandelate dehydrogenase 
(L-.mdh) and its independently expressed flavin-binding domain (L-mdh fd). 
Substrate Enzyme 
L-mdh L-mdh fd 
'H substrate 300 ± 5 316 ± 18 
'H substrate K. 0. 47 ± 0.03 0.74 ± 0.11 
2H substrate kcat 88 ± 4 99 ± 4 
2H substrate K. 0.53 ± 0.05 0.79 ± 0.08 
ME 3.5±0.2 3.2±0.3 
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Table 4.9. Pre-steady-state kinetic isotope effect values for L-mandelate dehydrogenase 
(L-mdh) and its independently expressed flavin-binding domain (L-mdhfd). 
Substrate 	 Enzyme 
L-mdh L-mdh fd 
'H substrate kf  210 ± 10 339 ± 9 
111 substrate K 0.47 ± 0.10 0.45 ± 0.07 
2H substrate kf  43 ± 5 81 ±3 
2H substrate K 0. 35 ± 0.05 0.33 ± 0.05 
KEE 	 4.9± 1.0 	 4.2±0.3 
4.3 Conclusion 
Recombinant L-mandelate dehydrogenase from R. graminis, expressed in E. 
coli has been shown to work very well with both its physiological electron acceptor, 
cytochrome c, and the artfficial electron acceptor, ferricyanide. The flavin-binding 
domain has also been independently expressed in E. coli. This functions well with 
ferricyanide, but is inactive with cyto chrome c. The kinetic parameters are comparable 
to those seen for S. cerevisiae L-lactate dehydrogenase with L-lactate. The kinetic 
isotope effect values show that the abstraction of the C-2 hydrogen contributes to the 
rate limitation of enzyme turnover. This effect, however, is eroded through the 
electron pathway until there is very little rate determination from the C-2 hydrogen 
cleavage in the transfer of electrons from intact protein to cytochrome c. The kinetic 
isotope effect results are also very similar to that of L-lactate dehydrogenase with 
L-lactate. This suggests that the transition states of the enzymic reactions are similar. 
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5. STRUCTIJRE-ACTWITY CORRELATION OF 
L-MANDELATE DEHYDROGENASE 
5.1 Introduction 
Many organisms, both eukaryotes and bacteria, possess one or two mandelate 
dehydrogenase enzymes. This, at first glance, seems to be somewhat surprising since 
mandelate is not prevalent in nature. There have been several reports of 
mandelate-utilising enzymes that tolerate a degree of ring substitution, for example 
naturally occurring hydroxylated and methoxylated substrates. These include the 
mandelate dehydrogenases from A. calcoaceticus (Kennedy and Fewson, 1968), P. 
putida (Gunter, 1953) and A. niger (Jamaluddin et al., 1970; Kishore et al., 1976) which 
all use 4-hydroxymandelate. A. calcoaceticus and P. putida have also been found to use 
4-hydroxy-3-methoxymandelate. Interestingly, in the case of P. putida, the enantiomer 
used depends on the strain, since the mandelate racemase enzyme is unusually specific 
and cannot use 4-hydroxy-3-methoxymandelate as a substrate (Fewson, 1992; Hegeman 
et al., 1970). The following sections provide some background to the broad specificity of 
the mandelate-utilising enzymes. 
For many years the major method of determining the specificity of enzymes was 
to grow the host organism on the substrate in question as the sole source of carbon and 
identify the enzymes involved. There are several studies that show that many enzymes 
that use mandelate can also use a variety of substituted mandelates. In 1953, Gunter 
showed that Pseudomonas fluorescens was capable of growth on both mandelate and 
4-hydroxymandelate. This type of study was designed to elucidate a mechanism by which 
the organism breaks down substrate (here, 4-hydroxymandelate). 4-Hydroxymandelate 
was degraded by a series of reactions parallel to the degradation of mandelate. 
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The degradation of mandelate was also investigated in Aspergillus niger 
(Jamaluddin et al., 1970). Again, 4-hydroxymandelate was oxidised by the cell-free 
extracts of the organism grown in the presence of mandelate. The same group confirmed 
that this was in the same pathway (Kishore et al., 1976). This showed that the enzymes of 
the mandelate pathway must have a broad specificity. 
A strain of Acinetobacter iwoffli degraded not just 4-hydroxymandelate, but also 
4-hydroxy-3-methoxymandelate (Sze and Dagley, 1987). This organism also had the 
enzymes of the mandelate degradation pathway, and thus the broad specificity was seen 
to be extended past 4-hydroxymandelate. 
Structure-activity correlation analyses of various enzymes have been carried out 
using mandelates as probes. The reaction mechanism of L-lactate oxidase from 
Aerococcus viridans was investigated using para-substituted L-mandelates (Yorita et al., 
1997). The results of the Hanimett plot gave a negative p value (suggesting an increasing 
positive charge in the transition state). Whilst this is inconsistent with the formation of a 
discrete carbanion in the transition state, it may be in line with the transition state 
required in a hydride transfer mechanism. 
This chapter will concern itself with the rates of reaction with a variety of 
substituted mandelates, to allow a more detailed understanding of the substrate specificity 
of this enzyme. Of course, carrying out such a series of experiments also allows us to 
examine the results using a Hammett-type approach. This will be explained with the aid 
of a previous study (Smekal et al., 1994) in section 5.2. 
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5.2 Structure-Activity Correlation of Native L-Mandelate 
Dehydrogenase 
This section introduces a structure-activity study on native L-mandelate 
dehydrogenase (Smekal et al., 1994). 
The oxidation of various substituted mandelates by enzymes can be analysed using 
a Hammett-type approach. The Hammett treatment of data aims to determine the effect 
of a meta- or para-substituent on the rate of reaction. Attempts were made by Smekal et 
al. (1994) to correlate kcat values (Table 5.1) with the classical Hammett relation 
(equation 5.1). 
log (kcat)R = log(kcat)H + UP 	Equation 5.1 
Excluding 4-hydroxymandelate, the kcat values for all substrates agreed fairly well 
with the standard type of Hanimett parameters; cy, a, up, cy. All fits resulted in a 
reasonable magnitude for the reaction constant (all positive p values and thus the reaction 
is helped by electron-withdrawing groups). The p values were all fairly small (< 0.5) 
indicating a small demand on electron density at the C-2 carbon of the transition state. 
A further insight into the separate contributions of inductive and resonance effects 
was gained by analysing the data in terms of dual substituent parameters. This correlation 
is given by Taft's dual substituent parameters equation (equation 5.2) 
log (k t)R = log(k)H + 	+ cYR) 	Equation 5.2 
Where (kcat)R, (kcat)H and p are as above; a, is the inductive contribution to the total 
electronic effect; (YR is the resonance contribution; and ?, is the proportional factor of (YR 
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Table 5.1. Steady-stale kinetic parameters for substituted mandelates with native L-mandelate 
dehydrogenase. All experiments were carried out at 25 'C in Tris1HC1 buffer, pH 7.5, I 0.10. 
Ferricyanide (1mM) was used as electron acceptor. The data is taken from Smekal et al. (1994). 
Where (k cajR = k, for substituted mandelate, R; (k) = k 0, for D,L-mandelate; a is the 
substituent (total electronic effect) constant; and pis the reaction constant. 
Substrate k,, t (s) K. (mM) 
L-mandelate 114 ±6 0.24 ± 0.04 
D,L-mandelate 94 ± 5 0.35 ± 0.05 
D,L-[2-2H1-mandelate 93 ± 5 0.74 ± 0.11 
4-chloro-D,L-mandelate 116 ± 6 0.38 ± 0.06 
4-bromo-D,L-mandelate 108 ± 5 0.26 ± 0.04 
4-fluoro-D,L-mandelate 98 ± 5 0.16 ± 0.02 
4-methyl-D,L-mandelate 80 ± 4 0.17 ± 0.03 
3-methoxy-D,L-mandelate 106 ± 5 0.12 ±0.02 
4-methoxy-D,i-mandelate 68 ±3 0.12 ± 0.02 
3-hydroxy-D,L-mandelate 108 ± 5 0.15 ± 0.02 
4-hydroxy-D,L-mandelate 146 ± 7 0.08 ± 0.01 
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versus cy1. The inductive contribution to the total electronic effect does not change 
whether a substituent is meta or para and is obtained from the literature (Hansch et al., 
1991). The a values however, are derived using the following equations (equations 5.3, 
5.4; Chapman and Shorter, 1978). 






and (YM are also obtained from the literature (Hansch et al., 1991). The constant, a, 
can either be 0.33 (standard Hammett relation) or 0.5. The a = 0.5 value takes into 
account reaction centres which are incapable of conjugation with the ring at any stage. 
For example, a = 0.5 would be used if the carboxylate in a phenylacetic acid series was 
the reaction centre (Figure 5.1). 
Substituted phenylacetate Substituted mandelate 
rel 
Figure 5.1. The structures of substituted phenylacetate and mandelate. The reaction centre in 
mandelate is the alcohol at C-2 and thus there is a capability of conjugation with the aromatic 
ring. 
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By plotting the Taft's dual substituent parameter against log kat, Smekal et al. 
made a number of deductions. The p value was found to be 0.36, in line with the simple 
Hammett plot. Of more interest from this plot was the ? value, which was found to be 
0.64. The ?. value gives an estimate of the resonance demand on the C-2 carbon of 
mandelate by the aromatic ring. The X = 0.64 value indicates that the relative importance 
of the resonance contribution was around two-thirds of the inductive effect. This obvious 
discrepancy between these contributions is explained in terms of the structure of the 
transition state. The resonance effect would be less than the inductive effect if the C-2 - 
C-3 bond was twisted so that the C-i - C-2 bond was no longer co-planar with the 
aromatic ring, i.e. less overlap of ir-orbitals between C-2 and the ring. 
The conclusions drawn from this work were: all the substituted mandelates are 
oxidised by L-mandelate dehydrogenase in the same way; the C-2 carbon is electron rich 
in the transition state; the transition state is non-planar; and importantly, the kinetic 
isotope effect evidence (Table 5.1) suggests that L-mandelate dehydrogenase catalyses 
the reaction with different transition state to L-lactate dehydrogenase. 
What is clear from the discussion above is that there are a number of flaws in the 
work that require updating. We can see from Table 5.1 that the kinetic isotope effect of 
substrate oxidation is given as 1. Chapter 4 has shown that since this time, the kinetic 
isotope effect has been found to be very significant. This may have been due to the 
mandelate used by Smekal not being fully deuterated, but in addition, there is evidence 
that the enzyme was not functioning optimally. The rate of turnover for L-mandelate in 
the Smekal study was 109 s_ I compared to the recent value of 550 
5I  (almost certainly 
due to a lack of flavin in the purified native enzyme). There was one further flaw in the 
previous investigation. The values used in the Hammett relation and Taft's dual 
substituent parameters relationship did not directly correspond to the rate of substrate 
oxidation. The values quoted were of enzyme catalytic turnover, kcat. This was probably 
another instance where the quantity and quality of protein prevented the study being 
backed up with microscopic rate constants from pre-steady-state kinetics. Here, a more 
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complete examination of the substrate specificity and structure-activity correlation of 
L-mandelate dehydrogenase from R. graminis is presented. It is the flavin-binding domain 
of L-mandelate dehydrogenase that is used in this study since it allows the absorbance of 
the flavin to be seen more clearly without masking from the haem. 
5.3 Results 
5.3.1 Determining the Best (Physiological?) Substrate 
Since it was felt that an analysis of this form would be best done using rate of 
fiavin reduction (equal to the rate of substrate oxidation), pre-steady-state rates were 
obtained using Stopped-Flow apparatus. Experiments were initially carried out at 25 °C. 
However, it was quickly realised that some of the rate constants for flavin reduction were 
approaching the limit of the apparatus. This problem was overcome by carrying out 
experiments at 5 °C. A typical trace is shown in Figure 5.2. Data were fitted to a 
Michaelis-like equation and Table 5.2 shows the kinetic parameters for the various 
substrates. 
The most striking observation from the pre-steady-state flavin reduction rates is 
the activity of 4-hydroxy-D,L-mandelate (Figure 5.3). The enzyme is much more active 
with this substrate than with any other, including mandelate. A comparison of the 
catalytic efficiencies of the enzyme with these two substrates dramatically demonstrates 
this (Figure 5.4). 
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Table 5.2. Pre-sleady-state kinetic parameters for the reaction of L-mandelate dehydrogenase 
flavin-binding domain with mandelate and substituted mandelates. All experiments were 
carried out at 5 °C in Tris/HCI, pH 7.5, 1 0.10. Errors quoted represent standard deviations 
from a non-linear, least squares fit. 
Substrate k (s') K(mM) k/K (mM's') 
L-mandelate 230 ± 14 0.12 ± 0.03 1.92 x 103 
D,L-mandelate 196 ± 16 0.53 ± 0.10 3.71 x 102 
nj-12-2H1-mandelate 31 ± 2 0.17 ± 0.04 1.85 x 102 
4-chloro-D,L-mandetate 340 ± 18 0.48 ± 0.06 7.08 x 102 
4-bromo-D,L-mandelate 387 ± 22 0.66 ± 0.09 5.86 x 102 
4-fluoro-D,L-mandelate 161 ± 12 0.44 ± 0.09 3.67 x 102 
3-methoxy-D,L-mandelate 118 ± 9 0.22 ± 0.04 5.38 x 102 
4-methoxy-D,L-mandetate 201 ± 17 0.14 ± 0.04 1.43 x 103 
3-hydroxy-D,L-mandelate 111 ± 7 0.55 ± 0.09 2.03 x 102 
4-hydroxy-D,L-mandelate 708 ± 42 0.09 ± 0.02 7.87 x 103 
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Figure 5.2. A typical pre-steady-state trace for L-mandelate dehydrogenase flavin-binding 
domain. The reaction shown is the FMIV reduction (followed at 450nm) by , 
4-chloro-D,L-mandelate (0.5mM). Enzyme was used at a concentration of I OpivI. The raw data 
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Figure 5.3. A Michaelis plot of 4-hydroxy-D.L-mandelate and DL -mandelate. A direct 
comparison can be made between the racemic mixtures. 
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Figure 5.4. Comparison of the enzyme efficiency of L-mandelate dehydrogenase 
flavin-binding domain with substrate analogues. Data as taken from Table 5.2. The substrates 
are: 1, L-mandelate; 2, D.L-mandelate; 3, D.L-[2-2HJ-mandelate; 4, 4-chloro-D.L-mandelate; 5, 
4-bromo-D.L-mandelate; 6, 4-fluoro-D,L-mandelate; 7, 3-met hoxy-D .L-mandelale; 8, 
4-melhoxy-D.L-mandelate; 9, 3-hydroxy-DL-mandelate; 10, 4-hydroxy-D.L-mandelate. 
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All the substrate analogues were obtained as the racemic mixtures and thus, it is 
appropriate that any comparisons between mandelate and its analogues be made with 
D,L-mandelate. Figure 5.4 shows that 4-hydroxy-D,L-mandelate is 20-fold more efficiently 
oxidised than mandelate itself. This result raises the distinct possibility that the natural 
substrate for L-mandelate dehydrogenase is, in fact, 4-hydroxy-L-mandelate. While it has 
been known that mandelate dehydrogenases have had the ability to use hydroxylated and 
methoxylated substrates, this would appear to be the first instance where such a clear 
selection for a substituted analogue is made. The preference of the enzyme for 
4-hydroxy-L-mandelate is in agreement with the prevalence of substrates in the 
environment, where mandelate is scarce (Fewson, 1988). The evidence presented here 
suggests that L-mandelate dehydrogenase flavin-binding domain should be classified as a 
4-hydroxy-L-mandelate dehydrogenase rather than a true mandelate dehydrogenase. 
5.3.2 Structure-Activity Correlations 
Since the rates measured by the pre-steady-state method for flavin reduction are 
presumably equal to the rate of substrate oxidation, it is clearly appropriate to analyse the 
reaction using a Hammett-type approach. To this end, Tail's dual substituent parameters 
equation was used to gain an insight into the contributions from both the inductive and 
resonance effect (Hansch et al., 1991; Chapman and Shorter, 1978). The equation used 
was very similar to equation 5.2. In this case however, kai is replaced by k, the rate of 
flavin reduction (equation 5.5). 
log (k)R = log (k)H + 	+ 2aR) 	equation 5.5 
As before, (k)R = k for substituted mandelate R, (k)H = k for mandelate, a is the 
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resonance contribution. The data fitted to this equation very well (Figure 5.5) with the 
exception of both the 4-hydroxy-D,L-mandelate and 4-methoxy-D,L-mandelate. Good 
hydrogen bond partners such as hydroxy, methoxy and nitro substituents have been 
shown to frequently disturb the fit to Hammett-type equations (Hartmann and Klinman, 
1991; Walker and Edmonson, 1994; Pollegioni et al., 1997; Yorita et al., 1997). This 
strongly suggests that there is a possibility of hydrogen bonding in the active site between 
an amino acid group and these para-substituents. This hydrogen bonding would appear to 
be confined to the region of the active site occupied by a para-group, since the 
meta-substituted equivalents adhere to the Hammett-type relation. 
The correlation demonstrated in figure 5.5 is significantly different to that 
obtained in the previous Smekal study. 
Figure 5.5. Hammett- Taft plot for the oxidation of the substituted mandelates by L-mandelate 
dehydrogenaseflavin-binding domain. The graph demonstrates the linear relationship between 
log k and the optimum combination of the Hammeti-Tafi parameters 
( + 0.92 crj ). 
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The p value obtained using the pre-steady-state data, 1.51, was more than 4 times 
greater than that found in the previous, steady-state study. The positive slope of the 
correlation points to a rate enhancement by electron-withdrawing substituents. This 
indicates a much greater demand on electron density from the ring substituents than was 
previously thought (where p = 0.36). The magnitude of the p value suggests that this is a 
significant effect. This is consistent with an electron rich C-2 (carbanion character) in the 
transition state. Superficially, this would seem to favour the carbanion mechanism (where 
the C-2 hydrogen leaves as a proton). However, the positive p value could also be 
indicative of the ability of the deprotonated alcoholic oxygen to feed negative charge to 
C-2, forcing the C-2 hydrogen to leave as a hydride (Figure 5.6). 
Of particular interest from the Hammett-Tafl plot is the value of A. A Xvalue of 
0.92 is obtained, indicating that the resonance contribution to the substituent constant is 
approximately the equal to that of the inductive contribution. The fact that X is 
approximately 1.0 is supportive of the idea that the transition state is planar. This would 
be expected if the carbanion species occurs at C-2. The electron would be diffused onto 
the ring and the ir-orbitals on the ring would align with those on C-2 (i.e. C-2--C-3 
would be planar, not twisted). The hydride transfer mechanism is however also supported 
by this planarity. The developing double bond between the alcoholic oxygen and C-2 
would require a planar C-2--C-3 bond. 
To fully test the results of the Hanimett relation, steady-state kinetic data were 
obtained for all the substrates at 5 °C (Table 5.3). The assumption was that these would 
be less appropriate for a Hammett-Taft analysis than pre-steady-state data. This was 
proven to be true since the data gave no straight line when analysed using Taft's dual 
substituent parameters equation (equation 5.2). It is notable that 
4-hydroxy-D,L-mandelate is still by far the best substrate for L-mandelate dehydrogenase 
under steady-state conditions (approximately 7-fold more efficiently used). This would 
appear to confirm the suggestion made earlier, that L-mandelate dehydrogenase is a 
4-hydroxy-L-mandelate dehydrogenase. 
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Figure 5.6. The possible mechanisms supported by a positive p value. (a) shows the carbanion 
mechanism where the C-2 hydrogen is abstracted as a proton by the active site base (histidine). 
As a carbanion forms on C-2, there is a developing negative charge. (b) shows the hydride 
transfer mechanism. The alcoholic proton is abstracted by the active site base, leaving a 
negative charge on the oxygen. The electron-withdrawing nature of the substituted aromatic 
ring pulls electron density towards C-2 (a developing negative charge at this carbon). This 
increasing negative charge forces the C-2 hydrogen to leave as a hydride to relieve the 
negative charge. 
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Table 5.3. Steady-state kinetic parameters for the reaction of L-mandelate dehydrogenase 
flavin-binding domain with mandelate and substituted mandelates. All experiments were 
carried out at 5 'C in Tris/HC1, pH 7.5, 10.10. Ferricyanide (3.33mM) was used as the electron 
acceptor. Errors quoted represent standard deviations from a non-linear, least squares fit. 
Substrate kcat (s') Km (mM) kcat 1Km (mM's) 
L-mandelate 207 ± 8 0.13 ± 0.02 1.59 x 103 
D,L-mandelate 213 ± 14 0.27 ± 0.06 7.88 x 102 
D,L-12-2H1-mandelate 44 ±3 0.18 ± 0.04 2.43 x 102 
4-chloro-D,L-mandelate 206 ± 15 0.18 ± 0.05 1.15 x 103 
4-bromo-D,L-mandelate 123 ± 7 0.17 ± 0.04 7.22 x 102 
4-fluoro-D,L-mandelate 170 ± 13 0.38 ± 0.11 4.47 x 102 
3-methoxy-D,L-mandelate 126 ± 7 0.13 ± 0.03 9.69 x 102 
4-methoxy-D,L-mandelate 230 ± 15 0.24 ± 0.07 9.60 x 102 
3-hydroxy-D,L-mandelate 100 ± 9 0.36 ± 0.11 2.79 x 102 
4-hydroxy-D,L-mandelate 506±35 0.10 ± 0.03 5.06 x 103 
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5.5 Conclusion 
The substrate analogue analysis of L-mandelate dehydrogenase (carried out using 
the flavin-binding domain) has shown that we must be careful when we refer to the 
enzyme simply as an L-mandelate dehydrogenase. Both steady-state and pre-steady-state 
analysis of the enzyme have shown that 4-hydroxymandelate is a much better substrate. 
Hammett-Taft analyses of both steady-state and pre-steady- state kinetic data were 
attempted with only the pre-steady-state data yielding a good correlation. This gave a 
reaction constant, p, of 1.51 suggesting that there is significant demand on electron 
density at C-2 in the transition state. It was found that the inductive and resonance 
contributions to the substituent constant, a, were almost identical, suggesting a planar 
transition state. Both p and A. are consistent with either a carbanion mechanism or a 
hydride transfer mechanism. 
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Chapter 6: 
Aliphatic Substrates of 
L-Mandelate Dehydrogen use 
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6. 	ALIPHATIC 	SUBSTRATES 	OF 
L-MANDELATE DEHYDROGENASE 
6.1 Introduction 
Over the last few years, there have been several pieces of work which have 
generated interest in the substrate specfficity of recombinant L-mandelate dehydrogenase 
and in particular, the independently expressed flavin domain. These have included 
examinations of the substrate specificity of other, related enzymes (Daff et al., 1994; 
Sinclair et al., 1998) and investigations into the substrate specificity of native L-mandelate 
dehydrogenase (Smekal et al., 1993; Yasin, 1993). In the following sections, some work 
on the specificity of L-lactate dehydrogenase and the results of this study are discussed. 
6.2 Altering the Specificity of L-Lactate Dehydrogenase from 
S. cerevisiae (Daff el aL, 1994) 
Attempts to alter the substrate selectivity of enzymes have been carried out on a 
number of occasions, notably for a lactate dehydrogenase from Bacillus 
stearothermophilus. A change in one amino acid lead to a huge increase in activity with 
oxaloacetate, rather than pyruvate (Wilks et al., 1988). Several mutations in the same 
enzyme resulted in a broad-specificity enzyme that had an increased ability to catalyse the 
oxidation of larger 2-hydroxyacids (Wilks et al., 1990). However, the focus here will be 
on the L-lactate dehydrogenase from S. cerevisiae. 
L-lactate dehydrogenase is a 2-hydroxyacid dehydrogenase which catalyses the 
oxidation of L-lactate to pyruvate very efficiently. Daff et al., (1994) carried out a 
detailed substrate specificity analysis with other aliphatic 2-hydroxyacids to investigate 
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the selectivity of the enzyme. An attempt was also made to alter the specificity of the 
enzyme by mutation of active site amino acids. 
Data were collected for the wild type enzyme with a range of 2-hydroxyacids 
(Daff et al., 1994). The substrates used were: glycolate; L-lactate; L-2-hydroxybutyrate; 
L-2-hydroxyvalerate; L-2-hydroxyhexanoate (L-2-hydroxycaproate); and 
L-2-hydroxyoctanoate. Figure 6.1 shows that, as expected, the enzyme turns over lactate 
at a much higher rate than the other substrates (from 5 times faster than 
L-2-hydroxybutyrate to 60 times faster than glycolate). It was not surprising, given the 
introduction of larger substrate side groups to the active site that the rate of turnover 
should be reduced. It was shown that the increase in activity shown with the longest chain 
substrates i.e. those of L-2-hydroxycaproate and L-2-hydroxyoctanoate is in line with the 
reduction in Km for these substrates. The tighter binding for longer chain substrates can 
be easily explained. The long, hydrophobic 'tail' of these molecules would find a more 
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Figure 6.1. Steady-stale kinetics for wild-type L-lactale dehydrogenase from S. cerevisiae with 
a variety of substrates. The substrates are labeled according to the number of carbon atoms: 2. 
glvcolate; 3, L-lactate; 4, L-2-hydroxybutyrate; 5, L-2-hydroxyvalerale; 6, L-2-hydroxycaproate; 
8, L-2-hydroxyoclanoate. 
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The next step in the Daff et al. (1994) study was to attempt to engineer more 
selectivity towards the larger substrates. It was thought that this would be most 
successfully done by simply increasing the space at the active site in the region of the side 
chain of pyruvate in the crystal structure. Upon inspection of the active site in the crystal 
structure and sequence alignment with similar proteins, it was thought that alteration of 
Alanine 198 and Leucine 230 would have the greatest effect on changing the substrate 
selectivity of the enzyme. The single mutation of A198G appeared to do little but destroy 
the enzymatic activity. The kcat values were universally reduced and the K. values 
increased. While the A198 residue appears to affect catalysis, it is not significantly 
involved in substrate selection. This would be explained if Al 98 interacted with the 
-CH2 of the substrate and thus its removal would disrupt catalysis non-specifically. 
Much more profound changes were seen when residue L230 was mutated to an 
alanine. The L-lactate dehydrogenase activity was greatly reduced, with the kcat more than 
10-fold lower and the K. more than 10-fold higher. At the same time, the rate of turnover 
of L-2-hydroxyoctanoate was unchanged within error, but, more importantly, was greater 
than that for L-lactate. This, of course, represented a change in substrate specificity for 
this enzyme. 
An interesting aside to this work involved the determination of whether branched 
substrate side chains had an effect on turnover. It was found that using 
L-2-hydroxyisovalerate (chain length 4, with a 51h  carbon (a methyl) branching off C-3), 
neither L-lactate dehydrogenase nor any of the mutants showed any activity. However, 
the extra steric bulk of L-2-hydroxyisocaproate (branched at C-4) maintained similar 
activity to L-2-hydroxycaproate. This was thought to be explained by the aromatic ring of 
Tyr-254 being in contact distance of C-3, thus due to steric hindrance, branching here 
results in no activity. 
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Figure 6.2 Substrate specificity profiles of L-lactate dehydrogenase and mutant enzymes. 
Substrates are labeled according to chain length: 2, glycolale; 3, L-laciaIe; 4, 
L-2-hydroxybuiyrate; 5, L-2-hydroxyvaleraie; 6, L-2-hydroxyCaprOate; 8, L-2-hydroxyoctanoate. 
The two mutant enzymes shown are more efficient with L-2-hydroxyoctanoaie than L-lactate, i.e. 
their specficity has been changed by the mutations. 
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6.3 Redesign of L-Lactate Dehydrogenase Towards 
Mandelate Dehydrogenase Activity (Sinclair et aL, 1998) 
Whereas L-lactate dehydrogenase from S. cerevisiae is very active towards 
L-lactate (a rate constant of 400 s_ I is seen), it is very poor at utilising mandelate as a 
substrate (the kcat value is only 0.02 s'). The rate is in fact so low, that a K. value is 
impossible to determine. 
Since the object of the Sinclair et al. (1998) study was to introduce more activity 
with mandelate, the strategy used was the same as in Daff et al. (1994), i.e. to create a 
larger cavity at the active site. This time three residues were singled out for mutations to 
make a larger hole at the active site: Ala-198, Leu-230 and Ile-326. The Ile-326 -> Ala 
mutation caused very little variation in activity of the enzyme towards L-mandelate. The 
increase in rates of turnover achieved were greatest when A198 and L230 were mutated 
to glycines (20-fold and 40-fold respectively). The Leu-230 -+ Ala mutation gave a 
5-fold gain in kcat value. The A198G/L230G double mutation would seem, from this 
observation, to be the most interesting double mutant. However, active enzyme was not 
produced on attempts to express this. The A198G1L230A double mutation was available 
and gave the best results, increasing the mandelate activity approximately 400-fold (to 
8.50 sd ). The double mutant also presented the first change in preference of substrate 
with mandelate being more efficiently oxidised than lactate (Figure 6.3). 
This was a very elegant piece of work that showed that the specificities of the 
flavocytochromes b2 are mainly controlled by just one or two amino-acid side-chains. It is 
more difficult to see where the remaining loss of rate between L-mandelate 
dehydrogenase (550 s) and L-lactate dehydrogenase A198GfL230A (8.50 .) comes 
from. This would seem to be evidence of the enzyme fine-tuning through evolution and 
there are probably many small, but important alterations involved in binding aromatic 
rather than aliphatic substrates. 
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Figure 6.3. Substrate spec j/icity profiles for wild type and mutant L-!aclate dehydrogenase. 
The catalytic efficiencies of the various enzymes are shown with L-mandelate and L-laclate. The 
enzymes are numbered as follows: I, wild type; 2, 1326A; 3, Al 98G; 4, L230A; 5, L230G; 6, 
A 198G/L230A; 7, A 198G/L230A. Enzymes I to 6 refer to intact L-lactale dehydrogenase, while 
7 refers to the fiavin-binding domain of L-lactate dehydrogenase. 
6.4 Results 
6.4.1 Long, Straight-Chain 2-Hydroxyacids 
The following results all refer to the independently expressed flavin-binding 
domain of L-mandelate dehydrogenase. This was chosen since the change in flavin 
absorbance can be more accurately measured in the absence of the much larger haem 
absorbance. 
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As has just been discussed, there have been attempts to change the specificity of 
L-lactate dehydrogenase from S. cerevisiae into a mandelate dehydrogenase with a great 
deal of success. Comparing the two studies that were used as an introduction to this 
work, we can see that whether by coincidence or design, the mutant L-lactate 
dehydrogenase with the most mandelate activity also was also the best long-chain 
2-hydroxyacid dehydrogenase. Interestingly, the A198G1L230A double mutant oxidised 
L-2-hydroxyoctanoate much more rapidly than L-mandelate (nearly 10-fold faster). This 
leads to an obvious question. Is the L-mandelate dehydrogenase from R. graminis a good 
long-chain 2-hydroxyacid dehydrogenase? 
Previous attempts to allow L-mandelate dehydrogenase to use 2-hydroxyacids as 
substrates (for example, L-2-hydroxycapro ate (Smekal et al., 1993) and 
2-hydroxy-D,L-valerate (Yasin,, 1993)) had failed, with inhibition the only process taking 
place. However, with recombinant protein, and more especially the independently 
expressed flavin-binding domain of L-mandelate dehydrogenase becoming available, it 
was felt that this study could be more accurately carried out. 
The rates of substrate oxidation were measured under steady-state conditions 
using ferricyanide as electron acceptor. Figure 6.4 shows an FMN reduction trace under 
steady-state conditions. The data were plotted and fitted using the Michaelis-Menten 
equation. The plots of the best and worst substrates tested, L-2-hydroxyvalerate and 
L-lactate are shown in Figure 6.4. Although the kcat values were much lower than for 
aromatic substrates, L-mandelate dehydrogenase flavin binding domain was found to have 
the ability to catalyse the oxidation of aliphatic 2-hydroxyacids (Table 6.1). 
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Figure 6.4. A Michaelis-Menten piot for two aliphatic substrates, L-iactate and 
L-2-hydroxyvalerate, with L-mandelale dehydrogenase flavin binding domain. The and Km  
values for these and the other long-chain 2-hydroxyacids can be found in Table 62. 
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Table 6.1. Steady-state kinetic parameters for oxidation of long-chain 2-hydroxyacids by 
L-mandelate dehydrogenaseflavin binding domain. All experiments were carried out at 25 'C 
in Tris/HC1, pH 7.5, I 0.10. Ferricyanide (3.33mM) was used as the electron acceptor. Errors 
quoted represent standard deviations from a non-linear, least-squares fit. 
Substrate chain length kcat (s4 ) K. (mM) kcat/Km  
(mM's) 
L-mandelate - 500 ± 50 0.35 ± 0.02 1.57 x 103 
L-Iactate 3 0.81 ± 0.12 1.00 ± 0.42 0.81 
L-2-hydroxybutyrate 4 2.96 ± 0.18 0.32 ± 0.08 8.94 
L-2-hydroxyvalerate 5 10.3 ± 0.3 0.34 ± 0.04 30.4 
L-2-hydroxycaproate 6 3.45 ± 0.17 0.21 ± 0.04 16.4 
1-2-hydroxyoctanoate 8 3.95 ± 0.21 0.14 ± 0.04 28.2 
The broad trend seen in Table 6.1, is that as chain length increases, the kcat is 
raised and the K. is reduced. This is shown very clearly in a plot of catalytic efficiency of 
the enzyme, Figure 6.5. While these kcat increases and the Km reductions are not large, 
they seem to agree with what our intuition might tell us. That is that the larger the side 
chain of substrate, the more able they are to fill the active site. In steric terms, they 
occupy an increasingly similar space as a phenyl ring. The Km may also be falling in part 
for the same reason that the K. was seen to reduce by Daff et al. (1994). The longer 
hydrophobic 'tail' finds the protein environment much more favourable than the solvent 
and will thus be more inclined to bind into the protein active site. Of course, a glance at 
Figure 6.5 tells us that while this trend is broadly true, there is one obvious deviation. The 
peak for L-2-hydroxyvalerate efficiency is greater even than that of 
L-2-hydroxyoctanoate. 
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Figure 6.5. The catalytic efficiency of L-mandelate dehydrogenase flavin-binding domain 
with long-chain 2-hydroxyacids. The substrates are labelled as follows: lac, L-lactate; but, 
L-2-hydroxybulyrale; val, L-2-hydroxyvalerate; cap, L-2-hydroxycaproate; oc,, 
L-2-hydroxyoctanoate. A clear trend is shown with L-2-hydroxyvalerate not conforming. 
The rate of turnover of the enzyme with L-2-hydroxyvalerate is 2 to 3 times faster than 
that of L-2-hydroxycaproate and L-2-hydroxyoctanoate. The reason for this departure 
from such an obvious and readily explained trend is unclear. What is interesting to note is 
that in the substrate specificity study on wild type L-lactate dehydrogenase, the activity 
and the efficiency of the enzyme with L-2-hydroxyvalerate is lower than the other 
long-chain 2-hydroxyacids. No reason for this was postulated. However, the mutant 
enzymes in the Daff et al. (1994) study throw up an important point. The A198G and 
A198G/L230A mutants, while changing the selectivity of the enzyme also universally 
reduce the efficiency of the enzyme. This is not true for the L230A mutant. Again, in 
most cases, the efficiency has been eroded with respect to the wild type enzyme. In 
contrast, the efficiency of the enzyme with L-2-hydroxyvalerate has improved (59 mMs1 
to 79 mMs'). This was thought to have arisen because this substrate may be the 
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appropriate length to occupy the hole in the active site created by removing a leucine and 
replacing it with the smaller alanine, avoiding steric crowding. It is possible that there is a 
similar reason for the anomaly in the trend in the present study. This, however, remains 
speculation in the absence of a crystal structure. 
6.4.2 Branched-Chain 2-Hydroxyacids 
An additional investigation into substrate specificity of aliphatic 2-hydroxyacids 
was carried out using more bulky, branched substrates. The rationale behind this was that 
we may have been able to fill the active site more fully and turnover rate may increase. 
Firstly however, we were interested to see if this enzyme tolerated branching of substrate 
side chain to a greater degree than L-lactate dehydrogenase. There were a number of 
interesting points taken from the results of the steady-state kinetic analyses of the chosen 
substrates (Figure 6.6, Table 6.2). In contrast to the results from the study on L-lactate 
dehydrogenase, we see that activity is achieved with branching at C-3. 
OH 
	








Figure 6.6. The various branched substrates used in this study. 
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Table 6.2. Steady-state kinetic parameters for the oxidation of branched 2-hydroxyacids with 
L-mandelaie dehydrogenaseflavin binding domain. All experiments were carried out at 25 C 
in Tris/HC1, pH 7.5, I 0.10. Ferricyanide (3.33mM) was used as the electron acceptor. Errors 
quoted represent standard deviations from a non-linear, least-squares fit. 




2.65 ± 0.21 	0.28 ± 0.09 	9.46 
L-2-hydroxyisocaproate 
	
13.8 ± 1.0 	0.37 ± 0.11 	37.3 
3,3-dimethyl-2-hydroxybutyrate 
	ND 	ND 	 ND 
1-hexahydromandelate 	7.44 ± 0.57 0.30 ± 0.09 	24.8 
Comparing the L-2-hydroxyisovalerate rate with the L-2-hydroxyvalerate rate 
shown in Table 6.2, we see that the rate achieved for L-2-hydroxyisovalerate is much 
lower (about 4-fold) than that of L-2-hydroxyvalerate. The reverse is true for the caproate 
substrates, where the turnover of L-2-hydroxyisocaproate is approximately 4-fold greater 
than L-2-hydroxycaproate. It follows therefore, that the most important factor in activity 
of these aliphatic substrates is not the number of carbons in the side chain. A closer 
inspection of the results shows that a much clearer trend is apparent. The rate of turnover 
for L-2-hydroxyisovalerate is much similar to that of L-2-hydroxybutyrate (Figure 6.7a) 
and L-2-hydroxyisocaproate is similar to L-2-hydroxyvalerate (Figure 6.7b). 
Consideration of the structures of the substrates suggests that it is the length of the 
substrate that allows the enzyme to discriminate. There is some evidence that although 
the length of the substrate is important, the initial hypothesis (that filling the active site 
may increase the rate) does hold. The rate constant for L-2-hydroxyisocaproate is about 
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deep in the active site cavity must be responsible for the increase in rate since the lengths 
are the same, i.e. the enzyme is more efficiently using the larger substrate. 
Introducing a branch to a substrate does not seem to have an adverse effect on 
activity. However, a second branch, for example, the tertiary butyl group of 
3,3-dimethyl-2-hydroxybutyrate, abolishes any activity. This is not surprising since a 
phenyl ring (as in mandelate) would bind best in a flat, thin active site. An active site of 
this nature would not accommodate the 3 methyl group. 
L-hexahydromandelate was previously reported to be unreactive and behave as an 
inhibitor of L-mandelate dehydrogenase (Smekal et al., 1993). This work has shown that 
L-hexahydromandelate is a substrate with a kcat value of 7 s_ I and a Km similar to that of 
L-mandelate. It would appear that having a six-membered ring on the substrate is not the 
most important factor. L-mandelate may have additional stabilisation at the active site 
with its aromatic character. it is likely that the 'flatness' of the phenyl ring compared to 
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Figure 6. 7a. For legend see over page. 
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Figure 6.7. Michaelis-Menten plots comparing branched chain 2-hydroxyacids with straight 
chain 2-hydroxyacids. (a) shows the close comparison between L-2-hydroxybulyrate and 
L-2-hydroxyisovalerate. (b) shows that there is a slight discrepancy between the plots of 
L-2-hydroxyvalerate and L-2-hydroxyisocaproate. The k, and K. values can be found in 
Tables 6.1 and 6.2. 
6.5 Conclusion 
Results described in this chapter show that L-mandelate dehydrogenase has a 
more varied substrate specificity than was previously thought. It has an ability to catalyse 
the oxidation of aliphatic 2-hydroxyacids, albeit a great deal slower than aromatic 
substrates. It has been shown that the optimal length of non-aromatic substrate is a 
5-carbon chain. This may allow the substrate to fill the 'hole' in the active site, but 
require 'coiling' of the chain. Branching off C-4 of a 5-carbon chain would seem to go 
further in filling the active site and thus the best substrate tested was 
L-2-hydroxyisocaproate. The 'hole' in the active site is likely to be a flat, thin channel, 
since this would be optimal for binding a phenyl ring tightly. This is shown by the fact 
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that 3,3-dimethyl-2-hydroxybutyate has no activity. The 
3rd  methyl of the tertiary butyl 
group cannot be accommodated. L-hexahydromandelate can be used as a substrate but is 









This thesis describes work carried out on the mandelate dehydrogenase enzymes 
from Rhodotorula graminis. The cloning of the D-mandelate dehydrogenase gene and 
subsequent expression in E. coil allowed attempts to overexpress the protein. The gene 
was successfully cloned into a number of tightly controlled expression vectors. Despite 
this, the protein was never obtained in quantities greater than could be isolated from the 
native host, R. graminis. With only very small quantities of the colourless protein 
available, purification proved difficult. The recombinant form of the protein would not 
purify under the same conditions as the native form. A purification aid (in the form of a 
histidine-tag) was engineered onto both termini of the protein. Purification trials on a 
nickel column failed under both denaturing and non-denaturing conditions, with protein 
washing through the column on loading. The inability to obtain significant amounts of 
pure protein prevented further kinetic characterisation. 
With regard to further work on this enzyme, it would be prudent to attempt 
further overexpression experiments only with a very different expression system. In the 
event of a good expression system being generated, a detailed characterisation of the 
recombinant enzyme would be appropriate to further understand this enzyme and the 
family of NAD-dependent 2-hydroxyacid dehydrogenases. Ideally, the 3-dimensional 
crystal structure of D-mandelate dehydrogenase would be a target, as this would provide 
a structural basis for further characterisation, for example, site directed mutagenesis. 
Expression and purification systems have been developed for L-mandelate 
dehydrogenase and its flavin-binding domain (lilias et ai., 1998). The steady-state kinetic 
parameters for intact enzyme and flavin-binding domain were determined using both an 
artificial electron acceptor (ferricyanide) and the physiological electron acceptor of 
L-mandelate dehydrogenase (cyto chrome c). Using ferricyanide, the kat and K. values 
were indistinguishable, but the flavin-binding domain showed no cyto chrome c reductase 
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activity. This suggests that the haem-binding domain of L-mandelate dehydrogenase is 
essential in the interprotein electron transfer path. 
There was a large discrepancy in the pre-steady-state values between the intact 
enzyme and the flavin-binding domain. The intact enzyme had a rate constant for FMN 
reduction a little over hail that for the flavin domain (the Km values were comparable). 
The low rate for intact enzyme was attributed to rapid reoxidation of flavin. 
Previous work (Smekal et al., 1993) showed L-mandelate dehydrogenase to have 
a steady-state kinetic isotope effect of 1.1 ± 0.1. This has now been disproved in the 
current study, which found a kinetic isotope effect of 3.5 ± 0.2, indicating a significant 
amount of rate determination by C2—H bond breakage. This was further shown by the 
pre-steady-state experiments that showed a kinetic isotope effect of 4.9 ± 1.0. The results 
for the flavin-binding domain were very similar. 
Interestingly, it would appear that L-mandelate may not be the primary 
physiological substrate of L-mandelate dehydrogenase. Both steady-state and 
pre-steady-state experiments (carried out at 5°C) gave much faster rates with 
4-hydroxy-D,L-mandelate than D,L-mandelate. Since 4-hydroxymandelate is more 
prevalent than mandelate in the environment (Fewson, 1988), it is proposed that the 
enzyme is, in fact, a 4-hydroxy-L-mandelate dehydrogenase. 
A Hammett-Taft plot demonstrating the relationship between log k (from 
pre-steady-state kinetics) and the optimum combination of Hammett-Taft parameters 
gave a p (reaction constant) value of 1.51, indicating an electron-rich C2 in the transition 
state. A resonance contribution to the substituent constant (indicted by .) of 0.92 
supports a planar transition state. Both of these values are consistent with the carbanion 
mechanism, although the hydride transfer mechanism cannot be ruled out. 
In contrast to the pre-steady-state data, the steady-state rate constants did not 
demonstrate a linear relationship in a Hammett-Tafi plot. This experiment did not 
measure the rate of substrate oxidation (or FIVIN reduction) as pre-steady-state 
experiments did. The rate was perturbed by other, subsequent rate determining steps 
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when transferring electrons to ferricyanide. For this reason, the Hammett relation did not 
hold. 
L-mandelate dehydrogenase can also turn over aliphatic substrates. The 
steady-state rate constants were between 50 and 500-fold lower than for L-mandelate. 
The broad trend displayed by a selection of long-chain 2-hydroxyacids was that kcat 
increased and Km decreased with increasing chain length. This was clearly expected since 
a longer chain occupies more of the space at the active site. One unexpected result was 
the fact that L-2-hydroxyvalerate (chain length 5) turned over faster than even longer 
chain acids. The reason for this is unclear, but the result was confirmed in a study of the 
branched-chain 2-hydroxyacids. Again, the acid of chain length 5 
(L-2-hydroxyisocaproate) proved to be the best substrate. While the enzyme could 
tolerate one branching point, and even a cyclohexane ring in place of mandelate's phenyl 
ring (L-hexahydromandelate), further branching (as in 3,3 -dimethyl-2-hydroxybutyrate) 
abolished all activity. 
With L-mandelate dehydrogenase and L-lactate dehydrogenase sharing so many 
properties, there is a temptation in future to repeat many experiments of one enzyme with 
the other. This would be of little value to the understanding of flavocytochromes b2. It is 
essential that the 3-dimensional crystal structure of L-mandelate dehydrogenase is 
determined before further characterisation. Any interesting differences in the crystal 
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1. Derivation of the Michaelis-Menten Equation 
The basic equation of enzyme kinetics is the Michaelis-Menten equation and was 
derived from the following scheme: 
k1 	 k2 
E + S 	ES 	> 'E+P 
k..1 	 (1) 
The rate of formation of ES (within the initial period when the product 
concentration is negligible) = k1 [E] [5]. The rate of breakdown of ES back to E and S 
= k 1 [ES]. Using the Michaelis-Menten assumption (that an equilibrium is set up 
between enzyme, substrate and enzyme-substrate complex instantly with product 
formation too slow to disturb the equilibrium): 
k 1 [E][S] = k. 1 [ES] 	(2) 
{E][S]k..IK 	(3) 
[ES] 	k1 
where K is the dissociation constant of ES. 
Since the total enzyme concentration, [E o], is equal to [E] + [ES], or 
rearranging [E] = [Eo] - [ES] 	 (4) 







Rearranging for [ES] = [ES] = [
Eo 
	 (6) 
[5] + Kr.  
From equation (1), we can see that the rate of formation of products is given by the 
following equation: 
uo =k2 [ES] (7) 
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where oo = initial rate of reaction. 




[S] + K5 
When substrate concentration is very high compared to enzyme concentration, all of 
the enzyme is considered to be present as the enzyme-substrate complex. Under these 
conditions, the limiting initial velocity is reached: 
Vmax = k2 [Eo] 	(9) 




Since the initial substrate concentration [So]  is very much greater than the initial 
enzyme concentration [E0], the formation of the enzyme-substrate complex results in 
an insignificant change in [S o] 
V114So] = 1)0= 	 (11) 
[So] + K5 
2. Derivation of the Briggs-Haldane Equation 
This equation modifies the Michaelis-Menten equation by adding a more general 
assumption, i.e. the steady-state approximation is applied to the concentration of the 
enzyme-substrate complex, [ES]. As before, 
k 1 
E + S ;ii 	ES 	> E+P 
k1 (1) 
In the steady-state, ES can breakdown to form products or reactants (rate of 
ES formation remains k1 [E] [5]) 
=> 	k 1 [E][S] = k. 1 [ES] + k2 [ES] = [ES](k 1 + k2) 	(12) 
[E][S]=kI+k2=Km 	 (13) 
 ki [ES]
where K. is another constant. 
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Substituting and rearranging as before (equations (5 and 6)): 
([Eo] - [ES]) [S] 
=> 	 K. 	 (14) 
[ES] 
[Eo][S] 
[ES]= 	 (15) 
[S] + K. 
Substituting equation (15) into (7): 
k2[Eo] [S] (16) 
[S]+Km 




[So] + K. 
The constant, kcat (turnover number) is obtained from V = kat[E0]. For reaction 
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i-Mandelate dehydrogenase from Rhodotorula graminis: cloning, sequencing 
and kinetic characterization of the recombinant enzyme and its 
independently expressed flavin domain 
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institute of Cell and Molecular Biology, University at Edinburgh, Maytield Road, Edinburgh EH9 3JR, Scotland, U.K., and tDepament at Chemistry, University of 
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The L-mandelate dehydrogenase (L-MDH) from the yeast 
Rhodotorula graminis is a mitochondrial flavocytochrome b2 
which catalyses the oxidation of mandelate to phenyiglyoxylate 
coupled with the reduction of cytochrome c. We have used the N-
terminal sequence of the enzyme to isolate the gene encoding this 
enzyme using the PCR. Comparison of the genomic sequence 
with the sequence of cDNA prepared by reverse transcription 
PCR revealed the presence of 11 introns in the coding region. 
The predicted amino acid sequence indicates a close relationship 
with the flavocytochromes b2 from Saccharomyces cerevisiae and 
Hansenula anomala, with about 40% identity to each. The 
sequence shows that a key residue for substrate specificity in S. 
cerevisiae flavocytochrome b2 , Leu-230, is replaced by Gly in L-
MDH. This substitution is likely to play an important part in 
determining the different substrate specificities of the two en-
zymes. We have developed an expression system and purification 
protocol for recombinant L-MDH. In addition, we have expressed 
INTRODUCTION 
Flavocytochrome b2 from the yeasts Saccharomyces cerevisiae 
and Hansenula anomala is a mitochondrial L-lactate dehydro-
genase (L-LDH) that transfers electrons directly to cytochrome c 
[1,2] and enables these organisms to utilize lactate as the sole 
source of carbon and energy [3]. The red yeast, Rhodotorula 
graminis, is one of few microorganisms capable of utilizing L-
mandelate (i-2-hydroxy-2-phenylacetate) as a substrate for 
growth [4,5]. The first enzyme of the catabolic pathway, L-
mandelate dehydrogenase (L-MDH), has been isolated and 
shown to share several features with the L-LDHs (flavocyto-
chromes b2) from S. cerevisiae and H. anomala [6,7]. These 
enzymes all contain FMN and protoporphyrin IX, their sizes are 
very similar and the N-terminal sequences indicate that they may 
be homologues [6]. 
Flavocytochrome b2 from S. cerevisiae is a tetramer of identical 
subunits, each consisting of two distinct domains [8]. The N-
terminal cytochrome domain is related to cytochrome b5 , whereas 
the FMN-containing C-terminal domain has a separate evol-
utionary history, with relatives found in plants, animals and 
bacteria. These relatives all oxidize 2-hydroxyacids, but their 
substrates differ in size, chemical nature and metabolic role. 
Members of this family include the plant peroxisomal glycolate 
oxidase [9], Pseudomonas putida L-MDH [10], Mycobacterium 
smegmatis lactate mono-oxygenase [11] and a long-chain 
2-hydroxyacid dehydrogenase from rat kidney [12]. 
We have reported previously that Leu-230 of S. cerevisiae 
and purified the flavin-containing domain of L-MDH inde-
pendently of its cytochrome domain. Detailed steady-state and 
pre-steady-state kinetic investigations of both L-MDH and its 
independently expressed flavin domain have been carried out. 
These indicate that L-MDH is efficient with both physiological 
(cytochrome c, k0 = 225 s_i at 25 °C) and artificial (ferricyanide, 
= 550 s_i at 25 °C) electron acceptors. Kinetic isotope effects 
with [2- 2H]mandelate indicate that H—C-2 bond cleavage con-
tributes somewhat to rate-limitation. However, the value of the 
isotope effect erodes significantly as the catalytic cycle proceeds. 
Reduction potentials at 25 °C were measured as —120 mY for 
the 2-electron reduction of the flavin and - 10 mV for the 1-
electron reduction of the haem. The general trends seen in the 
kinetic studies show marked similarities to those observed 
previously with the flavocytochrome b2 (L-lactate dehydrogenase) 
from S. cerevisiae. 
fiavocytochrome b2 is a major determinant of substrate specificity 
[13]. The crystal structure [8] shows that this side-chain is in 
contact with the methyl group of pyruvate, the product of lactate 
oxidation. L-Mandelate is not a substrate for this enzyme but 
acts as a competitive inhibitor. It is obvious from modelling 
studies that mandelate cannot be accommodated in an equivalent 
position because of steric interference between the Leu-230 side-
chain and the phenyl ring of mandelate. Sequence and structure 
comparisons show that Leu-230 is replaced by Trp in glycolate 
oxidase [9,14] and Ala in the L-MDH from P. putida [10]. 
Apparently, therefore, a large amino acid side-chain in this 
position correlates with a smaller preferred substrate, whereas a 
smaller side-chain permits access to larger substrates. 
Mechanistic studies with R. graminis L-MDH have shown 
some interesting differences between this enzyme and the L-LDH 
activity of S. cerevisiae flavocytochrome [7,15]. However, studies 
to date with L-MDH have been limited to steady-state experi-
ments, since the enzyme can only be isolated in small quantities 
from R. graminis. We have developed an efficient heterologous 
expression system to enable more detailed investigation of the 
mechanism of this enzyme. Studies with the intact enzyme are 
limited by the fact that spectral changes at the flavin cofactor are 
masked by the intensely absorbing haem group. To resolve this 
problem we have also expressed the flavin domain independently. 
In this paper we describe a detailed kinetic characterization of 
recombinant forms of both wild-type L-MDH and its inde-
pendently expressed flavin domain. 
Abbreviations used: L-MDH, L-mandelate dehydrogenase; L-LDH, L-lactate dehydrogenase; KIE, kinetic isotope ettect; PAL, phenylalanine ammonia 
!yase; RT-PCR, reverse transcription PCR. 
To whom correspondence should be addressed (e-mail Graeme.Reid@ed.ac.uk ). 
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MATERIALS AND METHODS 
Strains and plasmids 
R. graminis GX6000 (American Type Culture Collection 20804) 
was used as a source of RNA and DNA and was maintained, 
grown, harvested and stored as described previously [16]. Esch-
erichia co/i strains TG1, JM109 and NFl were used as hosts for 
recombinant plasmids. The plasmids pTZl9r and pTZ18r were 
used for cloning [17] and the expression vector pRC23 [18] was 
used to direct expression of L-MDH. E. co/i was routinely grown 
in Luna broth supplemented where appropriate with 100 ug m1' 
ampicillin. For expression of recombinant enzyme, growth was 
in Terrific Broth supplemented with 150 ug m1' ampicillin. 
DNA Isolation 
Chromosomal DNA was isolated from a 10 ml of stationary-
phase culture grown in YPD medium [1 % (w/v) yeast extract, 
2% (w/v) peptone and 2% (w/v) glucose]. The cells were 
harvested by centrifugation and resuspended in 1 ml of breakage 
buffer (0.9 M sorbitol/14 mM 2-mercaptoethanol/50 mM so-
dium phosphate buffer, pH 7.5). The cells were then disrupted by 
vortexing with acid-washed glass beads. To this suspension 50 1d 
of 0.5 M EDTA, pH 8.0, was added, vortexed briefly and then 
50 ul of 10% SDS and 100 sl proteinase K solution (5 mg ml- ') 
were added to help lysis. The mixture was mixed well and 
incubated at 65 °C for 30 mm, then extracted with 1: 1 phenol/ 
chloroform and the DNA was precipitated by addition of 0.5 ml 
of absolute ethanol. 
Plasmid DNA and single-stranded plasmid DNA were isolated 
from E. co/i transformants as described previously [19,20]. 
M13K07 was used as helper phage for single-stranded DNA 
production. 
Isolation of RNA 
RNA was isolated from a 100 ml culture of R. graminis grown 
until mid-exponential phase in medium containing D,L-man-
delate. The cells were harvested and resuspended in 1 ml of TNE 
(50 mM Tris/HCI, pH 7.5/100 mM NaCl/5 mM EDTA). Acid-
washed glass beads were used to disrupt the cells with vigorous 
vortexing for 2 mm. Then 4 ml of TNE, 0.2 ml of 20% SDS and 
4 ml of phenol were rapidly added and the suspension was 
vortexed for another 2 mm. The mixture was spun for 15 min to 
separate the phases. The aqueous phase containing RNA was 
removed and extracted with 1: 1 phenol : chloroform until a clear 
interphase was achieved. The upper phase containing the RNA 
was removed and to this 0.1 vol. of 3 M Na acetate, pH 5.5, and 
2 vol. of 100% ethanol were added to precipitate the RNA. 
Before use in reverse transcription (RT)-PCR, contaminating 
DNA was removed from the RNA by treatment with DNaseI. A 
100 Id mixture containing 100 g of total RNA and 10 units of 
DNaseI in 20 mM Tris/HC1, pH 8.4/12 mM MgCl,/50 mM 
KCI was incubated at 37 °C for 1 h. The reaction was stopped by 
heating to 65 °C for 10 min and extraction with phenol/ 
chloroform (1: 1). The RNA was precipitated with ethanol, 
pelleted, dried and dissolved in 50 tl of H 2O. 
First strand cDNA synthesis 
A mixture of 1 zl of oligo(dT), 2 . 18 (500 ig/ml) and 15-20 Itg of 
total R. graminis RNA (treated with DNase) in 10 zl of sterile 
distilled water was heated to 70 °C for 10 min and then quickly 
chilled on ice. The contents of the tube were collected by brief 
centrifugation, mixed with 4 l of 5 x first strand buffer (Gibco-
BRL), 2 ul of 0.1 M dithiothreitol, 2 ul of 5 mM dNTPs and 1 tl 
(200 units) of SuperscriptTM II RNase H - reverse transcriptase 
(Gibco-BRL) and incubated at 37 °C for 1 h. The products were 
used immediately for PCR or stored at —20 'C 
RT-PCR 
Forward primer H 1549 (GGAATTCGAYGCNCARCTNCC-
NGTNAARCA) and reverse primer N7501 (TCGAAGCTITR-
TGYTTNGCNACYTTCNGC) were designed for amplification 
of a short segment of the L-MDH coding sequence using the N-
terminal sequence of the isolated enzyme [6]. Unfractionated R. 
graminis RNA (15 g) was reverse transcribed in a 20 tl reaction 
mixture as described above. PCR was performed in a 50 Itl 
reaction mixture with 15 mM MgCl,, 5 pmol of each primer, 
200 1aM dNTPs and 1 pi of the reverse transcriptase reaction 
products. After denaturing at 94 °C for 2 mm, 40 cycles were 
carried out as follows: 94 °C for 40 s, 52 °C for 1 mm, 72 °C for 
1 mm. The reaction was completed by a further 7 min incubation 
at 72 °C. 
For amplification of the complete L-MDH coding sequence, 
the forward primer Ml (CAACCCGGGATGGATGCTCAG-
CTGCCGGT) and the reverse primer R12 (CGAAGCTTCT-
ACTCGGGCACCCACCG) were used. Reverse transcription 
and PCR were carried out as above, except that the first three 
cycles comprised 40 s at 94 °C, 30 s at 50 °C and 90 s at 72 °C. 
The annealing temperature was then increased to 56 °C for a 
further 35 cycles. 
Construction of R. graminis DNA libraries 
Approx. 10 ug of R. graminis genomic DNA was digested with 
XbaI, SphI, Sac!, BamHI, Hind!!!, PstI and EcoRI and separ-
ated on a 0.8 % agarose gel and transferred to a Hybond-N 
(Amersham) nylon membrane. The membrane was pre-hy-
bridized for 1 h at 65 °C, then hybridization was carried out 
overnight at 65 °C. The probe was prepared from recombinant 
pTZ19r containing the 85 bp product of RT-PCR that had been 
labelled by the random priming method [21]. After washing with 
increasing stringency, the membrane was allowed to dry and 
was autoradiographed at —70 °C. A genomic DNA library was 
constructed by complete digestion of genomic DNA with Hind!!!. 
The resulting fragments were ligated with plasmid pTZl9r that 
had also been cut with Hind!II. About 6000 recombinants were 
screened by hybridization under the same conditions as for 
Southern blotting. 
DNA sequence determination 
The sequences of cDNA and genomic DNA were determined on 
both strands using the dideoxy chain-termination method [22] 
with the Sequenase (U.S. Biochemical Corp.) T7 polymerase. 
Because of the relatively high GC content of R. graminis DNA 
we found it necessary to use the d!TP mixture in place of dGTP, 
but this gave good quality, unambiguous sequence information. 
The complete sequence of each DNA strand was determined 
using a combination of subclones and specifically designed 
internal primers. DNA sequence information was analysed using 
the Wisconsin Package Version 9.0, Genetics Computer Group 
(GCG), Madison, W!, U.S.A. 
Western blotting 
Proteins were separated by SDS/PAGE and electrophoretically 
transferred to a nylon membrane (Hybond-N) as described 
previously [23]. L-MDH was detected using antiserum raised in 
rabbit, followed by horse-radish peroxidase-conjugated goat 
-...------.--------- ........... 
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anti-rabbit IgG (Bio-Rad) as secondary antibody. After washing, 
enzyme activity was visualized using o-dianisidine as substrate. 
Fiavin domain expression 
The L-MDH coding sequence was modified by site-directed 
mutagenesis using the oligonucleotide GATTGGCGGCGAA-
TTCATGGGCAAGAATGC. This introduced an EcoRI cleav-
age site between the sequences encoding the haem- and flavin-
containing domains and places an ATG initiation codon im-
mediately preceding the codon for Gly-99, the first residue of the 
flavin domain. Resulting clones were screened for the intro-
duction of the EcoRI site and the entire flavin domain region was 
sequenced to ensure that no unwanted mutations had been 
introduced. The DNA encoding the flavin domain was trans-
ferred to the expression vector pRC23 as an EcoRl—HindIII 
fragment. The recombinant plasmid was transformed into E. co/i 
JMIO9 cells. Growth and expression were as for the holoenzyme. 
Purification of recombinant i-MDH 
The following buffers were used during the purification pro-
cedure: buffer A, 0.1 M phosphate, pH 7.0; buffer B, 30mM 
phosphate, pH 7.0, with 1 mM L-lactate; buffer C, 10 mM 
Tris/HCI, pH 7.5. Where possible, all manipulations were carried 
out at 4 °C. 
L-MDH was isolated from E. co/i using the following protocol. 
Approx. 25 g of pelleted wet cells (from 5 litres of culture) were 
snap-frozen in liquid nitrogen. The frozen cells were then 
resuspended in 250 ml of buffer A. Lysozyme was added to a 
concentration of approx. 0.2 mg ml' and EDTA to a final 
concentration of 1 mM. The suspension was left stirring for 
60 mm, after which it was centrifuged at 39000g for 10 min to 
remove cell debris. The red supernatant was then applied to a 
DE52 (Whatman) column (10 cm x 4.5 cm) equilibrated in buffer 
The red coloured L-MDH passed straight through the column 
and was collected. At this stage the solution containing the 
enzyme had an A 269 /A 423 ratio of around 8. This solution was 
then dialysed for - 2 h against a 10-fold greater volume of buffer 
After dialysis, the solution was loaded onto a DEAE-Sephacel 
column (20 cm x 3 cm) previously equilibrated with buffer B. 
The L-MDH bound as a tight red band at the top of the column. 
The column was then washed with several volumes of buffer B. 
The enzyme was eluted using a gradient from 0 to 0.3 M NaCl in 
buffer B. Fractions with an A 269/A 423 ratio of 2 (30% pure) 
were collected and pooled. The resulting solution was dialysed 
overnight against a 10-fold greater volume of buffer B. After 
dialysis, the protein was loaded on to a CQ Sepharose (Sigma) 
column (20 cm x 3 cm) equilibrated in buffer B. The column was 
washed with several columns of buffer B and then eluted using an 
identical gradient to that used for the DEAE-Sephacel column. 
Fractions with an A 269/A 423 ratio of < 1.0 (50% pure) were 
pooled and concentrated to 1 ml using a Centriprep 50 (Amicon). 
The concentrated solution was loaded on to an S300-HR 
Sephacryl gel-filtration column (1 in x 2.5 cm) which had been 
previously equilibrated in buffer C. The protein was eluted from 
the column in buffer C and fractions with an A 269 /A 423 ratio of 
0.5 ( 95% pure) were pooled, concentrated, snap-frozen 
and stored in liquid nitrogen. 
Purification of L-MDH-flavin domain 
Purification of the flavin domain was identical with that for the 
holoenzyme, with the exception that the final S300-HR Sephacryl 
gel-filtration column was not necessary. 
Kinetic analysis 
All experiments were carried out at 25±0.1°C in 10mM 
Tris/HCI at pH 7.5, 1 0.10. The buffer was 10 mM HCI 
adjusted to pH 7.5 with Tris and corrected to 10.10 by addition 
of NaCl. Steady-state measurements involving enzymic oxidation 
of L-mandelate were performed using a Shimadzu UV2 101 PC 
spectrophotometer. Cytochrome c (horse type VI; Sigma) or 
ferricyanide (potassium salt; BDH) were used as electron ac-
ceptors as previously described [24]. Pre-steady-state kinetics 
were carried out using an Applied Photophysics SF.I7MV 
stopped-flow spectrophotometer. Measurements of the rates of 
reduction of the cofactors of L-MDH by L-mandelate were 
monitored at 438.3 nm (a haem isosbestic) for the flavin and at 
either 557 or 423 nm for the haem group. Pre-steady-state 
reduction of the L-MDH flavin domain was monitored at 450 nm. 
Collection and analysis of data were as previously described for 
flavocytochrome b2 [24,25]. Measurements of kinetic isotope 
effect (KIE) values were also performed as previously described 
[24]. 
Synthesis of D,L-[2- 2H]mandelate 
D,L-[2- 2H] mandelic acid was prepared as the racemic mixture 
by a method completely different to that reported previously by 
Smékal et al. [7]. Although no special precautions are necessary, 
standard safety procedures (such as the wearing of safety 
spectacles) should be adopted and all operations should be 
carried out in a fume cupboard. Sodium metal (1.6 g, 0.07 mol) 
was carefully dissolved in 10 ml of 2H 20 (99.9% 2H, 9.03 g, 
0.45 mol; Fisher Acros) under a nitrogen atmosphere in a three-
necked flask fitted with condenser. Because of the enormous heat 
development, the flask was cooled with ice. After preparation of 
this solution, 1.15 g (7.56 mmol) of D,L-mandelic acid was added 
and this mixture was boiled for 4 h. The nitrogen atmosphere 
was retained while the solution cooled down overnight. The 
following day, 120 ml of 1 M hydrochloric acid was added to the 
reaction mixture to obtain acidic conditions. The crude product 
was extracted four times with 30 ml portions of ether and the 
organic layer was dried with 10 g of magnesium sulphate for 2 h. 
This solution was filtered and the ether was removed, leaving a 
slightly yellow crude product. Recrystallization was carried out 
with CHC1 3 and cyclohexane and yielded white crystals of DL-[2-
2H]mandelic acid (0.768 g, 5.01 mmol, 66.3% yield) with a 
melting point of 119 °C, in agreement with the literature value 
[26]. The isotopic content of this DL-[2- 2H]mandelic acid was 
determined to be 95% by MS using a KRATOS M. S. 50 TC 
spectrometer. The purity of the compound was further confirmed 
by 'H-NMR and 13C-NMR spectra recorded on a Bruker AC 
Spectrometer (250 MHz). 
Reduction potentials 
The mid-point potentials for the haem and flavin groups of L-
MDH were determined using the intact enzyme and the flavin 
domain respectively. Reduction potentials were measured spec-
trophotometrically using a previously published redox poten-
tiometry method [27]. All experiments were performed at 25 °C 
within a Belle Technology glove box under a nitrogen atmosphere 
with oxygen maintained at <5 p.p.m. Conditions for poten-
tiometric titrations, including mediators, electrodes and protein 
concentrations, were as described previously [28]. Nernst plots 
for both reductive and oxidative titration sequences showed no 
evidence of hysteresis, indicating that the systems were at 
equilibrium during measurements. In the case of the flavin 
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domain, only the potential for the two-electron couple from 
oxidized to reduced could be determined. 
RESULTS AND DISCUSSION 
Isolation of the i-MDH gene 
Fully degenerate oligonucleotide primers based on the N-terminal 
sequence of L-MDH were used to amplify R. graminis cDNA by 
the RT-PCR. The principal product was a fragment of the 
expected size (85 bp). This was cloned in pTZ19r and sequenced. 
Of eight clones that were sequenced, two had the expected coding 
potential. One of these (pLMI) was then used as a probe to 
isolate the entire L-MDH gene from R. graminis DNA. 
Aliquots of R. graminis genomic DNA were cut with various 
restriction enzymes and subjected to Southern blotting. Hybrid-
ization with labelled pLM 1 revealed that the amplified fragment 
1 aagcttgtccccccacccgcctcgaggcacccccggcacgattgacggcacgcatggcggggCCtCCaatcgcac 
76 qctgagcaacacggcgctgcctgcttagctaccagcgcactcaccaatgtcatttgcacgcgtgcgcacagctct 
m 5 1 a r V r t a 1 
151 acgctgccagagagcggcagcttcgcccgcgccgccaaaggtgcaggcgcgccgcttcgcaaacaaagcagcacc 
r C q r a a a S p a pp k v q a r r f a n k a a p 
226 gcacgccagcgcgtcgagcgcaggcagccgagccttccatctcggtcttgcagcaggcgctgccctggccgtcgg 
h a s a s s a g s r a f h 1 g 1 a a g a a 1 a v g 
301 tggagccggagtgagtccttggcctqgcggggagcggaAgaggCgcggtctt9CgCggaCgcgaagctqatcgg 
g a g 	 INTRON1 
376 gctgcttct&ctcagctctacctcttctctcgctctccagtccttctcgatgctcagCtgccggtcaagcaacgc 
gatgctcagctgccggtcaagcaacgc 
1 y ifs r S p vii D A Q L P V K OR 
451 gggcgagcccgcagtatctcggctgccgaggttgcgaagCacaattcgCgcgactCgatgtgggtctgcatcgac 
gggcgagcccgcagtatctcggctgccgaggttgcgaagcacaattCgCgcgactcgatgtgggtctgcatcgac 
G R AR SI S A A E V A K H N S RD SM WV CI 0 
526 gatgaggtctgggagtgcgtatctgccttctaccgagccttcttgtgcacacctgacgacgggcgctccgcagta 
gatgaggtctggga 	 INTRON 2 	 ta 
D E V W D I 
601 tcaccaactttgtcgagcttcacgtqcgtttctcttcaatgcgctgcgctcgtcctctattctgacgtgcgaagg 
tcaccaactttgtcgagcttcac 	 INTRON 3 
TN F V EL H 
676 ctcactcgctcgacctgcagcctggaggcgccaaagtgctcgagcagaatgctggcaaggatgtgaccaaggtCt 
cctggaggcgccaaagtgctcgagcagaatgctggcaaggatgtgaCCaaggtCt 
PG GA K V LEON AG K DV T K V F 
751 tcaagtcgatccacccgccgaaaacgctcgaaaagttcttgacggatgataatttcgtcggacggattgacgtCg 
tcaagtcgatccacccgccgaaaacgctcgaaaagttcttgacggatgataatttcgtcggacggattgacgtCg 
KS I H P P K P L E K F L T D D HF V G R I D V D 
826 acgaggtgaccaagattggcggcggcaagaatgcagaagacttgcgcattgagcaggcgcggaaggagctcagga 
acgaggtgaccaagattggcqgcggcaagaatgcagaagacttgCgCattgagCaggCgCggaaggagCtCagga 
E VT K I G G G K NA ED L RI EQ AR K EL RN 
901 acg tcgagacggtgcgcataccatgccgtccacaccatgttqaacccggaMctaatccctccttcgcaggttgt 
acgtcgagacg 	 INTRON 4 	 gttgt 
V E T V V 
976 ctgcctggacgagttcgaggagatctcgcagaagatcttgtccgagatggcgatggcatactacggaacaggagg 
ctgcctggacgagttcgaggagatctcgcagaagatcttgtccgagatggcgatggCataCtaCggaaCaggag 
CL D EF E El SOK IL SE MA M A Y Y G T GA 
1051 tacqccqctcgtttaatcccacatcggcgccagcctgactgaccttgscattgtoagccgaaacggagcagagta 
INTRON 5 	 ccgaaacggagcaga 
E T EQ T 
1126 ggccgacagaattgctgaggttgctcaacgtatggcgctcacactcgccctcttgcagcgttgcgcgacgaacgc 
INTRON 6 	 cgttgcgcgacgaacgc 
L RD ER 
1201 gaggcgtggcaaagggtccgcttccgtccgcgggtcctgcgcaagatgCgaCacatcgaCaCCaaCaCCaCCttC 
gaggcgtggcaaagggtccgcttccgtccgcgggtcctgcgcaagatgCgaCacatCgaCaCCaaCaCCaCCttC 
E A W OR V R FR PR V L R K MR MID T N T T F 
1276 ctcggcattcccgtacgcttcgtcgttccattgagccaacaagcgcttccgccgcg&gttqgacagaqaaaCtCa 
ctcggcattccc 	 INTRON 7 
L G I P 
1351 tqttqctqccgtqcagactcccctccccatctttgttgctcccgccggCCtcgCtCgtCtCggCcaCCCcgaCgg 
actcccctccccatctttgttgctcccgccggcCtCgCtCgtctCggccacCCCgacgg 
T FL P1 F V A P AG LA R L G H PD G 
Figure 1 For legend see opposite page 
- --- -----.--. ----•.---------.---- -.---.- -------.:--.------ 	 - 	
- 	 -- 
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1426 cgagcaaaatatcgttcgcggcgtcgccaagcacgacatcttgcaagtcgtgtcatcgggcgcaagttgctcgat 
cgagcaaaatatcgttcgcggcgtcgccaagcacgacatcttgcaagtcgtgtcatcgggcgcaagttgctcgat 
EQ N I V R G VA K H DI L Q V VS S GA SCSI 
1501 cgacgagatcttcgaggtgaaggagccagaccagaacctggcgtggcagttctacgtccattcggacaagaagat 
cgacgagatcttcgaggtgaaggagCCagaCCagaaCCtggCgtggCagttCtacgtccattcggacaagaagat 
D El FE V K E PD Q N L A W Q F Y V H S D K K I 
1576 cgcggaggagaagctgaagagggctctcgcgctgggcgcCaaggccatCttcgtcacggtqgacgtgcccgtcct 
cgcggaggagaagctgaagagggCtCtCgCgCtgggCgCCaaggCCatCttCgtCaCggtggaCgtgCCCgtcct 
A E E K L KR A L A L GA K A I F V TV DV P V L 
1651 gggcaagcgcgagcgcgatctcaagctcaaggcgCgCagCCagaaCtacgagcatccgatcgcagcggtacgtct 
gggcaagcgcgagcgcgatCtCaagCtCaaggCgCgCagCCagaaCtaCgagcatCCgatCgCagCg 
G K RE RD L K L K AR SQ N YE H P IA A 
1726 tqcgaattccggttcttttcgcggctgcgactgattc*agtgtgtggcttgcagcaatggaaagcggcaggaagC 
INTRON 8 	 caatggaaagcggcaggaagc 
Q N K A AG S 
1801 aaggtagaggagaccattgccaaacgtggagtgtCCgaCattCcCgaCagtgcgtCctttCCatgCCtCtCaggt 
aaggtagaggagaccattgccaaaCgtggagtgtCCgaCattCCCgaCa 
K V E ET IA KR G V SD I PD T 
1876 cgagccgtcgttgactgctgctgatggatgattttaCcggCagCtgCtCaCatagaCgCcaaCttgaaCtgggat 
INTRON 9 	 ctgctcacatagacgccaacttgaactgggat 
A H I D A N L NW D 
1951 ggttcgcttqctgtc8ctttgCtCtCgCCCtCCgctagCtgaC&CCtCaCCtagaCatCgCttggatC 
g 	 INTRON 10 	 acatcgcttggatc 
D IA WI 
2026 aaggagcgcgctccgggcgtacctatcgtcatCaagggtgtCggatgtgttgaggaCgtCgaaCtggCgaagCaa 
aaggagcgcgctccgggcgtaCCtatCgtCatCaagggtgtCggatgtgttgaggaCgtCgaaCtggCgaagCaa 
K E R A PG V P IV 1KG V G CV ED V EL A K Q 
2101 tatggggcggacggcgttgtcttgqtgcgtCtCatgtctCcttcgCtgcgCtgtctAgctcgcoagtaC&tCcgg 
tatggggcggacggcgttgtcttg 	 INTRON 11 






T H GA R Q L D GA R A P L DV L I E V R R K N P 
2326 cggctcttctcaaggaaatagaagtctacgttgacggacaagcccgccgtggaaccgacgtgctcaaggcactgt 
cggctcttctcaaggaaatagaagtctacgttgaCggaCaagCCCgCCgtggaaCCgaCgtgCtCaaggCaCtgt 
A L L K El E V Y V D G Q AR R G T DV L K AL C 
2401 gcctcggcgcccgcggcgtcggcttcggccgaggattcctctacgcccagtcggcgtacggagcagatggcgttg 
gcctcggcgcccgcggcgtcggcttcggccgaggattcctctacgcccagtcggCgtacggagcagatggcgttg 
L GA R G V G F G R G F L Y A Q S A Y G A D G V D 
2476 acaaggcgatccgcatccttgagaacgagattcagaaCgCaatgCgCCtCCtCggCgCcaaCaCgttggCagatC 
acaaggcgatccgcatccttgagaacgagattcagaaCgCaatgCgCctCCtCggCgcCaacaCgttggCagatC 
K Al R I L E N El Q HAM R L L GA NT L A D L 
2551 ttaagccggaaatggtcgagtgcagcttcccggagcggtgggtgcccgagtagcagttccgttcgtgtggaaCcg 
ttaagccggaaatggtcgagtgcagcttcccggagcggtgggtgCCCgagtag 
K P EM V E CS F P E R WV P E * 
2626 gagttcggtcacgaccattgcaatacacgagcaccgagactgcgattcttgggactttgttgaggctaagcggca 
2701 gactgatgtgaccttcgcaacttgcattccgccgtctgccggaaattcgtacaacggttgcatcccgaatcaagt 
2776 ctgagatgaaaaa 2788 
FIgure 1 Complete sequence at the i-MDH coding region 
The sequence of the genomic DNA (top line) is aligned with the cDNA sequence (second tine), clearly showing the positions of the ten introns in the region encoding the mature enzyme. The 
sequences of these introns (2-11) are shown in bold face, as is the predicted intron 1 which lies upstream of the region amptitied by RT-PCR. The amino acid sequence is shown below the 
cONA sequence, with the predicted mitochondrial targeting sequence in lower case. These sequences have been submitted to the EMBL database with the accession numbers AJ001430 and 
AJOO1 431. 
was contained on a Hindul fragment of 5.5 kb. A library of 
Hind!!! fragments of genomic DNA was constructed in pTZl9r 
and probed under conditions identical with those used for 
Southern blot hybridization. A positive clone (pLM3) was used 
for further DNA sequence analysis (Figure 1). 
Isolation and sequencing of i-MDH cDNA 
The presence of several introns in the L-MDH coding sequence 
was obvious from the presence of in-frame stop codons in the 
genomic DNA. We therefore isolated cDNA to determine the 
sequence of the protein encoded by this gene. This was achieved 
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Introos In the LMDH gene from S. gramuus 
Intron Position 5' branchpoint 2 
1 311-391 GT ....... CTGAT ....... CAG 
2 540-598 GT ....... CTGAC ....... CAG 
3 624-695 GT ....... CTGAC ....... CAG 
4 912-970 GT ....... CTAAT ....... CAG 
5 1050-1107 GT ....... CTGAC ....... CAG 
6 1123-1183 GT ....... CTCAC ....... CAG 
7 1288-1366 GT ....... CTCAT ....... CAG 
8 1717-1779 GT ....... CTGAT ....... CAG 
9 1850-1918 GT ....... CTGAT ....... CAG 
10 1952-2011 GT ....... CTGAC ....... TAG 
11 2125-2249 GT ....... CTTAC ....... CAG 
Introns In PAL genm from S. tondoides and S. rubro 
GT ....... CTGAC ....... CAG 
Introno In S. cerevisiae 
TACTAAC ....... CAG 
FIgure 2 Sequence features of Introns 
The sequences of the 5' and 3' ends and the putative branch points of the 11 introns in the 
L-MDH gene are indicated, along with their positions in the sequence. Sequence numbering is 
as shown in Figure 1. The corresponding sequences for other genes from R/iodotoru/a [32) and 
Saccharomyces cerevisiae [41) are shown for comparison. 
using primers (RI! and R12) that were designed according to the 
known N-terminal sequence of the isolated mature protein and 
the C-terminal sequence predicted from the genomic DNA. The 
latter primer contains a Hind!!! cleavage site and the former was 
designed to incorporate both an XmaI cleavage site and a 
methionine codon immediately preceding the first codon of the 
mature L-MDH coding sequence to allow later expression of the 
cDNA. RT-PCR using these primers yielded a fragment, as 
expected, of approx. 1.5 kb. This was cloned in pTZ18r and 
pTZl9r using the XmaI and Hind!!l sites to yield the recombinant 
plasmids pLM5 and pLM6, which were then used to determine 
the complete sequence of the cDNA (Figure 1). The absence of 
PCR-induced mutations was apparent from the exact corre-
spondence between the cDNA and genomic DNA sequences, 
except for the presence and absence of introns. 
The sequence of the gene from R. graminis encoding L-MDH 
has been determined and compared with the sequence of a 
cDNA encoding the mature polypeptide. The G + C content of 
the cloned DNA is 60% and does not differ significantly between 
coding and non-coding regions. The genomic sequence ap-
parently includes 11 short introns (Figure 2). The locations often 
of these are clearly identified by alignment with the cDNA 
sequence. Since the cDNA extended at the 5' end only as far as 
the start of mature L-MDH, there is no experimental evidence for 
the presence of intron 1 (Figure 1), which lies within the 
presequence coding region. However, the existence of this intron 
and its location as shown are supported by several observations. 
First, intron 1 shares sequence features, discussed below, with 
other introns in this and other Rhodozorula genes. Secondly, no 
in-frame ATG initiation codon is found in the region upstream 
of the sequence encoding the experimentally determined N-
terminal amino acid sequence of mature L-MDH. With the 
intron located as shown, the N-terminal presequence is similar to 
the presequences of flavocytochromes b2 from S. cerevisiae and 
H. anornala [29,30]. 
The genes encoding phenylalanine ammonia lyase (PAL) from 
Rhodosporidiurn toruloides [31] and Rhodotorula rubra [32], both 
of which are close relatives of R. graminis, revealed the presence 
of six and five introns respectively. All introns in both PAL genes 
contain the nucleotides GT at their 5' end and CAG at the 3' end. 
These introns also share the same internal consensus sequence of 
CTGAC, which presumably determines the RNA splicing branch 
point. Introns in the L-MDH gene are similar to introns in the 
PAL genes, with sizes ranging from 59 to 125 bp. All 11 introns 
have the invariant sequence of GT at their 5' ends. Intron 10 has 
the sequence TAG at its 3' end; the other ten introns have the 
consensus sequence CAG. The putative branch-point sequences 
in the introns within the L-MDH gene from R. graminis appear 
to be more variable than those in the PAL genes (Figure 2). 
Takahashi et al. [33] found that introns in the small nuclear RNA 
genes in R. hasegawae are similar to pre-mRNA introns and have 
a consensus internal sequence of CTRAC, where R is a purine (A 
or G). The sequences of introns in the MDH genes indicate even 
greater flexibility in the internal (branch-point) sequence. Only 
four of the eleven introns contain the sequence CTGAC, but all 
contain the sequence CTnAy. We have also noted flexibility in 
the intron sequences of the D-MDH gene from R. graminis 
(R. M.Illias,J. S. Miles, C. A. Fewson, S. K. ChapmanandG. A. 
Reid, unpublished work; EMBL database entry AJ001428). 
Mitochondrial targeting sequence 
L-MDH, like flavocytochromes b2 from S. cerevisiae [34], is 
located in the mitochondrial intermembrane space (A. War-
burton and G. A. Reid, unpublished work). Targeting of flavo-
cytochromes b2 in S. cerevisiae is directed by the N-terminal 
presequence, which is unusually long, consisting of 80 amino 
acid residues [29]. This peptide is removed by two distinct 
proteolytic enzymes during transport to the intermembrane space 
[35,36]. Functionally important features of the presequence 
include a basic N-terminal region and a long uncharged region 
towards the C-terminal end that is thought to span the mito-
chondrial inner membrane. These features are conserved in 
several proteins that are targeted to the intermembrane space 
and are also found in the predicted L-MDH presequence. 
Sequence of mature L-MDH 
The sequence of L-MDH is clearly very similar to the amino acid 
sequences of the L-LDHs from S. cerevisiae and H. anomala. 
These enzymes are all flavocytochromes b2 , which are composed 
of distinct cytochrome and flavoprotein domains, connected by 
a 'hinge' peptide [8,37]. The hinge is relatively poorly conserved, 
as is a surface loop within the flavin-binding domain that is 
apparently rather flexible [30]. The crystal structure of S. 
cerevisiae flavocytochrome b2 shows that the C-terminus, from 
residue 487 to 511, forms an extended structure that contacts 
each of the three other subunits within the homotetramer [8]. In 
L-MDH this C-terminal tail is absent, but this is unlikely to 
indicate a difference in quaternary structure. Removal of residues 
489-511 from S. cerevisiae flavocytochrome b2 by site-directed 
mutagenesis did not have a significant effect on tetramer for-
mation [38]. Furthermore, glycolate oxidase lacks a C-terminal 
tail, but still has a similar 4-fold axis to that found with 
flavocytochrome b2 [15]. Overall, the L-MDH sequence is 
42-43% identical with each of the other flavocytochromes b2 , 
whereas the two L-LDH5 are 60% identical. The flavoprotein 
domain of L-MDH belongs to a family of 2-hydroxyacid dehydro-
genases, members of which have been found in bacteria, plants 
and animals, as well as in fungi. The sequences of several of these 
are aligned in Figure 3. Residues that have been identified, both 
by examination of crystal structures and by biochemical charac-
terization of mutated enzymes, as being important for catalytic 
activity are all conserved in L-MDH. Whereas all enzymes in this 
family are L-2-hydroxyacid dehydrogenases and their catalytic 
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198 	 230 
Scb2 PFYVSATALC XLGNPLEGEK DVARGCGQGV TKVPQMISTL ASCSPEEIIE 
Hab2 PFYISATALA KLGHP.EGEV AIAKGAGR.E. .OVVOMISTL ASCSFDEIAD 
Gox PIMIAPTQ KMA.HP EGEY ATPRAASAA. GTIMTLSSW ATSSVEEVAS 
Mao PICISPTAFH SIAWP.DGEK STAPAAQEA. .NICYVISSY ASYSLEDIVA 
Ndh PLLIGPTGLN GALWP.KGDL A.LARAATKA. .GIPFVLSTA SNNSIEDLAR 
Lox PMFFAPIGVI ALC .AQDGHG DAASAQASAR TGVPYITSTL AVSSLEDIRK 
LctD PVALAPVGLC GMYAR. RGEV QAAKAADAH. GIPF1LSTV SVCPIEEVA. 
IH PIEVAPAGLA RLGHP.DGEO NIVRGVAKH. .DILQVVSSG ASCSIDEIFE 
FIgure 3 Sequence comparison of L(+)-MDH from R. graminis (i-MDH) 
and other 2-hydroxy acid dehydrogenases 
The residue numbering relates to flavocytochrome ti from S. cerevisiae (Scb2). The other 
sequences are: H. anomala flavocytochrome b2 (Hab2), spinach glycolate oxidase (Gox), rat 
hydroxy acid oxidase (Hao), P. putida i-MDH (Mdh), M. smegmatis lactate oxidase (Lox) and 
i-LOU from S coil (LctD). The amino acid sequences are shown in the vicinity of Ala-i 98 and 
Leu-230, the positions of which are indicated by the vertical arrows. 
mechanisms appear to be very similar, at least for substrate 
oxidation, they vary considerably in their substrate selectivities. 
L-MDH has a strong preference for an aromatic substituent at 
the 2-position and is inhibited for example by L-lactate [7]. 
Similarly, L-mandelate inhibits the L-LDH activity of S. cerevisiae 
flavocytochrome b2 . Leu-230 has been identified as a particularly 
critical residue in determining substrate specificity in flavo-
cytochromes b2 . The residue found at this position varies 
considerably within the L-2-hydroxyacid dehydrogenase family 
and there is an inverse correlation between the sizes of the 
substrate side-chain and the amino acid side-chain. This cor-
relation is extended in L-MDH, where the equivalent residue is a 
glycine (Gly-225). Substitution of Leu-230 in S. cerevisiae flavo-
cytochrome b2 by alanine results in an enzyme with a greater 
selectivity towards substrates with a longer aliphatic side-chain, 
such as 2-hydroxyoctanoate [14], clearly demonstrating the 
importance of this residue. Ala-198 in S. cerevisiae flavocyto-
chrome b2 has also been identified as important in determining 
substrate specificity [14], and the equivalent residue in i-MDH is 
a glycine (Gly-195). The function of these residues is demon-
strated more clearly in the accompanying paper [39], with the 
conversion of S. cerevisiae flavocytochrome b2 into an efficient L-
MDH. 
Expression of L-MDH in E. coil 
The L-MDH cDNA was isolated from pLM5 as an XmaI—HindiII 
fragment. This was ligated with the expression plasmid pKK223-
3 that had been cut with the same pair of enzymes to generate 
pLM7. We could not detect L-MDH expression in E. co/i JMIO5 
transformed with this plasmid. The L-MDH cDNA was then 
transferred to theE. co/i expression vector pRC23, which contains 
the bacteriophage k PL  promoter as an EcoRi—Hindili fragment 
isolated from pLM7. The resulting plasmid, pLM8, was used to 
transform E. co/i JM109. Total cell protein from these trans-
formants was subjected to SDS/PAGE and L-MDH was detected 
by Western blotting (results not shown). JMIO9 does not express 
a ci repressor so expression under these conditions was consti-
tutive. We found that levels of L-MDH achieved in this system 
were considerably higher than when pLM8 was used to drive 
inducible expression in E. co/i NFl, which also expresses a 
temperature-sensitive ci repressor (results not shown). 
The purification protocols developed for recombinant L-MDH 
and the independently expressed L-MDH-flavin domain have 
been described in detail in the Materials and methods section. 
Purification data for the preparation of recombinant L-MDH are 
summarized in Table I. These data demonstrate that one can 
Table 1 Purification data for i-MDH 
Details of the purification procedure are described in Materials and methods section. Amounts 
are expressed per litre of culture. 
Purification 
Step Total protein (mg) i-MOH (mg) Yiefd (%) (fold) 
Cell lysate - 1000 140 100 1 
0E52 750 110 79 1.1 
Sephacel -. 250 80 57 1.6 
0 Sepharose - 100 50 36 3.6 
S300 Sephacryf 20 20 14 7.1 
purify L-MDH to homogeneity with a yield of 20 mg from one 
litre of culture. 
Kinetic properties 
The steady-state kinetic parameters for the oxidation of L-
mandelate by both L-MDH and the L-MDH flavin domain are 
listed in Table 2. It is clear that the recombinant form of L-MDH 
can effectively catalyse the oxidation of L-mandelate with both 
physiological (cytochrome c) and artificial (ferricyanide) electron 
acceptors. In fact, with ferricyanide as electron acceptor, the keat 
value found with the recombinant L-MDH holoenzyme 
(550 ± 25 s') is considerably higher than the value previously 
reported for the native enzyme from R. graminis(109±3 s 1 )[7]. 
The lower activity reported for the native enzyme is explained by 
significant activity losses during the much longer purification 
protocol originally used [7]. This activity loss was almost certainly 
due to flavin dissociation from the enzyme, which was at very 
low concentration throughout the preparation. With the recom-
binant enzyme, the more rapid purification procedure and much 
higher concentrations of enzyme minimize flavin dissociation, 
and thus there is little activity loss. 
The values of keat  and  Km  listed in Table 2 are of a similar 
magnitude to those previously reported for the oxidation of L-
lactate by S. cerevisiae flavocytochrome b2 (L-LDH) and its 
independently expressed flavin domain [28,40]. This would be 
consistent with the idea that both these enzymes bind and 
activate their respective hydroxyacid substrates in a similar 
manner. Another similarity between the two enzymes is the fact 
Table 2 Steady-state kinetic parameters for the oxidation of i-mandeiate 
by the L-MDH ho!oenzyme and its independently expressed tlavin domain 
All experiments were at 25 °C in TrisIHCl butter, pH 7.5 ((0.10 M NaCl). Efectron acceptors 
were used at saturating concentrations: 1 mM ferricyanide and 35 uM cytochrome c for the 
holoenzyme and 6 mM ferricyanide for the tlavin domain. Values of k are expressed as 
electrons transferred per second per molecuin of enzyme. Vafues of K. are expressed in 
miflimolar L-mandefate. The L-MDH flavin domain has negligible activity with cytochrome C. ND, 
not determined. 
i-MON holoenzyme 	 i-MON ttavin domain 
Electron acceptor 	/c (s 1 ) 	K. (mM) 	k (s) 	K. (mM) 
Ferricyanide 	550 ± 25 	0.35 ±0.02 	500 ± 50 	0.33 ± 0.02 
Cytochrome c 225 ±15 	0.35±0.05 NO 	ND 
114 	R. Md. Illias and others 
Table 3 Pre-steady-state kinetic parameters and KIE values for the 
reduction of the prosthetic groups in L-MDH by mandelate 
All experiments were at 25 °C in Tris/HCI buffer, pH 7.5 (/0.10 M NaCl). Values for flavin 
reduction were obtained using the L-MDH-flavin domain (to avoid interference from the haem 
absorbances) and for haem using the i-MDH hotoenzyme. Rate constants (kr. flavin reduction; 
k, haem reduction) are expressed as the number of cofactors reduced per second. Therefore 
since reduction of flavin requires two electrons, values of k should be doubted to express them 
in electrons per second. 
Flavin reduction 	 Haem reduction 
k (s_i) 	/ç (mM) 	'ci (s') 	A (mM) 
i-[2-'l-$]Mandelate 	450 (±30)  0.39 (±0.10) 605 (±50) 0.39 (±0.10) 
o, i-[2-'H]Mandetate 340 (± 10) 0.45 (± 0.07) 505 (± 20) 0.49 (± 0.10) 
D, L-[2- 21-l]Mandelate 	81 (±3) 	0.45 (±0.07) 115 (±10) 0.56 (±0.05) 
KIE 	 4.2 (±0.3) 	 4.4 (±0.6) 
that the flavin domain of L-MDH, like its L-LDH counterpart 
[401, has negligible cytochrome c reductase activity. This indicates 
that electron flow from flavin to haem and then onto cytochrome 
c is alike in L-MDH and L-LDH. 
Under pre-steady-state conditions it is possible to determine 
rate constants for the reduction of both the flavin and haem 
groups in L-MDH and these are listed in Table 3. Values for 
haem reduction were determined using the L-MDH holoenzyme. 
Data for flavin reduction, on the other hand, were acquired using 
the L-MDH flavin domain, in order to avoid spectral interference 
from the much more intense haem absorbance. The values from 
Table 3, in combination with steady-state data, allow us to assign 
rate constants to the various steps in the L-MDH catalytic cycle 
as shown in Scheme 1. The rate constants for flavin and haem 
reduction (k and kH,  Table 3) are of a similar order of magnitude 
to those reported for S. cerevisiae flavocytochrome b2 [24] and its 
independently expressed flavin domain [40]. This indicates that 
Mand 	Phe 	 C. 	Cred 	 C. 	C 
F01. 	 Fred. Hox. 	 sq. 	 Hre ox. H01. Hox. F01. Fsq. Hre 
T 
450 s_ i 
605 s' 
225 s' 
Scheme 1 Linear representation of the catalytic cycle of mandelate oxidation and cytochrome c reduction by L-MDH 
Rate constants (25 °C) are reported for the following steps: 1 L-mandelate -. flavin electron transfer (from stopped-f low); 2, L-mandelate -. L-MDl-I-haem electron transfer (from stopped-f low); 
3, L-mandelate -+ cytochrome c electron transfer (from steady-state). Abbreviations: F, oxidized flavin: F, reduced flavin; F, flavin serriiquinone; H, oxidized haem; reduced haem; 
Mand, mandelate; Phe, phenylglyoxylate; C, oxidized cytochrome c; C,, reduced cytochrome c. 
Table 4 Steady.state kinetic parameters and 2H kinetic Isotope effects for the oxidation of D,L-mandelate by the L-MDH and L-MDH flavin domain 
Conditions were as described in Table 2, except that the normal and deuterated substrates were the racernic mixtures. The kinetic isotope effect, KIE, is defined as: 	[Hl/A[2H]. 
L-MOH holoenzyme i-MDH flavin domain 
Substrate (electron acceptor) k 	(s') K. (mM) 	KIE /c 	(5_I) ìç (mM) 	KIE 
0.L-[2- 1 H]Mandelate (ferricyanide) 300 (±10) 0.47 (±0.03) 316 (±19) 0.74 (±0.11) 
0,i-[2-2HlMandelate (ferricyanide) 88 (± 4) 0.53 (± 0.05) 	3.4 (± 0.3) 99 (± 4) 0.79 (± 0.08) 	3.2 (± 0.3) 
o,i-(2- 1 H]Mandelate (cytochrome c) 155 (± 5) 0.78 (± 0.02) ND ND 
o,L-(2- 2H]Mandelate (cytochrome c) 92 (±10) 1.33  (±0.10) 	1.7 (±0.2) ND ND 	 ND 
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the microscopic steps for electron transfer are essentially the 
same in both enzymes. 
Further kinetic characterization of L-MDH involved the 
determination of deuterium KIEs in both steady-state and pre-
steady-state conditions (Tables 3 and 4). To measure these 
isotope effects it was necessary to determine rate constants using 
the racemic mixture, i.e. D,L-mandelate, in order to make the 
comparison with the isotopically labelled racemic substrate D,L-
[2- 2H]mandelate (see the Materials and methods section). The 
KIE values from the steady-state experiments indicate that 
removal of the C-2 hydrogen contributes significantly to rate 
limitation with ferricyanide as electron acceptor, but much less 
so when cytochrome c is used as the acceptor. Such a trend in 
KIE values is similar to that reported previously for lactate 
oxidation by S. cerevisiae flavocytochrome b2 [24]. The obser-
vation of a significant KIE value for L-MDH with ferricyanide as 
acceptor contradicts a previous study [7] in which no isotope 
effect was observed. We believe that various limitations in the 
previous work, e.g. very small amounts of much less active 
enzyme, made the determination of any KIE value very difficult, 
and that these results are now superseded by the present more 
rigorous study. 
Kinetic isotope effects seen in the pre-steady-state lend support 
to the steady-state experiments and indicate a steady erosion of 
the KIE value at each step in the electron-transfer chain, e.g. 
approx. 4 for fiavin and haem reduction, 3 for ferricyanide 
reduction and 2 for cytochrome c reduction. This decrease in 
KIE values parallels observations from studies with S. cerevisiae 
fiavocytochrome b2  [24], lending support to the idea that the 
transition states are comparable in both enzymes. 
Reduction potentials 
Reduction potentials for the haem and flavin groups of L-MDH 
were determined using the holoenzyme and the flavin domain 
respectively. Values at 25 °C and pH 7.5 were measured as 
- 120 ± 10 mV for the two-electron reduction of the flavin group 
and - 10 ± 5 mV for the haem. It was not possible to separate the 
two one-electron couples (i.e. oxidized/semiquinone and 
semiquinone/reduced) for the flavin. These values can be com-
pared with the equivalent ones determined for S. cerevisiae 
flavocytochrome b2  (L-LDH) which are - 17 ± 3 mV for the 
haem group and -78 ± 5 mV for the two-electron reduction of 
the flavin. Thus, although the haem reduction potentials are the 
same within experimental error, there is a significant difference 
between the values for the flavin groups of the two enzymes. This 
difference of some 40 mV indicates that the driving force for the 
electron transfer from fiavin to haem is substantially greater in L-
MDH. This is in line with the fact that the rate constant for haem 
reduction in L-MDH (at 600 s') is faster than that for L-LDH 
(450 s') [24]. 
Conclusions 
The sequence of L-MDH shows a close relationship with other 
fiavocytochromes b2, but the differences in substrate specificity 
may depend on key amino acid residues, particularly Gly-225 
and Gly-195. Using the cloned cDNA, we have developed 
efficient expression systems and purification procedures for both 
the L-MDH holoenzyme and the independent i-MDH fiavin 
domain. Both steady-state and pre-steady-state kinetic measure- 
ments show that the recombinant L-MDH is an efficient L-MDH 
and cytochrome c reductase. The kinetic and potentiometric data 
for L-MDH are in most cases very similar to the analogous L-
LDH from S. cerevisiae, i.e. flavocytochrome b2 . 
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